10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________________________________ 

FORM 10-Q

__________________________________ 

(Mark One)

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2020

or

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from                     to                    

Commission File Number: 001-34452

__________________________________ 

Apollo Commercial Real Estate Finance, Inc.

(Exact name of registrant as specified in its charter)

__________________________________ 

Maryland	27-0467113
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

Apollo Commercial Real Estate Finance, Inc.

c/o Apollo Global Management, Inc.

9 West 57th Street, 43rd Floor,

New York, New York 10019

(Address of principal executive offices) (Zip Code)

(212) 515–3200

(Registrant’s telephone number, including area code)

__________________________________ 

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Common Stock, $0.01 par value	ARI	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of October 25, 2020, there were 140,296,764 shares, par value $0.01, of the registrant’s common stock issued and outstanding.

Table of Contents

	Page
Part I — Financial Information
Item 1. Financial Statements	4
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	35
Item 3. Quantitative and Qualitative Disclosures about Market Risk	50
Item 4. Controls and Procedures	52
Part II — Other Information
Item 1. Legal Proceedings	52
Item 1A. Risk Factors	52
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	54
Item 3. Defaults Upon Senior Securities	54
Item 4. Mine Safety Disclosures	54
Item 5. Other Information	54
Item 6. Exhibits	54

3

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

Apollo Commercial Real Estate Finance, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets (Unaudited)

(in thousands—except share data)

	September 30, 2020		December 31, 2019
Assets:
Cash and cash equivalents	$	438,234	$	452,282
Commercial mortgage loans, net(1)(2)	5,427,945		5,326,967
Subordinate loans and other lending assets, net(2)	1,009,092		1,048,126
Derivative assets, net	13,654		—
Other assets	43,644		52,716
Loan proceeds held by servicer	—		8,272
Total Assets	$	6,932,569	$	6,888,363
Liabilities and Stockholders' Equity
Liabilities:
Secured debt arrangements, net (net of deferred financing costs of $12,746 and $17,190 in 2020 and 2019, respectively)	$	3,465,337	$	3,078,366
Convertible senior notes, net	564,611		561,573
Senior secured term loan, net (net of deferred financing costs of $7,565 and $7,277 in 2020 and 2019, respectively)	484,191		487,961
Accounts payable, accrued expenses and other liabilities(3)	89,222		100,712
Payable to related party	9,927		10,430
Derivative liabilities	—		19,346
Total Liabilities	4,613,288		4,258,388
Commitments and Contingencies (see Note 15)
Stockholders’ Equity:
Preferred stock, $0.01 par value, 50,000,000 shares authorized, Series B, 6,770,393 shares issued and outstanding ($169,260 liquidation preference)	68		68
Common stock, $0.01 par value, 450,000,000 shares authorized, 143,288,347 and 153,537,296 shares issued and outstanding in 2020 and 2019, respectively	1,433		1,535
Additional paid-in-capital	2,739,851		2,825,317
Accumulated deficit	(422,071)		(196,945)
Total Stockholders’ Equity	2,319,281		2,629,975
Total Liabilities and Stockholders’ Equity	$	6,932,569	$	6,888,363

———————

(1) Includes $5,405,220 and $4,852,087 pledged as collateral under secured debt arrangements in 2020 and 2019, respectively

(2) Net of $236,207 CECL Allowances in 2020, comprised of $196,931 Specific CECL Allowance and $39,276 General CECL Allowance. Net of $56,981 provision for loan loss in 2019.

(3) Includes $3,595 of General CECL Allowance related to unfunded commitments on commercial mortgage loans, subordinate loans and other lending assets, net in 2020.

See notes to unaudited condensed consolidated financial statements.

4

Apollo Commercial Real Estate Finance, Inc. and Subsidiaries

Condensed Consolidated Statement of Operations (Unaudited)

(in thousands—except share and per share data)

	Three months ended September 30,				Nine months ended September 30,
	2020		2019		2020		2019
Net interest income:
Interest income from commercial mortgage loans	$	74,522	$	81,136	$	232,018	$	236,880
Interest income from subordinate loans and other lending assets	28,857		43,421		95,491		125,303
Interest expense	(34,824)		(39,341)		(113,527)		(109,147)
Net interest income	68,555		85,216		213,982		253,036
Operating expenses:
General and administrative expenses (includes equity-based compensation of $4,212 and $12,727 in 2020 and $3,889 and $12,084 in 2019, respectively)	(6,624)		(5,839)		(19,580)		(18,564)
Management fees to related party	(9,927)		(10,434)		(30,152)		(30,306)
Total operating expenses	(16,551)		(16,273)		(49,732)		(48,870)
Other income	128		429		1,479		1,431
Realized loss on investments	(1,037)		—		(17,442)		(12,513)
Reversal of (provision for) loan losses(1)	6,342		(35,000)		(151,954)		(20,000)
Foreign currency translation gain (loss)	27,002		(19,129)		(8,388)		(20,012)
Gain (loss) on foreign currency forward contracts (includes unrealized gains (losses) of $(35,076) and $18,356 in 2020 and $16,227 and $12,029 in 2019, respectively)	(34,537)		24,153		32,959		28,619
Loss on interest rate hedging instruments (includes unrealized gains (losses) of $(564) and $14,644 in 2020 and $(10,307) and $(23,420) in 2019, respectively)	(564)		(10,307)		(39,207)		(23,420)
Net income (loss)	$	49,338	$	29,089	$	(18,303)	$	158,271
Preferred dividends	(3,385)		(3,385)		(10,155)		(15,139)
Net income (loss) available to common stockholders	$	45,953	$	25,704	$	(28,458)	$	143,132
Net income (loss) per share of common stock:
Basic	$	0.31	$	0.16	$	(0.20)	$	0.97
Diluted	$	0.31	$	0.16	$	(0.20)	$	0.97
Basic weighted-average shares of common stock outstanding	146,612,313		153,531,678		150,679,773		144,638,237
Diluted weighted-average shares of common stock outstanding	146,612,313		153,531,678		150,679,773		144,638,237
Dividend declared per share of common stock	$	0.35	$	0.46	$	1.10	$	1.38

———————

(1) Comprised of $550 and $(139,950) of Specific CECL Reversal (Allowance) and $5,792 and $(12,004) of General CECL Reversal (Allowance) for the three and nine months ended September 30, 2020, respectively.

See notes to unaudited condensed consolidated financial statements.

5

Apollo Commercial Real Estate Finance, Inc. and Subsidiaries

Condensed Consolidated Statement of Changes in Stockholders’ Equity (Unaudited)

(in thousands—except share and per share data)

	Preferred Stock			Common Stock			Additional Paid-In-Capital		Accumulated Deficit		Total
	Shares	Par		Shares	Par
Balance at January 1, 2020	6,770,393	$	68	153,537,296	$	1,535	$	2,825,317	$	(196,945)	$	2,629,975
Adoption of ASU 2016-13, see Note 2	—	—		—	—		—		(30,867)		(30,867)
Capital increase (decrease) related to Equity Incentive Plan	—	—		503,251	5		(2,236)		—		(2,231)
Repurchase of common stock	—	—		(300,000)	(3)		(2,438)		—		(2,441)
Net loss	—	—		—	—		—		(127,842)		(127,842)
Dividends declared on preferred stock - $0.50 per share	—	—		—	—		—		(3,385)		(3,385)
Dividends declared on common stock - $0.40 per share	—	—		—	—		—		(62,298)		(62,298)
Balance at March 31, 2020	6,770,393	$	68	153,740,547	$	1,537	$	2,820,643	$	(421,337)	$	2,400,911
Capital increase related to Equity Incentive Plan	—	—		82,235	1		4,251		—		4,252
Repurchase of common stock	—	—		(5,495,976)	(55)		(43,783)		—		(43,838)
Net income	—	—		—	—		—		60,201		60,201
Dividends declared on preferred stock - $0.50 per share	—	—		—	—		—		(3,385)		(3,385)
Dividends declared on common stock - $0.35 per share	—	—		—	—		—		(52,635)		(52,635)
Balance at June 30, 2020	6,770,393	$	68	148,326,806	$	1,483	$	2,781,111	$	(417,156)	$	2,365,506
Capital increase related to Equity Incentive Plan	—	—		160	—		4,212		—		4,212
Repurchase of common stock	—	—		(5,038,619)	(50)		(45,472)		—		(45,522)
Net income	—	—		—	—		—		49,338		49,338
Dividends declared on preferred stock - $0.50 per share	—	—		—	—		—		(3,385)		(3,385)
Dividends declared on common stock - $0.35 per share	—	—		—	—		—		(50,868)		(50,868)
Balance at September 30, 2020	6,770,393	$	68	143,288,347	$	1,433	$	2,739,851	$	(422,071)	$	2,319,281

	Preferred Stock			Common Stock			Additional Paid-In-Capital		Accumulated Deficit		Total
	Shares	Par		Shares	Par
Balance at January 1, 2019	13,670,393	$	137	133,853,565	$	1,339	$	2,638,441	$	(130,170)	$	2,509,747
Capital increase (decrease) related to Equity Incentive Plan	—	—		433,426	4		(1,099)		—		(1,095)
Conversions of convertible senior notes for common stock	—	—		1,967,361	20		33,758		—		33,778
Net income	—	—		—	—		—		67,758		67,758
Dividends declared on preferred stock - $0.50 per share	—	—		—	—		—		(6,835)		(6,835)
Dividends declared on common stock - $0.46 per share	—	—		—	—		—		(63,529)		(63,529)
Balance at March 31, 2019	13,670,393	$	137	136,254,352	$	1,363	$	2,671,100	$	(132,776)	$	2,539,824
Capital increase related to Equity Incentive Plan	—	—		27,245	—		4,294		—		4,294
Issuance of common stock	—	—		17,250,000	172		314,985		—		315,157
Redemption of preferred stock	(6,900,000)	(69)		—	—		(172,431)		—		(172,500)
Offering costs	—	—		—	—		(406)		—		(406)
Net income	—	—		—	—		—		61,424		61,424
Dividends declared on preferred stock - $0.50 per share	—	—		—	—		—		(4,919)		(4,919)
Dividends declared on common stock - $0.46 per share	—	—		—	—		—		(71,475)		(71,475)

6

Balance at June 30, 2019	6,770,393	$	68	153,531,597	$	1,535	$	2,817,542	$	(147,746)	$	2,671,399
Capital increase related to Equity Incentive Plan	—	—		159	—		3,889		—		3,889
Offering costs	—	—		—	—		(12)		—		(12)
Net income	—	—		—	—		—		29,089		29,089
Dividends declared on preferred stock - $0.50 per share	—	—		—	—		—		(3,385)		(3,385)
Dividends declared on common stock - $0.46 per share	—	—		—	—		—		(71,470)		(71,470)
Balance at September 30, 2019	6,770,393	68		153,531,756	1,535		2,821,419		(193,512)		2,629,510

See notes to unaudited condensed consolidated financial statements.

7

Apollo Commercial Real Estate Finance, Inc. and Subsidiaries

Condensed Consolidated Statement of Cash Flows (Unaudited)

(in thousands)

	For the nine months ended September 30,
	2020		2019
Cash flows provided by operating activities:
Net income (loss)	$	(18,303)	$	158,271
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Amortization of discount/premium and PIK	(53,670)		(61,949)
Amortization of deferred financing costs	9,652		8,535
Equity-based compensation	12,721		7,084
Provision for loan losses	151,954		20,000
Foreign currency loss	34,225		22,111
Unrealized (gain) loss on derivative instruments	(33,000)		11,391
Realized loss on investments	17,442		12,513
Changes in operating assets and liabilities:
Proceeds received from PIK	—		11,469
Other assets	(6,251)		(4,216)
Accounts payable, accrued expenses and other liabilities	(1,233)		2,462
Payable to related party	(503)		630
Net cash provided by operating activities	113,034		188,301
Cash flows used in investing activities:
New funding of commercial mortgage loans	(457,449)		(1,277,606)
Add-on funding of commercial mortgage loans	(262,193)		(271,720)
New funding of subordinate loans and other lending assets	—		(493,017)
Add-on funding of subordinate loans and other lending assets	(47,627)		(18,323)
Proceeds received from the repayment and sale of commercial mortgage loans	528,782		570,305
Proceeds received from the repayment of subordinate loans and other lending assets	5,122		254,019
Origination and exit fees received on commercial mortgage loans, and subordinate loans and other lending assets, net	6,420		24,524
Increase (decrease) in collateral held related to derivative contracts, net	25,130		(19,830)
Net cash (used in) provided by investing activities	(201,815)		(1,231,648)
Cash flows from financing activities:
Proceeds from issuance of common stock	—		315,157
Redemption of preferred stock	—		(172,500)
Repurchase of common stock	(91,801)		—
Payment of offering costs	—		(153)
Proceeds from secured debt arrangements	1,465,757		1,948,037
Repayments of secured debt arrangements	(1,083,849)		(1,264,223)
Repayments of senior secured term loan principal	(3,750)		(1,250)
Proceeds from issuance of senior secured term loan	—		497,500
Exchanges of convertible senior notes	—		(704)
Payment of deferred financing costs	(8,092)		(11,043)
Other financing activities	(6,494)		—
Dividends on common stock	(186,883)		(197,757)
Dividends on preferred stock	(10,155)		(18,589)
Net cash (used in) provided by financing activities	74,733		1,094,475
Net increase in cash and cash equivalents	(14,048)		51,128
Cash and cash equivalents, beginning of period	452,282		109,806
Cash and cash equivalents, end of period	$	438,234	$	160,934
Supplemental disclosure of cash flow information:
Interest paid	$	100,573	$	96,201
Supplemental disclosure of non-cash financing activities:
Exchange of convertible senior notes for common stock	$	—	$	33,778
Dividend declared, not yet paid	$	54,254	$	74,855
Offering costs payable	$	—	$	200
Loan proceeds held by servicer	$	—	$	3,323
Deferred financing costs, not yet paid	$	2,596	$	5,420
Transfer of proceeds borrowed under secured credit facilities to Barclays Private Securitization	$	782,006	$	—
Restructuring of subordinate loan to commercial mortgage loan	$	68,500	$	—

See notes to unaudited condensed consolidated financial statements.

8

Apollo Commercial Real Estate Finance, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1 – Organization

Apollo Commercial Real Estate Finance, Inc. (together with its consolidated subsidiaries, is referred to throughout this report as the "Company," "ARI," "we," "us" and "our") is a corporation that has elected to be taxed as a real estate investment trust ("REIT") for U.S. federal income tax purposes and primarily originates, acquires, invests in and manages performing commercial first mortgage loans, subordinate financings, and other commercial real estate-related debt investments. These asset classes are referred to as our target assets.

We were formed in Maryland on June 29, 2009, commenced operations on September 29, 2009 and are externally managed and advised by ACREFI Management, LLC (the "Manager"), an indirect subsidiary of Apollo Global Management, Inc. (together with its subsidiaries, "Apollo").

We elected to be taxed as a REIT under the Internal Revenue Code of 1986, as amended, commencing with the taxable year ended December 31, 2009. To maintain our tax qualification as a REIT, we are required to distribute at least 90% of our taxable income, excluding net capital gains, to stockholders and meet certain other asset, income, and ownership tests.

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed consolidated financial statements include our accounts and those of our consolidated subsidiaries. All intercompany amounts have been eliminated. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Our most significant estimates include loan loss allowances. Actual results could differ from those estimates.

These unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019 ("Annual Report"), as filed with the Securities and Exchange Commission (the "SEC"). In the opinion of management, all adjustments (consisting only of normal recurring adjustments) necessary to present fairly our financial position, results of operations and cash flows have been included. Our results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the full year or any other future period.

We currently operate in one reporting segment.

Risks and Uncertainties

During the first quarter of 2020, there was a global outbreak of a novel coronavirus ("COVID-19"), which was declared by the World Health Organization as a pandemic. In response to COVID-19, the United States and numerous other countries have declared national emergencies, which has led to large scale quarantines as well as restrictions to business deemed non-essential. These responses to COVID-19 have disrupted economic activities and could have a continued significant adverse effect on economic and market conditions. As we are still in the midst of the COVID-19 pandemic we are not in a position to estimate the ultimate impact this will have on our business and the economy as a whole. We believe the estimates used in preparing our financial statements and related footnotes are reasonable and supportable based on the best information available to us as of September 30, 2020. The uncertainty surrounding COVID-19 may materially impact the accuracy of the estimates and assumptions used in the financial statements and related footnotes and, as a result, actual results may vary significantly from estimates.

Current Expected Credit Losses ("CECL")

In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-13 "Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments" ("ASU 2016-13"), which we refer to as the "CECL Standard." This update has changed how entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value. The CECL Standard replaced the "incurred loss" approach under existing guidance with an "expected loss" model for instruments measured at amortized cost. The CECL Standard requires entities to record allowances for held-to-maturity debt securities that are deducted from the carrying amount of the assets to present the net carrying value at the amounts expected to be collected on the assets. We continue to record loan specific allowances as a practical expedient under the CECL Standard ("Specific CECL Allowance"), which we apply to assets that are collateral

9

dependent and where the borrower or sponsor is experiencing financial difficulty. In addition, we now record a general allowance in accordance with the CECL Standard on the remainder of the loan portfolio ("General CECL Allowance", and together with the Specific CECL Allowance, "CECL Allowances") on a collective basis by assets with similar risk characteristics.

The CECL Standard requires us to record an allowance for credit losses that are deducted from the carrying amount of our loan portfolio to present the net carrying value at the amounts expected to be collected on the assets. We adopted the CECL Standard through a cumulative-effect adjustment to retained earnings on January 1, 2020. Subsequent changes to the General CECL Allowance are recognized through net income (loss) on our condensed consolidated statement of operations.

The CECL Standard requires an entity to consider historical loss experience, current conditions, and a reasonable and supportable forecast of the macroeconomic environment. The FASB recognizes the weighted average remaining maturity ("WARM") method as an acceptable approach for computing current expected credit losses. We have adopted the WARM method to comply with the CECL Standard in determining a General CECL Allowance for a majority of our portfolio. In the future, we may use other acceptable methods, such as a probability-of-default/loss-given-default method. For loans where we have deemed the borrower/sponsor to be experiencing financial difficulty, we have elected to apply a practical expedient in which the fair value of the underlying collateral is compared to the amortized cost of the loan in determining a Specific CECL Allowance.

In accordance with the WARM method, an annual historical loss rate is applied to the amortized cost of an asset or pool of assets over the remaining expected life. The WARM method requires consideration of the timing of expected future fundings of existing commitments and repayments over each asset’s remaining life. An annual loss factor, adjusted for macroeconomic estimates, is applied over each subsequent period and aggregated to arrive at the General CECL Allowance.

In determining the General CECL Allowance, we considered various factors including (i) historical loss experience in the commercial real estate lending market, (ii) timing of expected repayments and satisfactions, (iii) expected future funding, (iv) capital subordinate to us when we are the senior lender, (v) capital senior to us when we are the subordinate lender, and (vi) our current and future view of the macroeconomic environment. The standard requires the use of significant judgment to arrive at an estimated credit loss. There is significant uncertainty related to future macroeconomic conditions as the result of COVID-19.

We derived an annual historical loss rate based on a commercial mortgage backed securities ("CMBS") database with historical losses from 1998 through the third quarter of 2020 provided by a third party, Trepp LLC. We applied various filters to arrive at a CMBS dataset most analogous to our current portfolio from which to determine an appropriate historical loss rate. The annual historical loss rate was further adjusted to reflect our expectations of the macroeconomic environment for a reasonable and supportable forecast period which we have determined to be one year.

The General CECL Allowance on subordinate loans is calculated by incorporating both the loan balance of the position(s) of the structurally senior third-party lender(s) and the balance of our subordinate loan(s). The subordinate loans, by virtue of being the first loss position, are required to absorb losses prior to the senior position(s) being impacted, resulting in a higher percentage allowance attributable to the subordinate loan. The General CECL Allowance on unfunded loan commitments is time-weighted based on our expected commitment to fund such obligations. The General CECL Allowance on unfunded commitments is recorded as a liability on our condensed consolidated balance sheet within accounts payable, accrued expenses and other liabilities. At adoption, the General CECL Allowance was $30.9 million and was recorded in our condensed consolidated statement of changes in stockholders’ equity.

Refer to "Note 4 - Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net" for further information regarding CECL.

Secured Debt Arrangements

Secured debt arrangements are accounted for as financing transactions, unless they meet the criteria for sale accounting. Loans financed through a secured debt arrangement remain on our balance sheet as an asset and cash received from the purchaser is recorded on our condensed consolidated balance sheet as a liability. Interest incurred in accordance with secured debt arrangements is recorded as interest expense.

During the second quarter of 2020, we entered into a private securitization with Barclays Bank, plc (the "Barclays Private Securitization"). We have determined that the issuer of this securitization, ACRE Debt 2 PLC, is a Variable Interest Entity ("VIE") of which we were deemed to be the primary beneficiary and therefore, we consolidated the operations of this entity for GAAP. The collateral assets of the securitization are included in commercial mortgage loans, net on our condensed consolidated balance sheet. The liabilities of the securitization to the senior noteholders, excluding the notes held by us, are included in secured debt arrangements, net on our condensed consolidated balance sheet.

10

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06 "Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity" ("ASU 2020-06"). The intention of ASU 2020-06 is to address the complexities in accounting for certain financial instruments with a debt and equity component. Under ASU 2020-06, the number of accounting models for convertible notes will be reduced and entities that issue convertible debt will be required to use the if-converted method for the computation of diluted "Earnings per share" under ASC 260. ASC 2020-06 is effective for fiscal years beginning after December 15, 2021 and may be adopted through either a modified retrospective method of transition or a fully retrospective method of transition. We are currently assessing the impact this guidance will have on our condensed consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04 “Reference Rate Reform (Topic 848) – Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional expedients and exceptions for applying GAAP to debt instruments, derivatives, and other contracts that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform. This guidance is optional and may be elected through December 31, 2022 using a prospective application on all eligible contract modifications. We have loan agreements, debt agreements, and an interest rate cap that incorporate LIBOR as a referenced interest rate. It is difficult to predict what effect, if any, the phase-out of LIBOR and the use of alternative benchmarks may have on our business or on the overall financial markets. We have not adopted any of the optional expedients or exceptions through September 30, 2020, but will continue to evaluate the possible adoption of any such expedients or exceptions.

Note 3 – Fair Value Disclosure

GAAP establishes a hierarchy of valuation techniques based on the observability of the inputs utilized in measuring financial instruments at fair values. Market-based or observable inputs are the preferred source of values, followed by valuation models using management's assumptions in the absence of market-based or observable inputs. The three levels of the hierarchy as noted in ASC 820 "Fair Value Measurements and Disclosures" are described below:

Level I — Quoted prices in active markets for identical assets or liabilities.

Level II — Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants would use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others.

Level III — Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used.

While we anticipate that our valuation methods will be appropriate and consistent with valuation methods used by other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. We will use inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced.

The estimated fair values of our derivative instruments are determined using a discounted cash flow analysis on the expected cash flows of each instrument. Our derivative instruments are classified as Level II in the fair value hierarchy.

The fair values of foreign exchange forwards are determined by comparing the contracted forward exchange rate to the current market exchange rate. The current market exchange rates are determined by using market spot rates, forward rates and interest rate curves for the underlying countries.

The fair value of interest rate swaps is determined by comparing the present value of remaining fixed payments to the present value of expected floating rate payments based on the forward one-month London Inter-bank Offered Rate ("LIBOR") curve. As of September 30, 2020, we had no interest rate swaps on our condensed consolidated balance sheet.

The fair value of our interest rate cap is determined by using the market standard methodology of discounting the future expected cash receipts that would occur if variable interest rates rise above the strike rate of the interest rate cap. The variable interest rates used in the calculation of projected receipts on the interest rate cap are based on a third party expert's expectation of future interest rates derived from observable market interest rate curves and volatilities.

11

The following table summarizes the levels in the fair value hierarchy into which our derivative assets were categorized as of September 30, 2020 and December 31, 2019 ($ in thousands): 

	Fair Value as of September 30, 2020								Fair Value as of December 31, 2019
	Level I		Level II		Level III		Total		Level I		Level II		Level III		Total
Foreign currency forward, net	$	—	$	13,481	$	—	$	13,481	$	—	$	—	$	—	$	—
Interest rate cap	—		173		—		173		—		—		—		—
Total financial instruments assets	$	—	$	13,654	$	—	$	13,654	$	—	$	—	$	—	$	—

The following table summarizes the levels in the fair value hierarchy into which our derivative liabilities were categorized as of September 30, 2020 and December 31, 2019 ($ in thousands): 

	Fair Value as of September 30, 2020								Fair Value as of December 31, 2019
	Level I		Level II		Level III		Total		Level I		Level II		Level III		Total
Foreign currency forward, net	$	—	$	—	$	—	$	—	$	—	$	4,876	$	—	$	4,876
Interest rate swap liability	—		—		—		—		—		14,470		—		14,470
Total financial instrument liabilities	$	—	$	—	$	—	$	—	$	—	$	19,346	$	—	$	19,346

12

Note 4 – Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net

Our loan portfolio was comprised of the following at September 30, 2020 and December 31, 2019 ($ in thousands):

Loan Type	September 30, 2020		December 31, 2019
Commercial mortgage loans, net (1)	$	5,427,945	$	5,326,967
Subordinate loans and other lending assets, net	1,009,092		1,048,126
Carrying value, net	$	6,437,037	$	6,375,093

  ———————

(1)Includes $156.4 million and $126.7 million in 2020 and 2019, respectively, of contiguous financing structured as subordinate loans.

Our loan portfolio consisted of 95% floating rate loans, based on amortized cost, as of September 30, 2020 and December 31, 2019, respectively.

Activity relating to our loan portfolio, for the nine months ended September 30, 2020, was as follows ($ in thousands):

	Principal Balance		Deferred Fees/Other Items (1)		Specific Provision for Loan Loss		Carrying Value, Net
December 31, 2019	$	6,467,842	$	(35,768)	$	(56,981)	$	6,375,093
New loan fundings	457,449		—		—		457,449
Add-on loan fundings (2)	309,820		—		—		309,820
Loan repayments and sales	(543,535)		—		—		(543,535)
Gain (loss) on foreign currency translation	(15,060)		543		—		(14,517)
Specific CECL Allowance	—		—		(139,950)		(139,950)
Realized loss on investment	(20,569)		3,127		—		(17,442)
Deferred fees	—		(6,027)		—		(6,027)
PIK interest and amortization of fees	38,197		17,225		—		55,422
September 30, 2020	$	6,694,144	$	(20,900)	$	(196,931)	$	6,476,313
General CECL Allowance (3)							(39,276)
Carrying value, net							$	6,437,037

———————

(1)Other items primarily consist of purchase discounts or premiums, cost recovery interest, exit fees and deferred origination expenses.

(2)Represents fundings for loans closed prior to 2020.

(3)$3.6 million of the General CECL Allowance is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheet.

The following table details overall statistics for our loan portfolio at the dates indicated ($ in thousands):

	September 30, 2020			December 31, 2019
Number of loans	70			72
Principal balance	$	6,694,144		$	6,467,842
Carrying value, net	$	6,437,037		$	6,375,093
Unfunded loan commitments (1)	$	1,426,404		$	1,952,887
Weighted-average cash coupon (2)	5.6		%	6.5		%
Weighted-average remaining fully-extended term (3)	2.9 years			3.3 years
Weighted-average expected term (4)	2.0 years			1.8 years

———————

(1)Unfunded loan commitments are funded to finance construction costs, tenant improvements, leasing commissions, or carrying costs. These future commitments are funded over the term of each loan, subject in certain cases to an expiration date.

(2)For floating rate loans, based on applicable benchmark rates as of the specified dates. For loans placed on non-accrual or cost recovery the interest rate used in calculating weighted-average cash coupon is 0%.

(3)Assumes all extension options are exercised.

13

(4)Expected term represents our estimated timing of repayments as of September 30, 2020 and December 31, 2019, respectively.

Property Type

The table below details the property type of the properties securing the loans in our portfolio at the dates indicated ($ in thousands):

	September 30, 2020				December 31, 2019
Property Type	Carrying Value		% of Portfolio(1)		Carrying Value		% of Portfolio
Office	$	1,832,607	28.3	%	$	1,401,400	22.0	%
Hotel	1,578,614		24.4		1,660,162		26.0
Residential-for-sale: construction	894,610		13.8		692,816		10.9
Residential-for-sale: inventory	150,015		2.3		321,673		5.1
Urban Retail	636,308		9.8		643,706		10.1
Urban Predevelopment	295,728		4.6		409,864		6.4
Healthcare	363,170		5.6		371,423		5.8
Industrial	228,674		3.5		227,940		3.6
Other	496,587		7.7		646,109		10.1
Total	$	6,476,313	100.0	%	$	6,375,093	100.0	%
General CECL Allowance (2)	(39,276)
Carrying value, net	$	6,437,037

———————

(1)Percentage of portfolio calculations are made prior to consideration of General CECL Allowance.

(2)$3.6 million of the General CECL Allowance is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheet.

Geography

The table below details the geographic distribution of the properties securing the loans in our portfolio at the dates indicated ($ in thousands):

	September 30, 2020				December 31, 2019
Geographic Location	Carrying Value		% of Portfolio(1)		Carrying Value		% of Portfolio
New York City	$	2,393,012	37.0	%	$	2,167,487	34.0	%
Northeast	138,448		2.1		110,771		1.7
United Kingdom	1,179,761		18.2		1,274,390		20.0
West	741,971		11.5		728,182		11.4
Midwest	556,011		8.6		614,337		9.6
Southeast	576,420		8.9		564,166		8.9
Other	890,690		13.7		915,760		14.4
Total	$	6,476,313	100.0	%	$	6,375,093	100.0	%
General CECL Allowance (2)	(39,276)
Carrying value, net	$	6,437,037

———————

(1)Percentage of portfolio calculations are made prior to consideration of General CECL Allowance.

(2)$3.6 million of the General CECL Allowance is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheet.

Risk Rating

We assess the risk factors of each loan and assign a risk rating based on a variety of factors, including, without limitation, loan-to-value ratio ("LTV"), debt yield, property type, geographic and local market dynamics, physical

14

condition, cash flow volatility, leasing and tenant profile, loan structure and exit plan, and project sponsorship. This review is performed quarterly. Based on a 5-point scale, our loans are rated "1" through "5," from less risk to greater risk, which ratings are defined as follows:

    1.    Very low risk

    2.    Low risk

    3. Moderate/average risk

    4. High risk/potential for loss: a loan that has a risk of realizing a principal loss

    5. Impaired/loss likely: a loan that has a high risk of realizing principal loss, has incurred principal loss or an impairment has been recorded

The following tables allocate the carrying value of our loan portfolio based on our internal risk ratings and date of origination at the dates indicated ($ in thousands):

September 30, 2020
						Year Originated
Risk Rating	Number of Loans	Total		% of Portfolio		2020		2019		2018		2017		2016		Prior
1	—	$	—	—	%	$	—	$	—	$	—	$	—	$	—	$	—
2	1	32,000		0.5	%	—		—		—		—		—		32,000
3	62	6,035,647		93.2	%	450,119		2,685,060		1,350,949		815,789		88,685		645,045
4	—	—		—	%	—		—		—		—		—		—
5	7	408,666		6.3	%	—		—		28,872		137,798		114,910		127,086
Total	70	$	6,476,313	100.0	%	$	450,119	$	2,685,060	$	1,379,821	$	953,587	$	203,595	$	804,131
General CECL Allowance		(39,276)
Total carrying value, net		$	6,437,037
Weighted Average Risk Rating		3.1

December 31, 2019
						Year Originated
Risk Rating	Number of Loans	Total		% of Portfolio		2019		2018		2017		2016		2015		Prior
1	—	$	—	—	%	$	—	$	—	$	—	$	—	$	—	$	—
2	8	348,324		5.5	%	—		241,676		—		36,250		24,546		45,852
3	61	5,707,555		89.5	%	2,736,825		1,355,014		912,636		72,540		499,700		130,840
4	1	182,910		2.9	%	—		—		—		182,910		—		—
5	2	136,304		2.1	%	—		—		—		—		—		136,304
Total	72	$	6,375,093	100.0	%	$	2,736,825	$	1,596,690	$	912,636	$	291,700	$	524,246	$	312,996
Weighted Average Risk Rating		3.0

Current Expected Credit Losses

Refer to the following schedule of the General CECL Allowance as of September 30, 2020, and as of the date of adoption, January 1, 2020 ($ in thousands):

	September 30, 2020		January 1, 2020(1)
Commercial mortgage loans, net	$	20,161	$	12,149
Subordinate loans and other lending assets, net	19,115		15,630
Unfunded commitments(2)	3,595		3,088
Total General CECL Allowance	$	42,871	$	30,867

15

 ———————

(1)As of January 1, 2020, we adopted the CECL Standard through a cumulative-effect adjustment to retained earnings

(2)The General CECL Allowance on unfunded commitments is recorded as a liability on our condensed consolidated balance sheet within accounts payable, accrued expenses and other liabilities

In assessing the General CECL Allowance, we consider macroeconomic factors, including unemployment rate, commercial real estate prices, and market liquidity. We compared the historical data for each metric to historical commercial real estate losses in order to determine the correlation of the data. We used projections, obtained from third-party service providers, of each factor to approximate the impact the macroeconomic outlook may have on our loss rate.

The General CECL Allowance increased by $12.0 million from initial adoption on January 1, 2020, to September 30, 2020. The increase is primarily related to a change in our view of estimated future macroeconomic conditions in the backdrop of the global COVID-19 pandemic and an increase in our view of the remaining expected term of our loan portfolio as of September 30, 2020.

The General CECL Allowance decreased by $5.8 million in the quarter ended September 30, 2020. The decrease is primarily related to an improved view of estimated future macroeconomic conditions since the prior quarter end.

Although our secured debt obligations and senior secured term loan financing have a minimum tangible net worth maintenance covenant, the General CECL Allowance has no impact on these covenants as we are permitted to add back the General CECL Allowance for the computation of tangible net worth as defined in the respective agreements.

We have made an accounting policy election to exclude $38.4 million accrued interest receivable, included in Other Assets on our condensed consolidated balance sheet, from the amortized cost basis of the related commercial mortgage loans and subordinate loans and other lending assets in determining the General CECL Allowance as any uncollected accrued interest receivable is written off in a timely manner. We discontinue accruing interest on loans if we deem the interest to be uncollectible with any previously accrued uncollected interest on the loan charged to interest income in the same period. Under certain circumstances, we may apply the cost recovery method under which interest collected on a loan is a reduction to its amortized cost. The amortized cost basis for loans on cost recovery was $408.7 million and $136.3 million as of September 30, 2020 and December 31, 2019, respectively. For the three and nine months ended September 30, 2020, we received $0.3 million and $1.6 million, respectively, in interest that reduced amortized cost under the cost recovery method. Accrued interest is past due for 90 or more days for loans with an amortized cost basis of $408.7 million and $136.3 million as of September 30, 2020 and December 31, 2019, respectively.

The following schedule illustrates the quarterly changes in the CECL Allowance since we adopted the CECL Standard on January 1, 2020 ($ in thousands):

		Specific CECL Allowance(1)		General CECL Allowance						Total CECL Allowance		CECL Allowance as % of Amortized Cost
				Funded		Unfunded		Total				General		Total
December 31, 2019		$56,981		$	—	$	—	$	—	$	56,981	—	%	—	%
Changes:
	January 1, 2020 - Adoption of CECL Standard	—		27,779		3,088		30,867		30,867
	Q1 Allowances	150,000		30,494		2,971		33,465		183,465
March 31, 2020		$	206,981	$	58,273	$	6,059	$	64,332	$	271,313	1.08	%	4.05	%
Changes:
	Q2 Allowances (Reversals)	5,500		(13,729)		(1,940)		(15,669)		(10,169)
	Realized Loss	(15,000)		—		—		—		(15,000)
June 30, 2020		$	197,481	$	44,544	$	4,119	$	48,663	$	246,144	0.81	%	3.71	%
Changes:
	Q3 Reversals	(550)		(5,268)		(524)		(5,792)		(6,342)
September 30, 2020		$	196,931	$	39,276	$	3,595	$	42,871	$	239,802	0.71	%	3.59	%

 ———————

(1)As of December 31, 2019, amount represents specific loan loss provisions recorded on assets before the adoption of the CECL Standard. After the adoption of the CECL Standard on January 1, 2020, amounts represent Specific CECL Allowances.

16

Specific CECL Allowance

We regularly evaluate the extent and impact of any credit migration associated with the performance and/or value of the underlying collateral property as well as the financial and operating capability of the borrower/sponsor on a loan by loan basis. Specifically, a property’s operating results and any cash reserves are analyzed and used to assess (i) whether cash from operations is sufficient to cover the debt service requirements currently and into the future, (ii) the ability of the borrower to refinance the loan and/or (iii) the liquidation value of the underlying collateral. We also evaluate the financial wherewithal of any loan guarantors as well as the borrower’s competency in managing and operating the properties. In addition, we consider the overall economic environment, real estate sector and geographic sub-market in which the borrower operates. Such impairment analysis is completed and reviewed by asset management and finance personnel who utilize various data sources, including (i) periodic financial data such as debt service coverage ratio, property occupancy, tenant profile, rental rates, operating expenses, the borrower’s exit plan, and capitalization and discount rates, (ii) site inspections and (iii) current credit spreads and discussions with market participants.

We evaluate our loans on a quarterly basis. For loans where we have deemed the borrower/sponsor to be experiencing financial difficulty, we have elected to apply a practical expedient in accordance with the CECL Standard. In accordance with the practical expedient approach, we determine the loan loss provision to be the difference between the fair value of the underlying collateral and the carrying value of the loan (prior to the loan loss provision). When the repayment or satisfaction of a loan is dependent on a sale, rather than operations, of the collateral, the fair value is adjusted for the estimated cost to sell the collateral. The fair value of the underlying collateral is determined by using method(s) such as discounted cash flow, the market approach, or direct capitalization approach. The key unobservable inputs used to determine the fair value of the underlying collateral may vary depending on the information available to us and market conditions as of the valuation date.

We evaluate modifications to our loan portfolio to determine if the modifications constitute a troubled debt restructuring ("TDR") and/or substantial modification, under ASC Topic 310 "Receivables". During the second quarter of 2020, one commercial mortgage loan, secured by a hotel in New York City, was restructured and was deemed to be a TDR. In connection with this restructuring, the borrower contributed additional equity of $15.0 million and concurrently we wrote down our principal on this loan by $15.0 million, which had been previously recorded as a Specific CECL Allowance. As of September 30, 2020, the loan had a principal balance and amortized cost of $142.8 million and $144.5 million, respectively, has a risk rating of 3, and is on accrual status. During the three months ended June 30, 2020, the CECL Allowance of $15.0 million was reversed through reversal of loan losses, while the write-down was recorded in realized loss on investments in our condensed consolidated statement of operations.

The following table summarizes the specific provision for loan losses that has been recorded on our portfolio as of September 30, 2020 ($ in thousands):

Type	Property type	Location	Amortized cost(1)		Interest recognition status/ as of date
Mortgage
	Urban Predevelopment(3)	Brooklyn, NY	128,418		Cost Recovery/ 3/1/2020
	Urban Predevelopment(3)	Miami, FL	114,910		Cost Recovery/ 3/1/2020
	Retail Center(4)(5)	Cincinnati, OH	105,561		Cost Recovery/ 10/1/2019
	Hotel(2)	Pittsburgh, PA	28,872		Cost Recovery/ 3/31/2020
	Residential-for-sale: inventory(6)(7)	Bethesda, MD	3,095		Cost Recovery/ 1/1/2018
Mortgage total:			$	380,856
Mezzanine
	Hotel(2)	Washington, DC	18,430		Cost Recovery/ 3/31/2020
	Hotel(8)	Anaheim, CA	9,380		Cost Recovery/ 9/30/2020
Mezzanine total:			$	27,810
Grand total:			$	408,666

———————

(1)Amortized cost is shown net of $196.9 million of net loan loss provisions. During the three and nine months ended September 30, 2020, there was $(0.6) million and $140.0 million in (reversals)/provisions taken due to factors including COVID-19. See Note 2 for additional information regarding COVID-19.

(2)The fair value of hotel collateral was determined by applying a discount rate ranging from 8.5% to 11.0% and a capitalization rate ranging from 7.0% to 9.0%. For the hotel located in Washington, DC, during the three and nine months ended September 30, 2020, there was $0 and $0.2 million of interest paid applied towards reducing the carrying value of the loan, respectively.

(3)The fair value of urban predevelopment collateral was determined by assuming rent per square foot ranging from $48 to $225 and a capitalization rate ranging from 5.0% to 5.5%.

17

(4)The fair value of retail collateral was determined by applying a capitalization rate of 8.3%.

(5)The entity in which we own an interest and which owns the underlying property was deemed to be a VIE and we determined that we are not the primary beneficiary of that VIE. During the three and nine months ended September 30, 2020, $0.4 million and $1.1 million, respectively, of interest paid was applied towards reducing the carrying value of the loan.

(6)Subsequent to September 30, 2020, the remaining collateral on this loan was sold. In connection with the sale of the underlying collateral, a $1.9 million reversal of the previously recognized specific CECL Allowance was recorded during the three months ended September 30, 2020. Refer to "Note 18 - Subsequent Events" for more information.

(7)A $3.0 million portion of this provision was recorded on an investment previously recorded under other assets on our condensed consolidated balance sheet.

(8)The fair value of the hotel, located in Anaheim, California, was determined using the market approach where the fair market value of the underlying collateral, less projected closing costs, was compared to the amortized cost of the loan.

Other Loan and Lending Assets Activity

We recognized payment-in-kind ("PIK") interest of $12.5 million and $37.3 million for the three and nine months ended September 30, 2020, respectively, and $13.7 million and $42.8 million for the three and nine months ended September 30, 2019, respectively.

We recognized $0 and $0.2 million in pre-payment penalties and accelerated fees for the three and nine months ended September 30, 2020, respectively, and $0.3 million and $4.0 million for the three and nine months ended September 30, 2019, respectively.

Our portfolio includes two other lending assets, which are subordinate risk retention interests in securitization vehicles. The underlying mortgages related to our subordinate risk retention interests are secured by a portfolio of properties located throughout the United States. Our maximum exposure to loss from the subordinate risk retention interests is limited to the book value of such interests of $68.1 million as of September 30, 2020. These interests have a weighted average maturity of 6.07 years. We are not obligated to provide, and do not intend to provide financial support to these subordinate risk retention interests. Both interests are accounted for as held-to-maturity and recorded at amortized cost on our condensed consolidated balance sheet.

In January 2020, we sold £62.2 million ($81.3 million assuming conversion into U.S. dollars) in a mezzanine loan and £50.0 million ($65.3 million assuming conversion into U.S. dollars) unfunded commitment of a senior mortgage secured by a mixed-use property in London, UK to a fund managed by an affiliate of the Manager, that was originated by us in December 2019. This transaction was evaluated under ASC 860 - Transfers and Servicing, and we determined that it qualifies as a sale and accounted for it as such. We recorded no gain or loss related to this sale.

In the second quarter of 2020, we sold interests in three construction loans, with aggregate commitments of $376.9 million (of which approximately $127 million was funded at the time of sale). The sales were to entities managed by affiliates of the Manager. In connection with these sales, we agreed to indemnify each buyer on a limited basis for realized losses of up to 10% of the committed amount on each of the loans provided that; (i) the loan is in default on or prior to December 15, 2020 and (ii) the buyer realized a loss from an enforcement action pursuant to the underlying loan agreement on or prior to June 15, 2021. The limited indemnity does not cover a loss on sale of the loan or an unrealized mark-to-market loss. We recorded a loss of approximately $1.4 million in connection with these sales. These transactions were evaluated under ASC 860 - Transfers and Servicing, and we determined that they qualify as sales and accounted for them as such.

In July 2020, we sold our interest in a foreign residential-for-sale inventory loan, with outstanding principal of £97.5 million ($124.2 million assuming conversion into USD). We recorded a loss of approximately $1.0 million in connection with this sale. This transaction was evaluated under ASC 860 - Transfers and Servicing, and we determined that it qualifies as a sale and accounted for it as such.

18

Note 5 – Loan Proceeds Held by Servicer

Loan proceeds held by servicer represents principal payments held by our third-party loan servicer as of the balance sheet date which were remitted to us subsequent to the balance sheet date. There were no loan proceeds held by servicer as of September 30, 2020. Loan proceeds held by servicer were $8.3 million as of December 31, 2019.

Note 6 – Other Assets

The following table details the components of our other assets at the dates indicated ($ in thousands):

	September 30, 2020		December 31, 2019
Interest receivable	$	38,401	$	35,581
Collateral deposited under derivative agreements	1,810		17,090
Other	3,433		45
Total	$	43,644	$	52,716

Note 7 – Secured Debt Arrangements, Net

At September 30, 2020 and December 31, 2019, our borrowings included the following secured debt arrangements, maturities and weighted-average interest rates ($ in thousands):

	September 30, 2020					December 31, 2019
	Maximum Amount of Borrowings(1)		Borrowings Outstanding(1)		Maturity (2)	Maximum Amount of Borrowings(1)		Borrowings Outstanding(1)		Maturity (2)
JPMorgan (USD)	$	1,132,013	$	989,278	June 2024	$	1,154,109	$	1,090,160	June 2024
JPMorgan (GBP)	97,661		97,661		June 2024	51,702		50,410		June 2024
JPMorgan (EUR)	70,326		70,326		June 2024	94,189		94,189		June 2024
DB (USD)	1,000,000		526,743		March 2023	1,250,000		513,876		March 2021
Goldman (USD)	500,000		362,139		November 2021	500,000		322,170		November 2021
CS - USD	378,903		378,781		January 2023(3)	226,068		218,644		June 2020
CS - GBP	—		—		N/A(4)	93,915		93,915		June 2020
HSBC - USD	47,223		47,223		January 2021	50,625		50,625		October 2020
HSBC - GBP	—		—		N/A	34,634		34,634		June 2020
HSBC - EUR	157,148		157,148		July 2021	154,037		154,037		January 2021
Barclays (USD)	200,000		35,192		March 2024	N/A		N/A		N/A
Barclays (GBP)	—		—		N/A(4)	538,916		290,347		February 2024(5)
Barclays (EUR)	—		—		N/A(4)	182,549		182,549		November 2020
Total Secured Credit Facilities	3,583,274		2,664,491			4,330,744		3,095,556
Barclays Private Securitization	813,592		813,592		March 2024(5)	N/A		N/A		N/A
Total Secured Debt Arrangements	4,396,866		3,478,083			4,330,744		3,095,556
less: deferred financing costs	N/A		(12,746)			N/A		(17,190)
Total Secured Debt Arrangements, net(6)(7)(8)	$	4,396,866	$	3,465,337		$	4,330,744	$	3,078,366

———————

(1)As of September 30, 2020, British Pound Sterling ("GBP") and Euros ("EUR") borrowings were converted to U.S. Dollars ("USD") at a rate of 1.29 and 1.17, respectively. As of December 31, 2019, GBP and EUR borrowings were converted at a rate of 1.33 and 1.12, respectively.

(2)Maturity date assumes extensions at our option are exercised with consent of financing providers, where applicable.

(3)Assumes financings are extended in line with the underlying loans.

19

(4)As of September 30, 2020, there are no loans pledged to this facility.

(5)Represents weighted average maturity across various financings with the counterparty. See below for additional details.

(6)Weighted-average borrowing costs as of September 30, 2020 and December 31, 2019 were USD L + 2.15% / GBP L + 1.82% / EUR L + 1.46% and USD L + 2.07% / GBP L + 1.75% / EUR L + 1.36%, respectively.

(7)Weighted average advance rates based on cost as of September 30, 2020 and December 31, 2019 were 64.3% (63.8% (USD) / 67.9% (GBP) / 61.3% (EUR)) and 63.8% (66.7% (USD) / 47.1% (GBP) / 76.1% (EUR)).

(8)As of September 30, 2020 and December 31, 2019, approximately 55% and 54% of the outstanding balance under these secured borrowings were recourse to us.

Each of our existing secured debt arrangements include "credit based and other mark-to-market" features. "Credit mark-to-market" provisions in repurchase facilities are designed to keep the lenders' credit exposure generally constant as a percentage of the underlying collateral value of the assets pledged as security to them. If the credit of the underlying collateral value decreases, the amount of leverage available to us will be reduced as our assets are marked-to-market, which would reduce our liquidity. Generally, the lender under the applicable secured debt arrangement calls for and/or sets the valuation and any revaluation of the collateral assets in its sole, good faith discretion. If it is determined (subject to certain conditions) that the market value of the underlying collateral has decreased by more than a defined minimum amount, the lender may require us to provide additional collateral or may make margin calls, which may require us to repay all or a portion of the funds advanced. We closely monitor our liquidity and intend to maintain sufficient liquidity on our balance sheet in order to meet any margin calls in the event of any significant decreases in asset values. As of September 30, 2020 and December 31, 2019, the weighted average haircut under our secured debt arrangements was approximately 35.7% and 36.2%, respectively. In addition, our existing secured debt arrangements are not entirely term-matched financings and may mature before our commercial real estate debt investments that represent underlying collateral to those financings. We are in frequent dialogue with the lenders under our secured debt arrangements regarding our management of their collateral assets and as we negotiate renewals and extensions of these liabilities, we may experience lower advance rates and higher pricing under the renewed or extended agreements.

JPMorgan Facility

In November 2019, through three indirect wholly-owned subsidiaries, we entered into a Sixth Amended and Restated Master Repurchase Agreement with JPMorgan Chase Bank, National Association (as amended, the "JPMorgan Facility"). The JPMorgan Facility allows for $1.3 billion of maximum borrowings (with amounts borrowed in British pounds and Euros converted to USD for purposes of calculating availability based on the greater of the spot rate as of the initial financing under the corresponding mortgage loan and the then-current spot rate) and matures in June 2022 and has two one-year extensions available at our option, which are subject to certain conditions. The JPMorgan Facility enables us to elect to receive advances in USD, GBP, or EUR. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $1.2 billion (including £75.6 million and €60.0 million assuming conversion into USD) of borrowings outstanding under the JPMorgan Facility secured by certain of our commercial mortgage loans.

DB Facility

In March 2020, through an indirect wholly-owned subsidiary, we entered into a Third Amended and Restated Master Repurchase Agreement with Deutsche Bank AG, Cayman Islands Branch, London Branch (as amended, the "DB Facility"), which provides for advances of up to $1.0 billion for the sale and repurchase of eligible first mortgage loans secured by commercial or multifamily properties located in the United States, United Kingdom and the European Union, and enables us to elect to receive advances in USD, GBP, or EUR. The repurchase facility matures in March 2021, and has two one-year extensions available at our option, subject to certain conditions. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $526.7 million of borrowings outstanding under the DB Facility secured by certain of our commercial mortgage loans.

Goldman Facility

In November 2017, through an indirect wholly-owned subsidiary, we entered into a master repurchase and securities contract agreement with Goldman Sachs Bank USA (the "Goldman Facility"), which provides advances up to $500.0 million and matures in November 2020, and has one one-year extension available at our option, subject to certain conditions. Margin calls may occur any time at specified margin deficit thresholds.

As of September 30, 2020, we had $362.1 million of borrowings outstanding under the Goldman Facility secured by certain of our commercial mortgage loans.

20

CS Facility - USD

In July 2018, through an indirect wholly-owned subsidiary, we entered into a Master Repurchase Agreement with Credit Suisse AG, acting through its Cayman Islands Branch and Alpine Securitization Ltd (the "CS Facility - USD"), which provides for advances for the sale and repurchase of eligible commercial mortgage loans secured by real estate. The CS Facility - USD has an "evergreen" feature such that the facility continues unless terminated at any time by Credit Suisse with six months' notice. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $378.8 million of borrowings outstanding under the CS Facility - USD secured by certain of our commercial mortgage loans.

CS Facility - GBP

In June 2018, through an indirect wholly-owned subsidiary, we entered into a Global Master Repurchase Agreement with Credit Suisse Securities (Europe) Limited (the "CS Facility - GBP"). During the third quarter of 2020, the facility was repaid in connection with the sale of the underlying loan.

HSBC Facility - USD    

In October 2019, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement with HSBC Bank plc (the "HSBC Facility - USD"), which provides for a single asset financing. The facility is scheduled to mature in January 2021. Margin calls may occur any time at specified aggregate margin thresholds.

As of September 30, 2020, we had $47.2 million of borrowings under the HSBC Facility - USD secured by one commercial mortgage loan.

HSBC Facility - GBP

In September 2018, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement with HSBC Bank plc (the "HSBC Facility - GBP"), which provided for a single asset financing. The facility matured and was repaid in June 2020 in connection with the repayment of the underlying loan.

HSBC Facility - EUR

In July 2019, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement with HSBC Bank plc (the "HSBC Facility - EUR"), which provides for a single asset financing. The facility matures in July 2021. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $157.1 million (€134.1 million assuming conversion into USD) of borrowings outstanding under the HSBC Facility - EUR secured by one commercial mortgage loan.

Barclays Facility - USD

In March 2020, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement pursuant to a Master Repurchase Agreement with Barclays Bank plc ("Barclays Facility - USD"). The Barclays Facility - USD allows for $200.0 million of maximum borrowings and initially matures in March 2023 with extensions available at our option, subject to certain conditions. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $35.2 million of borrowings outstanding under the Barclays Facility - USD secured by one commercial mortgage loan.

Barclays Facility - GBP/EUR

Beginning in October 2019, through an indirect wholly-owned subsidiary, we entered into five secured debt arrangements pursuant to a Global Master Repurchase Agreement with Barclays Bank plc (the "Barclays Facility - GBP/EUR"). In June 2020, all assets previously financed pursuant to this facility were refinanced under the Barclays Private Securitization.

21

Barclays Private Securitization

In June 2020, through a newly formed entity, we entered into a private securitization with Barclays Bank plc, of which Barclays Bank plc retained $782.0 million of senior notes. This Barclays Private Securitization finances the loans that were previously financed under the Barclays Facility - GBP/EUR. In addition, we pledged an additional commercial mortgage loan with an outstanding principal balance of £26.0 million and pledged additional collateral of a financed loan of €5.3 million as of June 30, 2020.

The securitization eliminates daily margining provisions and grants us significant discretion to modify certain terms of the underlying collateral including waiving certain loan-level covenant breaches and deferring or waiving of debt service payments for up to 18 months. The securitization includes LTV based covenants with significant headroom to existing levels that are also subject to a six-month holiday through December 2020. These deleveraging requirements are based on significant declines in the value of the collateral as determined by an annual third-party (engaged by us) appraisal process tied to the provisions of the underlying loan agreements. We believe this provides us with both cushion and predictability to avoid sudden unexpected outcomes and material repayment requirements. In addition to the pledge of the additional collateral noted above, we paid down the previous financing by €16.5 million (totaling $18.5 million in USD) and agreed to increase the financing spreads by 0.25%.

The table below provides the borrowings outstanding (on an as converted basis) and weighted-average fully-extended maturities by currency for the assets financed under the Barclays Private Securitization as of September 30, 2020 ($ in thousands):

	Borrowings outstanding	Fully-Extended Maturity(1)
Total/Weighted-Average GBP	$670,024	January 2024
Total/Weighted-Average EUR	143,568	August 2021(2)
Total/Weighted-Average Securitization	$813,592	March 2024

———————

(1)Assumes underlying loans extend to fully extended maturity and extensions at our option are exercised.

(2)The EUR portion of the Barclays Private Securitization has an "evergreen" feature such that the facility continues for one year and can be terminated by either party on certain dates with, depending on the date of notice, a minimum of nine to twelve months' notice.

    The table below provides the assets and liabilities of the Barclays Private Securitization VIE included in our condensed consolidated balance sheet ($ in thousands):

	September 30, 2020
Assets:
Cash	$	921
Commercial mortgage loans, net(1)	1,224,154
Other Assets	9,401
Total Assets	$	1,234,476
Liabilities:
Secured debt arrangements, net (net of deferred financing costs of $0.2 million)	$	813,431
Accounts payable, accrued expenses and other liabilities(2)	1,084
Total Liabilities	$	814,515

———————

(1)Net of the General CECL Allowance of $6.1 million.

(2)Represents General CECL Allowance related to unfunded commitments on commercial mortgage loans, net of $0.3 million.

22

	Three months ended
	September 30, 2020
Net Interest Income:
Interest income from commercial mortgage loans	$	15,075
Interest expense	(4,278)
Net interest income	$	10,797
Provision for loan losses and impairments	$	(2,318)
Foreign currency gain	17,078
Net Income	$	25,557

As of September 30, 2020, we had $813.6 million (£518.6 million and €122.5 million assuming conversion into USD) of borrowings outstanding under the Barclays Private Securitization secured by certain of our commercial mortgage loans.

At September 30, 2020, our borrowings had the following remaining maturities ($ in thousands):

	Less than 1 year		1 to 3 years		3 to 5 years		More than 5 years		Total
JPMorgan	$	45,918	$	432,440	$	678,907	$	—	$	1,157,265
DB	15,594		511,149		—		—		526,743
Goldman	—		362,139		—		—		362,139
CS - USD	94,299		146,994		137,488		—		378,781
HSBC - USD	47,223		—		—		—		47,223
HSBC - EUR	157,148		—		—		—		157,148
Barclays - USD	—		—		35,192		—		35,192
Barclays Private Securitization	143,568		289,769		380,255		—		813,592
Total	$	503,750	$	1,742,491	$	1,231,842	$	—	$	3,478,083

The table above reflects the fully extended maturity date of the facility and assumes facilities with an "evergreen" feature continue to extend through the fully-extended maturity of the underlying asset and assumes underlying loans are extended with consent of financing providers.

The table below summarizes the outstanding balances at September 30, 2020, as well as the maximum and average month-end balances for the nine months ended September 30, 2020 for our borrowings under secured debt arrangements ($ in thousands).

	As of September 30, 2020				For the nine months ended September 30, 2020
	Balance		Amortized Cost of Collateral		Maximum Month-End Balance		Average Month-End Balance
JPMorgan	$	1,157,265	$	1,976,965	$	1,192,288	$	1,106,461
DB	526,743		804,835		526,743		501,470
Goldman	362,139		548,671		362,139		343,882
CS - USD	378,781		523,272		378,781		339,425
CS - GBP	—		—		90,111		57,459
HSBC - USD	47,223		67,203		50,625		48,357
HSBC - GBP	—		—		34,500		32,900
HSBC - EUR	157,148		204,040		160,034		152,982
Barclays - USD	35,192		49,929		35,193		27,372
Barclays - GBP	—		—		666,810		347,590

23

Barclays - EUR	—		—		180,595	94,028
Barclays Private Securitization	813,592		1,230,305		839,563	814,844
Total	$	3,478,083	$	5,405,220

The table below summarizes the outstanding balances at December 31, 2019, as well as the maximum and average month-end balances for the year ended December 31, 2019 for our borrowings under secured debt arrangements ($ in thousands).

	As of December 31, 2019				For the year ended December 31, 2019
	Balance		Amortized Cost of Collateral		Maximum Month-End Balance		Average Month-End Balance
JPMorgan	$	1,234,759	$	1,845,400	$	1,234,759	$	947,400
DB	513,876		766,676		757,117		604,067
Goldman	322,170		513,559		324,821		246,318
CS - USD	218,644		308,884		218,644		182,646
CS - GBP	93,915		129,723		150,811		134,694
HSBC - USD	50,625		66,960		50,625		50,625
HSBC - GBP	34,634		49,976		50,784		42,296
HSBC - EUR	154,037		190,780		154,037		151,889
Barclays - GBP	290,347		738,455		290,347		139,004
Barclays - EUR	182,549		241,674		182,549		181,159
Total	$	3,095,556	$	4,852,087

We were in compliance with the covenants under each of our secured debt arrangements at September 30, 2020 and December 31, 2019.

Note 8 – Senior Secured Term Loan, Net

In May 2019, we entered into a $500.0 million senior secured term loan. The senior secured term loan bears interest at LIBOR plus 2.75% and was issued at a price of 99.5%. The senior secured term loan matures in May 2026 and contains restrictions relating to liens, asset sales, indebtedness, and investments in non-wholly owned entities.

During the three and nine months ended September 30, 2020, we repaid $1.3 million and $3.8 million of principal related to the senior secured term loan, respectively. The outstanding principal balance as of September 30, 2020 and December 31, 2019 was $493.8 million and $497.5 million, respectively. As of September 30, 2020, the senior secured term loan had a carrying value of $484.2 million net of deferred financing costs of $7.6 million and an unamortized discount of $2.0 million. As of December 31, 2019, the senior secured term loan had a carrying value of $488.0 million net of deferred financing costs of $7.3 million and an unamortized discount of $2.3 million.

Covenants

The senior secured term loan includes the following financial covenants: (i) our ratio of total recourse debt to tangible net worth cannot be greater than 3:1; and (ii) our ratio of total unencumbered assets to total pari-passu indebtedness must be at least 1.25:1.

We were in compliance with the covenants under the senior secured term loan at September 30, 2020 and December 31, 2019.

Interest Rate Swap

In connection with the senior secured term loan, we previously entered into an interest rate swap to fix LIBOR at 2.12% effectively fixing our all-in coupon on the senior secured term loan at 4.87%. During the second quarter of 2020 we terminated the interest rate swap and recognized a realized loss of $53.9 million.

Interest Rate Cap

During the second quarter of 2020, we entered into a three-year interest rate cap to cap LIBOR at 0.75%. This effectively limits the maximum all-in coupon on our senior secured term loan to 3.50%. In connection with the interest rate cap, we incurred up-front fees of $1.1 million, which we recorded as a deferred financing cost on our condensed consolidated balance

24

sheet and interest expense will be recognized over the duration of the interest rate cap in our condensed consolidated statement of operations.

Note 9 – Convertible Senior Notes, Net

In two separate offerings during 2014, we issued an aggregate principal amount of $254.8 million of 5.50% Convertible Senior Notes due 2019 (the "2019 Notes"), for which we received $248.6 million, after deducting the underwriting discount and offering expenses. The 2019 Notes were exchanged or converted for shares of our common stock and cash as follows:

(i) On August 2, 2018, we entered into privately negotiated exchange agreements with a limited number of holders of the 2019 Notes pursuant to which we exchanged $206.2 million of the 2019 Notes for an aggregate of (a) 10,020,328 newly issued shares of our common stock, and (b) $39.3 million in cash. We recorded $166.0 million of additional paid-in-capital in our condensed consolidated statement of changes in stockholders' equity in connection with these transactions,

(ii) Certain holders elected to convert $47.9 million of the 2019 Notes, which were settled for an aggregate of (a) 2,775,509 newly issued shares of our common stock, and (b) $0.2 million in cash. We recorded $13.9 million of additional paid-in-capital in our condensed consolidated statement of changes in stockholders' equity in connection with these transactions. These conversions occurred from August 2018 through maturity.

The remaining $0.7 million in principal amount of the 2019 Notes was repaid at maturity on March 15, 2019.

In two separate offerings during 2017, we issued an aggregate principal amount of $345.0 million of 4.75% Convertible Senior Notes due 2022 (the "2022 Notes"), for which we received $337.5 million, after deducting the underwriting discount and offering expenses. At September 30, 2020, the 2022 Notes had a carrying value of $339.7 million and an unamortized discount of $5.3 million.

During the fourth quarter of 2018, we issued $230.0 million of 5.375% Convertible Senior Notes due 2023 (the "2023 Notes" and, together with the 2022 Notes, the "Notes"), for which we received $223.7 million after deducting the underwriting discount and offering expenses. At September 30, 2020, the 2023 Notes had a carrying value of $224.9 million and an unamortized discount of $5.1 million.

The following table summarizes the terms of the Notes ($ in thousands):

	Principal Amount		Coupon Rate		Effective Rate (1)		Conversion Rate (2)	Maturity Date	Remaining Period of Amortization
2022 Notes	$	345,000	4.75	%	5.60	%	50.2260	8/23/2022	1.90
2023 Notes	230,000		5.38	%	6.16	%	48.7187	10/15/2023	3.04
Total	$	575,000

———————

(1)Effective rate includes the effect of the adjustment for the conversion option (See footnote (2) below), the value of which reduced the initial liability and was recorded in additional paid-in-capital.

(2)We have the option to settle any conversions in cash, shares of common stock or a combination thereof. The conversion rate represents the number of shares of common stock issuable per one thousand principal amount of the Notes converted, and includes adjustments relating to cash dividend payments made by us to stockholders that have been deferred and carried-forward in accordance with, and are not yet required to be made pursuant to, the terms of the applicable supplemental indenture.

We may not redeem the Notes prior to maturity except in limited circumstances. The closing price of our common

stock on September 30, 2020 of $9.01 was less than the per share conversion price of the Notes.

In accordance with ASC 470 "Debt," the liability and equity components of convertible debt instruments that may be settled in cash upon conversion (including partial cash settlement) are to be separately accounted for in a manner that reflects the issuer’s nonconvertible debt borrowing rate. GAAP requires that the initial proceeds from the sale of the Notes be allocated between a liability component and an equity component in a manner that reflects interest expense at the interest rate of similar nonconvertible debt that could have been issued by us at such time. We measured the fair value of the debt components of the Notes as of their issuance date based on effective interest rates. As a result, we attributed approximately $15.4 million of the proceeds to the equity component of the Notes ($11.0 million to the 2022 Notes and $4.4 million to the 2023 Notes), which represents the excess proceeds received over the fair value of the liability component of the Notes at the date of issuance. The equity component of the Notes has been reflected within additional paid-in capital in our condensed consolidated balance sheet

25

as of September 30, 2020. The resulting debt discount is being amortized over the period during which the Notes are expected to be outstanding (the maturity date) as additional non-cash interest expense. The additional non-cash interest expense attributable to each of the Notes will increase in subsequent reporting periods through the maturity date as the Notes accrete to their par value over the same period.

The aggregate contractual interest expense was approximately $7.2 million and $21.6 million for the three and nine months ended September 30, 2020, respectively, as compared to $7.2 million and $21.9 million for the three and nine months ended September 30, 2019, respectively. With respect to the amortization of the discount on the liability component of the Notes as well as the amortization of deferred financing costs, we reported additional non-cash interest expense of approximately $1.5 million and $4.5 million for the three and nine months ended September 30, 2020, respectively, as compared to $1.5 million and $4.6 million for the three and nine months ended September 30, 2019, respectively.

Note 10 – Derivatives

We use forward currency contracts to economically hedge interest and principal payments due under our loans denominated in currencies other than USD.

We have entered into a series of forward contracts to sell an amount of foreign currency (GBP and EUR) for an agreed upon amount of USD at various dates through December 2024. These forward contracts were executed to economically fix the USD amounts of foreign denominated cash flows expected to be received by us related to foreign denominated loan investments.

    The following table summarizes our non-designated foreign exchange ("Fx") forwards and our interest rate cap as of September 30, 2020:

	September 30, 2020
	Number of Contracts	Aggregate Notional Amount (in thousands)	Notional Currency	Maturity	Weighted-Average Years to Maturity
Fx contracts - GBP	106	422,585	GBP	October 2020 - December 2024	2.16
Fx contracts - EUR	70	238,817	EUR	November 2020 - August 2024	2.79
Interest rate cap	1	500,000	USD	June 2023	2.71

The following table summarizes our non-designated Fx forwards and our interest rate swap as of December 31, 2019:

	December 31, 2019
	Number of Contracts	Aggregate Notional Amount (in thousands)	Notional Currency	Maturity	Weighted-Average Years to Maturity
Fx contracts - GBP	156	735,349	GBP	January 2020 - December 2024	1.49
Fx contracts - EUR	44	168,879	EUR	February 2020 - August 2024	3.22
Interest rate swap	1	500,000	USD	May 2026	6.37

We have not designated any of our derivative instruments as hedges as defined in ASC 815 - Derivatives and Hedging and, therefore, changes in the fair value of our derivative instruments are recorded directly in earnings. The following table summarizes the amounts recognized on our condensed consolidated statements of operations related to our derivatives for the three and nine months ended September 30, 2020 and 2019 ($ in thousands):

26

		Amount of gain (loss) recognized in income
		Three months ended September 30,				Nine months ended September 30,
	Location of Gain (Loss) Recognized in Income	2020		2019		2020		2019
Forward currency contracts	Unrealized gain (loss) on derivative instruments	$	(35,076)	$	16,227	$	18,356	$	12,029
Forward currency contracts	Realized gain on derivative instruments	539		7,926		14,603		16,590
Total		$	(34,537)	$	24,153	$	32,959	$	28,619

In connection with our senior secured term loan, in May 2019, we entered into an interest rate swap to fix LIBOR at 2.12% or an all-in interest rate of 4.87%. We used our interest rate swap to manage exposure to variable cash flows on our borrowings under our senior secured term loan. Our interest rate swap allowed us to receive a variable rate cash flow based on LIBOR and pay a fixed rate cash flow, mitigating the impact of this exposure. However during the second quarter of 2020, we terminated our interest rate swap due to a significant decrease in LIBOR and recognized a realized loss on the accompanying condensed consolidated statement of operations.

In June 2020, we entered into an interest rate cap for approximately $1.1 million. We use our interest rate cap to manage exposure to variable cash flows on our borrowings under our senior secured term loan by effectively limiting LIBOR from exceeding 0.75%. This effectively limits the maximum all-in coupon on our senior secured term loan to 3.50%. Unrealized gains or losses related to the interest rate swap and cap were recorded net under interest expense in our condensed consolidated statement of operations.

		Amount of loss recognized in income
		Three months ended September 30,				Nine months ended September 30,
	Location of Loss Recognized in Income	2020		2019		2020		2019
Interest rate cap(1)	Unrealized gain (loss) on interest rate cap	$	(564)	$	—	$	174	$	—
Interest rate swap(2)	Unrealized gain (loss) on interest rate swap	—		(10,307)		14,470		(23,420)
Interest rate swap(2)	Realized loss on interest rate swap	—		—		(53,851)		—
Total		$	(564)	$	(10,307)	$	(39,207)	$	(23,420)

———————

(1)With a notional amount of $500.0 million and $0 at September 30, 2020, and 2019, respectively.

(2)With a notional amount of $0 and $500.0 million at September 30, 2020, and 2019, respectively.

The following tables summarize the gross asset and liability amounts related to our derivatives at September 30, 2020 and December 31, 2019 ($ in thousands)

	September 30, 2020						December 31, 2019
	Gross Amount of Recognized Assets		Gross Amounts Offset in our Condensed Consolidated Balance Sheet		Net Amounts of Assets Presented in our Condensed Consolidated Balance Sheet		Gross Amount of Recognized Assets		Gross Amounts Offset in our Condensed Consolidated Balance Sheet		Net Amounts of Assets Presented in our Condensed Consolidated Balance Sheet
Forward currency contracts	$	20,788	$	(7,307)	$	13,481	$	—	$	—	$	—
Interest rate cap	173		—		173		—		—		—
Total	$	20,961	$	(7,307)	$	13,654	$	—	$	—	$	—

27

	September 30, 2020						December 31, 2019
	Gross Amount of Recognized Liability		Gross Amounts Offset in our Condensed Consolidated Balance Sheet		Net Amounts of Liability Presented in our Condensed Consolidated Balance Sheet		Gross Amount of Recognized Liabilities		Gross Amounts Offset in our Condensed Consolidated Balance Sheet		Net Amounts of Liabilities Presented in our Condensed Consolidated Balance Sheet
Interest rate swap	$	—	$	—	$	—	$	14,470	$	—	$	14,470
Forward currency contracts	—		—		—		12,687		(7,811)		4,876
Total derivative liabilities	$	—	$	—	$	—	$	27,157	$	(7,811)	$	19,346

Note 11 – Accounts Payable, Accrued Expenses and Other Liabilities

The following table details the components of our accounts payable, accrued expense and other liabilities ($ in thousands):

	September 30, 2020		December 31, 2019
Accrued dividends payable	$	53,689	$	74,771
Collateral deposited under derivative agreements	12,780		2,930
Accrued interest payable	13,013		16,089
Accounts payable and other liabilities	6,145		6,922
General CECL Allowance on unfunded commitments(1)	3,595		—
Total	$	89,222	$	100,712

  ———————

(1)Refer to Note 4 - Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net for additional disclosure related to the General CECL Allowance on unfunded commitments for the quarter ended September 30, 2020.

Note 12 – Related Party Transactions

Management Agreement

In connection with our initial public offering in September 2009, we entered into a management agreement (the "Management Agreement") with the Manager, which describes the services to be provided by the Manager and its compensation for those services. The Manager is responsible for managing our day-to-day operations, subject to the direction and oversight of our board of directors.

Pursuant to the terms of the Management Agreement, the Manager is paid a base management fee equal to 1.5% per annum of our stockholders’ equity (as defined in the Management Agreement), calculated and payable (in cash) quarterly in arrears.

The current term of the Management Agreement will expire on September 29, 2021, and is automatically renewed for successive one-year terms on each anniversary thereafter. The Management Agreement may be terminated upon expiration of the one-year extension term only upon the affirmative vote of at least two-thirds of our independent directors, based upon (1) unsatisfactory performance by the Manager that is materially detrimental to ARI or (2) a determination that the management fee payable to the Manager is not fair, subject to the Manager’s right to prevent such a termination based on unfair fees by accepting a mutually acceptable reduction of management fees agreed to by at least two-thirds of our independent directors. The Manager must be provided with written notice of any such termination at least 180 days prior to the expiration of the then existing term and will be paid a termination fee equal to three times the sum of the average annual base management fee during the 24-month period immediately preceding the date of termination, calculated as of the end of the most recently completed fiscal quarter prior to the date of termination. Following a meeting by our independent directors in February 2020, which included a discussion of the Manager’s performance and the level of the management fees thereunder, we determined not to seek termination of the Management Agreement.

We incurred approximately $9.9 million and $30.2 million in base management fees under the Management Agreement for the three and nine months ended September 30, 2020, respectively, as compared to $10.4 million and $30.3 million for the three and nine months ended September 30, 2019, respectively.

28

In addition to the base management fee, we are also responsible for reimbursing the Manager for certain expenses paid by the Manager on our behalf or for certain services provided by the Manager to us. For the three and nine months ended September 30, 2020 we paid expenses totaling $0.6 million and $1.7 million, respectively, related to reimbursements for certain expenses paid by the Manager on our behalf under the Management Agreement as compared to $0.5 million and $2.0 million, respectively Expenses incurred by the Manager and reimbursed by us are reflected in the respective condensed consolidated statement of operations expense category or our condensed consolidated balance sheet based on the nature of the item.

Included in payable to related party on our condensed consolidated balance sheet at September 30, 2020 and December 31, 2019 are approximately $9.9 million and $10.4 million, respectively, for base management fees incurred but not yet paid under the Management Agreement.

Loans receivable

In January 2020, we sold £62.2 million ($81.3 million assuming conversion into U.S. dollars) in a mezzanine loan and £50.0 million ($65.3 million assuming conversion into U.S. dollars) unfunded commitment of a senior mortgage secured by a mixed-use property in London, UK to a fund managed by an affiliate of the Manager, that was originated by us in December 2019. This transaction was evaluated under ASC 860 - Transfers and Servicing, and we determined that it qualifies as a sale and accounted for as such.

In the second quarter of 2020, we sold our interests in three construction loans to entities managed by affiliates of the Manager. Refer to "Note 4 - Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net" for additional information related to these sales.

Term Loan

In May 2019, Apollo Global Funding, LLC, an affiliate of the Manager, served as one of the five arrangers for the issuance of our senior secured term loan and received $0.6 million of arrangement fees.

Note 13 – Share-Based Payments

On September 23, 2009, our board of directors approved the Apollo Commercial Real Estate Finance, Inc. 2009 Equity Incentive Plan ("2009 LTIP") and on April 16, 2019, our board of directors approved the Amended and Restated Apollo Commercial Real Estate Finance, Inc. 2019 Equity Incentive Plan ("2019 LTIP," and together with the 2009 LTIP, the "LTIPs"), which amended and restated the 2009 LTIP. Following the approval of the 2019 LTIP by our stockholders at our 2019 annual meeting of stockholders on June 12, 2019, no additional awards will be granted under the 2009 LTIP and all outstanding awards granted under the 2009 LTIP remain in effect in accordance with the terms in the 2009 LTIP.

The 2019 LTIP provides for grants of restricted common stock, restricted stock units ("RSUs") and other equity-based awards up to an aggregate of 7,000,000 shares of our common stock. The LTIPs are administered by the compensation committee of our board of directors (the "Compensation Committee") and all grants under the LTIPs must be approved by the Compensation Committee.

We recognized stock-based compensation expense of $4.2 million and $12.7 million for the three and nine months ended September 30, 2020, respectively, related to restricted stock and RSU vesting, as compared to $3.9 million and $12.1 million for the three and nine months ended September 30, 2019, respectively.

The following table summarizes the grants, vesting and forfeitures of restricted common stock and RSUs during the nine months ended September 30, 2020:

	Type	Restricted Stock	RSUs	Grant Date Fair Value ($ in thousands)
Outstanding at December 31, 2019		25,356	2,007,355
	Granted	82,235	54,867	906
	Vested	(25,356)	(264)	N/A
	Forfeiture	—	(13,587)	N/A
Outstanding at September 30, 2020		82,235	2,048,371

29

Below is a summary of restricted stock and RSU vesting dates as of September 30, 2020: 

Vesting Year	Restricted Stock	RSU	Total Awards
2020	—	956,738	956,738
2021	82,235	699,903	782,138
2022	—	373,441	373,441
2023	—	18,289	18,289
Total	82,235	2,048,371	2,130,606

At September 30, 2020, we had unrecognized compensation expense of approximately $0.3 million and $22.9 million, respectively, related to the vesting of restricted stock awards and RSUs noted in the table above.

RSU Deliveries

During the nine months ended September 30, 2020 and 2019, we delivered 503,411 and 433,585 shares of common stock for 868,421 and 730,980 vested RSUs, respectively. We allow RSU participants to settle their tax liabilities with a reduction of their share delivery from the originally granted and vested RSUs. The amount, when agreed to by the participant, results in a cash payment to the Manager related to this tax liability and a corresponding adjustment to additional paid in capital on our condensed consolidated statement of changes in stockholders' equity. The adjustment was $6.5 million and $5.0 million for the nine months ended September 30, 2020 and 2019, respectively. The adjustment is a reduction of capital related to our equity incentive plan and is presented net of increases of capital related to our equity incentive plan in our condensed consolidated statement of changes in stockholders' equity.

Note 14 – Stockholders’ Equity

Our authorized capital stock consists of 450,000,000 shares of common stock, $0.01 par value per share and 50,000,000 shares of preferred stock, $0.01 par value per share. As of September 30, 2020, 143,288,347 shares of common stock were issued and outstanding, and 6,770,393 shares of 8.00% Fixed-to-Floating Series B Cumulative Redeemable Perpetual Preferred Stock ("Series B Preferred Stock") were issued and outstanding.

On June 10, 2019, we redeemed all 6,900,000 shares of 8.00% Series C Cumulative Redeemable Perpetual Preferred Stock ("Series C Preferred Stock") outstanding. Holders of the Series C Preferred Stock received the redemption price of $25.00 plus accumulated but unpaid dividends to the redemption date of $0.2223 per share.

Dividends. The following table details our dividend activity:

	Three months ended		Nine months ended
Dividend declared per share of:	September 30, 2020	September 30, 2019	September 30, 2020	September 30, 2019
Common Stock	$0.35	$0.46	$1.10	$1.38
Series B Preferred Stock	0.50	0.50	1.50	1.50
Series C Preferred Stock	N/A	N/A	N/A	0.7223

Common Stock Offerings. During the first quarter of 2019, we issued 1,967,361 shares of our common stock, at a per share conversion price of $17.17, related to conversions of the 2019 Notes, the remainder of which matured on March 15, 2019. We recorded a $33.8 million increase in additional paid in capital in our condensed consolidated statement of changes in stockholders' equity. Refer to "Note 9 - Convertible Senior Notes, Net" for a further discussion on the conversions of the 2019 Notes.

During the second quarter of 2019, we completed a follow-on public offering of 17,250,000 shares of our common stock, including shares issued pursuant to the underwriters' option to purchase additional shares, at a price of $18.27 per share. The aggregate net proceeds from the offering were $314.8 million after deducting offering expenses.

Common Stock Repurchases. The following table details our common stock repurchase activity during the nine months ended September 30, 2020:

30

	Three months ended
	March 31, 2020	June 30, 2020	September 30, 2020	Total
Shares Repurchased	300,000	5,495,976	5,038,619	10,834,595
Weighted Average Price	$8.12	$7.96	$9.01	$	8.45

Note 15 – Commitments and Contingencies

Legal Proceedings. From time to time, we may be involved in various claims and legal actions arising in the ordinary course of business. On June 28, 2018, AmBase Corporation, 111 West 57th Street Manager Funding LLC and 111 West 57th Investment LLC commenced an action captioned AmBase Corporation et al v. ACREFI Mortgage Lending, LLC et al (No 653251/2018) in New York Supreme Court. The complaint names as defendants (i) ACREFI Mortgage Lending, LLC, a subsidiary of the Company, (ii) the Company, and (iii) certain funds managed by Apollo, which are co-lenders on a mezzanine loan against the development of a residential condominium building in Manhattan, New York. The plaintiffs allege that the defendants tortiously interfered with the contractual equity put right in the plaintiffs’ joint venture agreement with the developers of the project, and that the defendants aided and abetted breaches of fiduciary duty by the developers of the project. The plaintiffs allege the loss of a $70.0 million investment as part of total damages of $700.0 million, which includes punitive damages. The defendants' motion to dismiss was granted on October 23, 2019 and the Court entered judgment dismissing the complaint in its entirety on November 8, 2019. Plaintiffs filed a timely notice of appeal on December 6, 2019 and, as of September 28, 2020, the parties have now fully briefed the appeal. We are awaiting scheduling of oral argument. We believe the claims are without merit and do not believe this will have a material adverse effect on our condensed consolidated financial statements.

Loan Commitments. As described in "Note 4 - Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net" at September 30, 2020, we had $1.4 billion of unfunded commitments related to our commercial mortgage and subordinate loans. The timings and amounts of fundings are uncertain as these commitments relate to loans for construction costs, capital expenditures, leasing costs, interest and carry costs, among others. As such, the timings and amounts of future fundings depend on the progress and performance of the underlying assets of our loans. Certain of our lenders are contractually obligated to fund their ratable portion of these loan commitments over time, while other lenders have some degree of discretion over future loan funding obligations. The total unfunded commitment is expected to be funded over the remaining expected 4.1 years weighted average tenor of these loans.

COVID-19. The COVID-19 global pandemic has brought forth uncertainty and disruption to the global economy. The magnitude and duration of the COVID-19 pandemic and its impact on our borrowers and their tenants, cash flows and future results of operations could be significant and will largely depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the COVID-19 pandemic, the success of actions taken to contain or treat the pandemic, and reactions by consumers, companies, governmental entities and capital markets. The prolonged duration and impact of the COVID-19 pandemic could materially disrupt our business operations and impact our financial performance.

As of September 30, 2020, we have not recorded any contingencies on our condensed consolidated balance sheet related to COVID-19. To the extent COVID-19 continues to cause dislocations in the global economy, our financial condition, results of operations, and cash flows may continue to be adversely impacted. Refer to “Note 2 - Summary of Significant Accounting Policies” for further discussion regarding COVID-19.

Note 16 – Fair Value of Financial Instruments

The following table presents the carrying value and estimated fair value of our financial instruments not carried at fair value on our condensed consolidated balance sheet at September 30, 2020 and December 31, 2019 ($ in thousands):

31

	September 30, 2020				December 31, 2019
	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
Cash and cash equivalents	$	438,234	$	438,234	$	452,282	$	452,282
Commercial mortgage loans, net	5,427,945		5,337,301		5,326,967		5,380,693
Subordinate loans and other lending assets, net(1)	1,009,092		982,961		1,048,126		1,050,961
Secured debt arrangements, net	(3,465,337)		(3,465,337)		(3,078,366)		(3,078,366)
Senior secured term loan, net	(484,191)		(471,531)		(487,961)		(499,988)
2022 Notes	(339,695)		(326,867)		(337,755)		(348,060)
2023 Notes	(224,916)		(206,126)		(223,818)		(234,600)

———————

(1)Includes subordinate risk retention interests in securitization vehicles with an estimated fair value that approximates their carrying value.

To determine estimated fair values of the financial instruments listed above, market rates of interest, which include credit assumptions, are used to discount contractual cash flows. The estimated fair values are not necessarily indicative of the amount we could realize on disposition of the financial instruments. The use of different market assumptions or estimation methodologies could have a material effect on the estimated fair value amounts. Estimates of fair value for cash and cash equivalents, convertible senior notes, net and senior secured term loan, net are measured using observable Level I inputs as defined in "Note 3 - Fair Value Disclosure." Estimates of fair value for all other financial instruments in the table above are measured using significant estimates, or unobservable Level III inputs as defined in "Note 3 - Fair Value Disclosure."

Note 17 – Net Income (Loss) per Share

ASC 260 "Earnings per share" requires the use of the two-class method of computing earnings per share for all periods presented for each class of common stock and participating security as if all earnings for the period had been distributed. Under the two-class method, during periods of net income, the net income is first reduced for dividends declared on all classes of securities to arrive at undistributed earnings. During periods of net losses, the net loss is reduced for dividends declared on participating securities only if the security has the right to participate in the earnings of the entity and an objectively determinable contractual obligation to share in net losses of the entity.

The remaining earnings are allocated to common stockholders and participating securities to the extent that each security shares in earnings as if all of the earnings for the period had been distributed. Each total is then divided by the applicable number of shares to arrive at basic earnings per share. For the diluted earnings, the denominator includes all outstanding shares of common stock and all potential shares of common stock assumed issued if they are dilutive. The numerator is adjusted for any changes in income or loss that would result from the assumed conversion of these potential shares of common stock.

The table below presents the computation of basic and diluted net income (loss) per share of common stock for the three and nine months ended September 30, 2020 and 2019 ($ in thousands except per share data): 

	For the three months ended September 30,				For the nine months ended September 30,
	2020		2019		2020		2019
Basic Earnings
Net income (loss)	$	49,338	$	29,089	$	(18,303)	$	158,271
Less: Preferred dividends	(3,385)		(3,385)		(10,155)		(15,139)
Net income (loss) available to common stockholders	$	45,953	$	25,704	$	(28,458)	$	143,132
Less: Dividends on participating securities	(717)		(847)		(2,238)		(2,547)
Basic Earnings	$	45,236	$	24,857	$	(30,696)	$	140,585
Diluted Earnings
Net income (loss) available to common stockholders	$	45,953	$	25,704	$	(28,458)	$	143,132
Less: Dividends on participating securities	(717)		—		(2,238)		—
Add: Interest expense on Notes	—		—		—		—
Diluted Earnings	$	45,236	$	25,704	$	(30,696)	$	143,132

32

Number of Shares:
Basic weighted-average shares of common stock outstanding	146,612,313		153,531,678		150,679,773		144,638,237
Diluted weighted-average shares of common stock outstanding	146,612,313		153,531,678		150,679,773		144,638,237
Earnings Per Share Attributable to Common Stockholders
Basic	$	0.31	$	0.16	$	(0.20)	$	0.97
Diluted	$	0.31	$	0.16	$	(0.20)	$	0.97

The dilutive effect to earnings per share is determined using the "if-converted" method whereby interest expense on the outstanding Notes is added back to the diluted earnings per share numerator and all of the potentially dilutive shares are included in the diluted earnings per share denominator. For the three and nine months ended September 30, 2020, 28,533,271 weighted-average potentially issuable shares with respect to the Notes were excluded from the calculation of diluted net income per share because the effect was anti-dilutive. For the three and nine months ended September 30, 2019, 28,533,271 and 29,041,856 weighted-average potentially issuable shares with respect to the Notes, respectively, were excluded from the calculation of diluted net income per share because the effect was anti-dilutive. Refer to "Note 9 - Convertible Senior Notes, Net" for further discussion.

For the three and nine months ended September 30, 2020, 2,051,311 and 2,028,573 weighted-average unvested RSUs, respectively, were excluded from the calculation of diluted net income per share because the effect was anti-dilutive. For the three and nine months ended September 30, 2019, 1,839,631 and 1,845,086 of weighted-average unvested RSUs, respectively, were excluded from the calculation of diluted net income per share because the effect was anti-dilutive.

Note 18 – Subsequent Events

Subsequent to the quarter ended September 30, 2020, the following events took place:

Investment activity: We funded approximately $33.0 million for previously closed loans.

Loan Repayments. We received approximately $1.3 million from loan repayments.

In addition, the remaining collateral of for-sale residential condominium units located in Bethesda, MD, was sold for net proceeds approximately equal to the carrying value of the loan.

Loan Sales: We sold, at par, a $25.0 million subordinate position of a residential-for-sale: construction loan with a total commitment of $110.0 million.

Unconsolidated Joint Venture: We entered into a joint venture which owns the underlying properties that secure our $180.0 million first mortgage predevelopment loan located in Miami, FL. The entity in which we own an interest, and which owns the underlying properties was deemed to be a VIE and we determined that we are not the primary beneficiary of that VIE.

33

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

FORWARD-LOOKING INFORMATION

We make forward-looking statements herein and will make forward-looking statements in future filings with the SEC, press releases or other written or oral communications within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). For these statements, we claim the protections of the safe harbor for forward-looking statements contained in such Sections. Forward-looking statements are subject to substantial risks and uncertainties, many of which are difficult to predict and are generally beyond our control. These forward-looking statements include information about possible or assumed future results of our business, financial condition, liquidity, results of operations, plans and objectives. When we use the words "believe," "expect," "anticipate," "estimate," "plan," "continue," "intend," "should," "may" or similar expressions, it intends to identify forward-looking statements. Statements regarding the following subjects, among others, may be forward-looking: the macro- and micro-economic impact of the COVID-19 pandemic; the severity and duration of the COVID-19 pandemic; actions taken by governmental authorities to contain the COVID-19 pandemic or treat its impact; the impact of the COVID-19 pandemic on our financial condition, results of operations, liquidity and capital resources; market trends in our industry, interest rates, real estate values, the debt securities markets or the general economy; the demand for commercial real estate loans; our business and investment strategy; our operating results; actions and initiatives of the U.S. government and governments outside of the United States, changes to government policies and the execution and impact of these actions, initiatives and policies; the state of the economy generally or in specific geographic regions; economic trends and economic recoveries; our ability to obtain and maintain financing arrangements, including secured debt arrangements and securitizations; the timing and amount of expected future fundings of unfunded commitments; the availability of debt financing from traditional lenders; the volume of short-term loan extensions; the demand for new capital to replace maturing loans; expected leverage; general volatility of the securities markets in which we participate; changes in the value of our assets; the scope of our target assets; interest rate mismatches between our target assets and any borrowings used to fund such assets; changes in interest rates and the market value of our target assets; changes in prepayment rates on our target assets; effects of hedging instruments on our target assets; rates of default or decreased recovery rates on our target assets; the degree to which hedging strategies may or may not protect us from interest rate volatility; impact of and changes in governmental regulations, tax law and rates, accounting, legal or regulatory issues or guidance and similar matters; our continued maintenance of our qualification as a REIT for U.S. federal income tax purposes; our continued exclusion from registration under the Investment Company Act of 1940, as amended; the availability of opportunities to acquire commercial mortgage-related, real estate-related and other securities; the availability of qualified personnel; estimates relating to our ability to make distributions to our stockholders in the future; our present and potential future competition; and unexpected costs or unexpected liabilities, including those related to litigation.

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. Forward-looking statements are not predictions of future events. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us. See "Item 1A. Risk Factors" of this Quarterly Report on Form 10-Q and our Annual Report. These and other risks, uncertainties and factors, including those described in the annual, quarterly and current reports that we file with the SEC, could cause our actual results to differ materially from those included in any forward-looking statements we make. All forward-looking statements speak only as of the date they are made. New risks and uncertainties arise over time and it is not possible to predict those events or how they may affect us. Except as required by law, we are not obligated to, and do not intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Overview

We are a Maryland corporation and have elected to be taxed as a REIT for U.S. federal income tax purposes. We primarily originate, acquire, invest in and manage performing commercial first mortgage loans, subordinate financings, and other commercial real estate-related debt investments. These asset classes are referred to as our target assets.

We are externally managed and advised by the Manager, an indirect subsidiary of Apollo, a leading global alternative investment manager with a contrarian and value-oriented investment approach in private equity, credit and real estate with assets under management of approximately $413.6 billion as of June 30, 2020.

The Manager is led by an experienced team of senior real estate professionals who have significant expertise in underwriting and structuring commercial real estate financing transactions. We benefit from Apollo’s global infrastructure and operating platform, through which we are able to source, evaluate and manage potential investments in our target assets.

34

Current Market Conditions

During the first quarter of 2020, there was a global outbreak of COVID-19, which was declared by the World Health Organization as a pandemic. In response to COVID-19, the United States and numerous other countries declared national emergencies, which has led to large scale quarantines as well as restrictions to business deemed non-essential. These responses to COVID-19 have disrupted economic activities and could have a significant continued adverse effect on economic and market conditions, and could result in a recession. As we are still in the midst of the COVID-19 pandemic we are not in a position to estimate the ultimate impact this will have on our business and the economy as a whole. The effects of COVID-19 have adversely impacted the value of our assets, business, financial condition, results of operations and cash flows, and our ability to operate successfully. Some of the factors that impacted us to date and may continue to affect us are outlined in "Item 1A. Risk Factors" of this Quarterly Report on Form 10-Q. Please see "Liquidity and Capital Resources" below for additional discussion surrounding the ongoing impact we expect COVID-19 will have on our liquidity and capital resources.

Critical Accounting Policies

A summary of our critical accounting policies is set forth in our Annual Report under "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Policies and Use of Estimates." There have been no material changes to our critical accounting policies described in our Annual Report other than the adoption of the CECL Standard, as described in "Note 2 - Summary of Significant Accounting Policies."

Results of Operations

All non-USD denominated assets and liabilities are translated to USD at the exchange rate prevailing at the reporting date and income, expenses, gains, and losses are translated at the prevailing exchange rate on the dates that they were recorded.

Loan Portfolio Overview

The following table sets forth certain information regarding our commercial real estate debt portfolio as of September 30, 2020 ($ in thousands):

Description	Amortized Cost		Weighted-Average Coupon (1)		Weighted Average All-in Yield (1)(2)		Secured Debt Arrangements (3)		Cost of Funds		Equity at cost(4)
Commercial mortgage loans, net	$	5,427,945	4.7	%	5.2	%	$	3,478,083	2.2	%	$	1,949,862
Subordinate loans and other lending assets, net	1,009,092		10.5	%	11.4	%	—		—		1,009,092
Total/Weighted-Average	$	6,437,037	5.6	%	6.2	%	$	3,478,083	2.2	%	$	2,958,954

———————    

(1)    Weighted-Average Coupon and Weighted-Average All-in Yield are based on the applicable benchmark rates as of September 30, 2020 on the floating rate loans.

(2)     Weighted-Average All-in Yield includes the amortization of deferred origination fees, loan origination costs and accrual of both extension and exit fees. Weighted-Average All-in Yield excludes the benefit of forward points on currency hedges relating to loans denominated in currencies other than USD.

(3)    Gross of deferred financing costs of $12.7 million.

(4)    Represents loan portfolio at amortized cost less secured debt outstanding.

The following table provides details of our commercial mortgage loan portfolio and subordinate and other lending assets portfolio, on a loan-by-loan basis, as of September 30, 2020 ($ in millions):

Commercial Mortgage Loan Portfolio
#	Property Type	Risk Rating	Origination Date	Amortized Cost	Unfunded Commitment	Construction Loan	Fully-extended Maturity	Location
1	Urban Retail	3	08/2019	$317	$—		09/2024	Manhattan, NY
2	Urban Retail	3	12/2019	320	—		12/2023	London, UK
3	Hotel	3	10/2019	261	50		08/2024	Various
4	Healthcare	3	10/2019	220	29		10/2024	Various
5	Office	3	02/2020	216	—		02/2025	London, UK

35

6	Industrial	3	01/2019	197	7		02/2024	Brooklyn, NY
7	Office	3	06/2019	204	29		11/2026	Berlin, Germany
8	Office	3	10/2018	197	3		01/2022	Manhattan, NY
9	Urban Predevelopment (1)	5	01/2016	115	—		09/2021	Miami, FL
10	Office	3	09/2019	179	—		09/2023	London, UK
11	Office	3	01/2020	184	103		02/2025	Long Island City, NY
12	Office	3	11/2017	151	—		01/2023	Chicago, IL
13	Urban Predevelopment(1)	5	03/2017	128	—		12/2020	Brooklyn, NY
14	Hotel	3	04/2018	152	—		04/2023	Honolulu, HI
15	Hotel	3	09/2015	145	—		06/2024	Manhattan, NY
16	Hotel	3	05/2018	140	—		06/2023	Miami, FL
17	Hotel	3	08/2019	139	—		08/2024	Puglia, Italy
18	Office	3	01/2018	135	56		01/2022	Renton, WA
19	Retail center(1)	5	11/2014	105	—		09/2021	Cincinnati, OH
20	Office	3	10/2018	135	51	Y	10/2023	Manhattan, NY
21	Residential-for-sale: construction	3	12/2019	135	15	Y	01/2023	Boston, MA
22	Hotel	3	03/2017	105	—		03/2022	Atlanta, GA
23	Hotel	3	11/2018	100	—		12/2023	Vail, CO
24	Hotel	3	12/2017	91	—		12/2022	Manhattan, NY
25	Office	3	03/2018	92	—		04/2023	Chicago, IL
26	Residential-for-sale: inventory	3	12/2019	73	—		07/2021	Manhattan, NY
27	Office	3	04/2019	97	62	Y	09/2025	Culver City, CA
28	Office	3	12/2017	87	37		07/2022	London, UK
29	Mixed Use	3	12/2019	75	1		12/2024	London, UK
30	Residential-for-sale: construction	3	12/2018	71	107	Y	12/2023	Manhattan, NY
31	Residential-for-sale: construction	3	10/2015	69	—		08/2021	Manhattan, NY
32	Multifamily	3	04/2014	66	—		07/2023	Various
33	Hotel	3	08/2019	67	—		09/2022	Manhattan, NY
34	Hotel	3	04/2018	64	—		05/2023	Scottsdale, AZ
35	Urban Predevelopment	3	12/2016	52	—		06/2022	Los Angeles, CA
36	Hotel	3	09/2019	60	—		10/2024	Miami, FL
37	Residential-for-sale: construction	3	01/2018	68	12	Y	01/2023	Manhattan, NY
38	Hotel	3	12/2019	59	—		01/2025	Tucson, AZ
39	Multifamily	3	11/2014	54	—		11/2021	Various
40	Hotel	3	05/2019	52	—		06/2024	Chicago, IL
41	Multifamily	3	02/2020	50	1		03/2024	Cleveland, OH
42	Hotel	3	12/2015	42	—		08/2024	St. Thomas, USVI
43	Residential-for-sale: construction	3	12/2018	65	38	Y	01/2024	Hallandale Beach, FL
44	Hotel(1)	5	02/2018	29	—		03/2023	Pittsburgh, PA
45	Office	3	12/2019	34	3		12/2022	Edinburgh, Scotland
46	Residential-for-sale: inventory	3	05/2018	24	—		03/2021	Manhattan, NY
47	Residential-for-sale: inventory	3	06/2018	13	—		07/2021	Manhattan, NY
48	Residential-for-sale: inventory(1)	5	02/2014	3	—		04/2021	Bethesda, MD
49	Mixed Use	3	12/2019	11	789	Y	06/2025	London, UK
	General CECL Allowance			(20)
	Sub total / Weighted-Average Subordinate Loans and Other Lending Assets	3.1		$5,428	$1,393		3.0 Years

Subordinate Loan and Other Lending Asset Portfolio
#	Property Type	Risk Rating	Origination Date	Amortized Cost	Unfunded Commitment	Construction Loan	Fully-extended Maturity	Location
1	Residential-for-sale: construction (2)	3	06/2015	$224	—	Y	12/2020	Manhattan, NY
2	Residential-for-sale: construction	3	12/2017	108	11	Y	06/2022	Manhattan, NY

36

3	Office	3	01/2019	100	—		12/2025	Manhattan, NY
4	Healthcare(3)	3	01/2019	76	—		01/2024	Various
5	Residential-for-sale: construction (2)	3	11/2017	85	—	Y	12/2020	Manhattan, NY
6	Residential-for-sale: construction	3	12/2017	72	—	Y	04/2023	Los Angeles, CA
7	Healthcare(4)	3	07/2019	51	—		06/2024	Various
8	Mixed Use	3	01/2017	42	—		02/2027	Cleveland, OH
9	Residential-for-sale: inventory	3	10/2016	36	—		10/2020	Manhattan, NY
10	Mixed Use	3	02/2019	38	—	Y	12/2022	London, UK
11	Industrial	2	05/2013	32	—		05/2023	Various
12	Mixed Use	3	12/2018	29	22	Y	12/2023	Brooklyn, NY
13	Hotel	3	06/2015	24	—		07/2025	Phoenix, AZ
14	Hotel	3	06/2018	20	—		06/2023	Las Vegas, NV
15	Multifamily	3	05/2018	19	—		05/2028	Cleveland, OH
16	Healthcare(3)(4)	3	02/2019	17	—		01/2034	Various
17	Office	3	07/2013	14	—		07/2022	Manhattan, NY
18	Hotel(1)	5	06/2015	18	—		12/2022	Washington, DC
19	Hotel(1)	5	05/2017	9	—		06/2027	Anaheim, CA
20	Office	3	08/2017	7	—		09/2024	Troy, MI
21	Mixed Use	3	07/2012	7	—		08/2022	Chapel Hill, NC
	General CECL Allowance			(19)
	Sub total / Weighted-Average Subordinate Loans and Other Lending Assets	3.0		$1,009	$33		2.5 Years
	Total / Weighted-Average Loan Portfolio	3.1		$6,437	$1,426		2.9 Years

———————

(1)Amortized cost for these loans is net of the recorded provisions for loan losses.

(2)Both loans are secured by the same property.

(3)Loan and Single Asset, Single Borrower CMBS are secured by the same properties.

(4)Single Asset, Single Borrower CMBS.

Our average asset and debt balances for the nine months ended September 30, 2020 were ($ in thousands):

	Average month-end balances for the nine months ended September 30, 2020
Description	Assets		Related debt
Commercial mortgage loans, net	$	5,635,603	$	3,399,455
Subordinate loans and other lending assets, net	1,048,555		—

Portfolio Management

Due to the impact of COVID-19, some of our borrowers have experienced consequences which are preventing the execution of their business plans and in some cases temporary closures. As a result, we have worked with borrowers to execute loan modifications which are typically coupled with additional equity contributions from borrowers. Loan modifications to date have included repurposing of reserves, temporary deferrals of interest or principal, and partial deferral of coupon interest as payment-in-kind interest. None of these modifications are troubled debt restructurings.

Investment Activity

During the nine months ended September 30, 2020, we committed $562.0 million of capital to loans ($457.4 million of which was funded during the nine months ended September 30, 2020). In addition, during the nine months ended September 30, 2020, we received $543.5 million in repayments and sales and funded $309.8 million for loans closed prior to 2020.

Net Income (Loss) Available to Common Stockholders

For the three months ended September 30, 2020 and 2019 our net income available to common stockholders was $46.0 million, or $0.31 per diluted share of common stock, and $25.7 million, or $0.16 per diluted share of common

37

stock, respectively. For the nine months ended September 30, 2020 and 2019, our net income (loss) available to common stockholders was $(28.5) million, or $(0.20) per diluted share of common stock, and $143.1 million, or $0.97 per diluted share of common stock, respectively.

Operating Results

The following table sets forth information regarding our consolidated results of operations and certain key operating metrics ($ in thousands):

	Three months ended September 30,				2020 vs 2019		Nine months ended September 30,				2020 vs. 2019
	2020		2019				2020		2019
Net interest income:
Interest income from commercial mortgage loans	$	74,522	$	81,136	$	(6,614)	$	232,018	$	236,880	$	(4,862)
Interest income from subordinate loans and other lending assets	28,857		43,421		(14,564)		95,491		125,303		(29,812)
Interest expense	(34,824)		(39,341)		4,517		(113,527)		(109,147)		(4,380)
Net interest income	68,555		85,216		(16,661)		213,982		253,036		(39,054)
Operating expenses:
General and administrative expenses	(6,624)		(5,839)		(785)		(19,580)		(18,564)		(1,016)
Management fees to related party	(9,927)		(10,434)		507		(30,152)		(30,306)		154
Total operating expenses	(16,551)		(16,273)		(278)		(49,732)		(48,870)		(862)
Other income	128		429		(301)		1,479		1,431		48
Realized loss on investments	(1,037)		—		(1,037)		(17,442)		(12,513)		(4,929)
Reversal of (provision for) loan losses - Specific CECL Allowance	550		(35,000)		35,550		(139,950)		(20,000)		(119,950)
Reversal of (provision for) loan losses - General CECL Allowance	5,792		—		5,792		(12,004)		—		(12,004)
Foreign currency translation gain (loss)	27,002		(19,129)		46,131		(8,388)		(20,012)		11,624
Gain (loss) on foreign currency forwards	(34,537)		24,153		(58,690)		32,959		28,619		4,340
Loss on interest rate hedging instruments	(564)		(10,307)		9,743		(39,207)		(23,420)		(15,787)
Net income (loss)	$	49,338	$	29,089	$	20,249	$	(18,303)	$	158,271	$	(176,574)

Net Interest Income

Net interest income decreased by $16.7 million and $39.1 million during the three and nine months ended September 30, 2020, respectively, as compared to the same periods in 2019. The decrease was primarily due to (i) a 2.02% and 1.73% decrease in average one-month LIBOR, respectively, for the three and nine months ended September 30, 2020 compared to the same periods in September 30, 2019 and (ii) loans with an aggregate principal balance of $602.2 million being on cost recovery or non-accrual status as of September 30, 2020 compared to $196.4 million as of September 30, 2019. This decrease was offset by (i) a $0.5 billion increase in loan principal balance as of September 30, 2020 compared to the same date in 2019 and (ii) in the money LIBOR floors on several of our loans.

We recognized PIK interest of $12.5 million and $37.3 million for the three and nine months ended September 30, 2020, respectively, and $13.7 million and $42.8 million for the three and nine months ended September 30, 2019, respectively.

We recognized $0 and $0.2 million in pre-payment penalties and accelerated fees for the three and nine months ended September 30, 2020, respectively, and $0.3 million and $4.0 million for the three and nine months ended September 30,

38

2019, respectively.

Operating Expenses

General and administrative expenses

General and administrative expenses increased by $0.8 million for the three months ended September 30, 2020 compared to the same period in 2019. The increase was primarily driven by a $0.5 million increase in general operating expenses and $0.3 million increase in non-cash restricted stock and RSU amortization related to shares of stock awarded under the LTIPs.

General and administrative expenses increased by $1.0 million for the nine months ended September 30, 2020 compared to the same period in 2019. The increase was primarily due to a $0.6 million increase in non-cash restricted stock and RSU amortization related to shares of common stock awarded under the LTIPs and $0.4 million increase in general operating expenses.

Management fees to related party

Management fee expense decreased by $0.5 million during the three months ended September 30, 2020 as compared to the same periods in 2019. The decrease is primarily attributable to a decrease in our stockholders’ equity (as defined in the Management Agreement) as a result of our common stock repurchase of 10,834,595 shares during the nine months ended September 30, 2020 (as described in "Note 14 - Stockholders' Equity").

Management fees decreased by $0.2 million during the nine months ended September 30, 2020 as compared to the same period in 2019. The decrease is primarily attributable to the decrease in our stockholders' equity as noted above and was partially offset by an increase in our management fee as a result of a decrease in our quarterly dividend during 2020.

Management fees and the relationship between us and the Manager under the Management Agreement are discussed further in the accompanying condensed consolidated financial statements, in "Note 12 - Related Party Transactions."

Reversal of (provision for) loan losses - General CECL Allowance

The General CECL Allowance decreased by $5.8 million during the three months ended September 30, 2020 and increased by $12.0 million during the nine months ended September 30, 2020. For the three months ended September 30, 2020, the decrease is primarily related to an improvement in our view of estimated future market conditions since prior quarter end; for the nine months ended September 30, 2020, the increase is primarily related to a more negative view of estimated future macroeconomic conditions in the backdrop of the global COVID-19 pandemic and an increase in our view of the remaining expected term of our loan portfolio. Refer to "Note 2 - Summary of Significant Accounting Policies" and "Note 4 - Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net" for additional information related to our General CECL Allowance.

Reversal of (provision for) loan losses - Specific CECL Allowance

During the three months ended September 30, 2020, we recorded a net reversal of $0.6 million of Specific CECL Allowances predominately due to a reversal of a previously recorded allowance. During the nine months ended September 30, 2020, we recorded Specific CECL Allowances on eight loans, totaling $156.9 million, two of which had existing loan loss provisions, partially offset by $16.9 million in reversals of previously recorded allowances. Refer to "Note 4 - Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net" for additional information related to our Specific CECL Allowance.

Foreign currency gain and (loss) on derivative instruments

We use forward currency contracts to economically hedge interest and principal payments due under our loans denominated in currencies other than USD. When foreign currency gain and (loss) on derivative instruments are evaluated on a combined basis, the net impact for the three and nine months ended September 30, 2020 was $(7.5) million and $24.6 million, respectively, and the net impact for the three and nine months ended September 30, 2019 was $5.0 million and $8.6 million, respectively.

Loss on interest rate hedges

In connection with the senior secured term loan, we had previously entered into an interest rate swap to fix LIBOR at 2.12% effectively fixing our all-in coupon on the senior secured term loan at 4.87%. During the second quarter of 2020 we terminated the interest rate swap and recognized a realized loss of $53.9 million. Subsequent to the termination of the

39

interest rate swap in the second quarter of 2020, we entered into a three-year interest rate cap to cap LIBOR at 0.75%. This effectively limits the maximum all-in coupon on our senior secured term loan to 3.50%. During the three and nine months ended September 30, 2020, the interest rate cap had an unrealized loss of $0.6 million and an unrealized gain of $0.2 million, respectively.

Dividends

The following table details our dividend activity:

	Three months ended		Nine months ended
Dividend declared per share of:	September 30, 2020	September 30, 2019	September 30, 2020	September 30, 2019
Common Stock	$0.35	$0.46	$1.10	$1.38
Series B Preferred Stock	0.50	0.50	1.50	1.50
Series C Preferred Stock	N/A	N/A	N/A	0.7223

Subsequent Events

Refer to "Note 18 - Subsequent Events" to the accompanying condensed consolidated financial statements for disclosure regarding significant transactions that occurred subsequent to September 30, 2020.

Liquidity and Capital Resources

Liquidity is a measure of our ability to meet potential cash requirements, including ongoing commitments to repay borrowings, fund and maintain our assets and operations, make distributions to our stockholders and other general business needs. As of September 30, 2020, we had $1.1 billion of corporate debt and $3.5 billion of asset specific financings. We have no corporate debt maturities until August 2022. As of September 30, 2020, we had $438 million of cash on hand and $11.9 million of approved and undrawn capacity from our secured debt arrangements. In addition, we have a significant amount of unencumbered loan assets. In light of COVID-19 and its severe impact on the economy we have taken steps to increase our cash balances in order to maintain an adequate level of liquidity to meet future outflows. As the duration and severity of COVID-19 remain unknown, so does the impact it will have on our borrowers, lenders, and the economy as a whole. We will continue to closely monitor developments related to COVID-19 as it relates to our liquidity position and financial obligations. At this time we believe we have sufficient liquidity and access to additional liquidity to meet financial obligations for at least the next 12 months.

Debt-to-Equity Ratio

The following table presents our debt-to-equity ratio:

	September 30, 2020	December 31, 2019
Debt to Equity Ratio (1)	1.7	1.4

———————

(1)Represents total debt less cash and loan proceeds held by servicer to total stockholders' equity.

Our primary sources of liquidity are as follows:

Cash Generated from Operations

Cash from operations is generally comprised of interest income from our investments, net of any associated financing expense, principal repayments from our investments, net of associated financing repayments, proceeds from the sale of investments, and changes in working capital balances. See "Results of Operations – Loan Portfolio Overview" above for a summary of interest rates related to our investment portfolio as of September 30, 2020.

Borrowings Under Various Financing Arrangements

JPMorgan Facility

In November 2019, through three indirect wholly-owned subsidiaries, we entered into a Sixth Amended and Restated Master Repurchase Agreement with JPMorgan Chase Bank, National Association. The JPMorgan Facility allows for $1.3 billion of maximum borrowings (with amounts borrowed in British pounds and Euros converted to USD for

40

purposes of calculating availability based on the greater of the spot rate as of the initial financing under the corresponding mortgage loan and the then-current spot rate) and matures in June 2022 and has two one-year extensions available at our option, which are subject to certain conditions. The JPMorgan Facility enables us to elect to receive advances in USD, GBP, or EUR. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $1.2 billion (including £75.6 million and €60.0 million assuming conversion into USD) of borrowings outstanding under the JPMorgan Facility secured by certain of our commercial mortgage loans.

DB Facility

In March 2020, through an indirect wholly-owned subsidiary, we entered into a Third Amended and Restated Master Repurchase Agreement with Deutsche Bank AG, Cayman Islands Branch, London Branch, which provides for advances of up to $1.0 billion for the sale and repurchase of eligible first mortgage loans secured by commercial or multifamily properties located in the United States, United Kingdom and the European Union, and enables us to elect to receive advances in USD, GBP, or EUR. The repurchase facility matures in March 2021, and has two one-year extensions available at our option, subject to certain conditions. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $526.7 million of borrowings outstanding under the DB Facility secured by certain of our commercial mortgage loans.

Goldman Facility

In November 2017, through an indirect wholly-owned subsidiary, we entered into a master repurchase and securities contract agreement with Goldman Sachs Bank USA, which provides advances up to $500.0 million and matures in November 2020, and has one one-year extension available at our option, subject to certain conditions. Margin calls may occur any time at specified margin deficit thresholds.

As of September 30, 2020, we had $362.1 million of borrowings outstanding under the Goldman Facility secured by certain of our commercial mortgage loans.

CS Facility - USD

In July 2018, through an indirect wholly-owned subsidiary, we entered into a Master Repurchase Agreement with Credit Suisse AG, acting through its Cayman Islands Branch and Alpine Securitization Ltd, which provides for advances for the sale and repurchase of eligible commercial mortgage loans secured by real estate. The CS Facility - USD has an "evergreen" feature such that the facility continues unless terminated at any time by Credit Suisse with six months' notice. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $378.8 million of borrowings outstanding under the CS Facility - USD secured by certain of our commercial mortgage loans.

CS Facility - GBP

In June 2018, through an indirect wholly-owned subsidiary, we entered into a Global Master Repurchase Agreement with Credit Suisse Securities (Europe) Limited. During the third quarter of 2020, the facility was repaid in connection with the sale of the underlying loan.

HSBC Facility - USD    

In October 2019, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement with HSBC Bank plc, which provides for a single asset financing. The facility is scheduled to mature in January 2021. Margin calls may occur any time at specified aggregate margin thresholds.

As of September 30, 2020, we had $47.2 million of borrowings under the HSBC Facility - USD secured by one commercial mortgage loan.

HSBC Facility - GBP

In September 2018, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement with HSBC Bank plc, which provided for a single asset financing. The facility matured and was repaid in June 2020 in connection with the repayment of the underlying loan.

HSBC Facility - EUR

41

In July 2019, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement with HSBC Bank plc, which provides for a single asset financing. The facility matures in July 2021. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $157.1 million (€134.1 million assuming conversion into USD) of borrowings outstanding under the HSBC Facility - EUR secured by one commercial mortgage loan.

Barclays Facility - USD

In March 2020, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement pursuant to a Master Repurchase Agreement with Barclays Bank plc. The Barclays Facility - USD allows for $200.0 million of maximum borrowings and initially matures in March 2023 with extensions available at our option, subject to certain conditions. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $35.2 million of borrowings outstanding under the Barclays Facility - USD secured by one commercial mortgage loan.

Barclays Facility - GBP/EUR

Beginning in October 2019, through an indirect wholly-owned subsidiary, we entered into five secured debt arrangements pursuant to a Global Master Repurchase Agreement with Barclays Bank plc. In June 2020, all assets previously financed pursuant to this facility were refinanced under the Barclays Private Securitization.

Barclays Private Securitization

In June 2020, through a newly formed entity, we entered into a private securitization with Barclays Bank plc, of which Barclays Bank plc retained $813.6 million of senior notes. This Barclays Private Securitization finances the loans that were previously financed under the Barclays Facility - GBP/EUR. In addition, we pledged an additional commercial mortgage loan with an outstanding principal balance of £26.0 million and pledged additional collateral of a financed loan of €5.3 million as of June 30, 2020.

The securitization eliminates daily margining provisions and grants us significant discretion to modify certain terms of the underlying collateral including waiving certain loan-level covenant breaches and deferring or waiving of debt service payments for up to 18 months. The securitization includes LTV based covenants with significant headroom to existing levels that are also subject to a six-month holiday through December 2020. These deleveraging requirements are based on significant declines in the value of the collateral as determined by an annual third-party (engaged by us) appraisal process tied to the provisions of the underlying loan agreements. We believe this provides us with both cushion and predictability to avoid sudden unexpected outcomes and material repayment requirements. In addition to the pledge of the additional collateral noted above, we paid down the previous financing by €16.5 million (totaling $18.5 million in USD) and agreed to increase the financing spreads by 0.25%.

The table below provides the borrowings outstanding (on an as converted basis) and weighted-average fully-extended maturities by currency for the assets financed under the Barclays Private Securitization as of September 30, 2020 ($ in thousands):

	Borrowings outstanding	Fully-Extended Maturity(1)
Total/Weighted-Average GBP	$670,024	January 2024
Total/Weighted-Average EUR	143,568	August 2021(2)
Total/Weighted-Average Securitization	$813,592	March 2024

———————

(1)Assumes underlying loans extend to fully extended maturity and extensions at our option are exercised.

(2)The EUR portion of the Barclays Private Securitization has an "evergreen" feature such that the facility continues for one year and can be terminated by either party on certain dates with, depending on the date of notice, a minimum of nine to twelve months' notice.

As of September 30, 2020, we had $813.6 million (£518.6 million and €122.5 million assuming conversion into USD) of borrowings outstanding under the Barclays Private Securitization secured by certain of our commercial mortgage loans.

42

Debt Covenants

The guarantees related to our secured debt arrangements contain the following financial covenants (i) tangible net worth must be greater than $1.25 billion plus 75% of the net cash proceeds of any equity issuance after March 31, 2017 (ii) our ratio of total indebtedness to tangible net worth cannot be greater than 3.75:1; and (iii) our liquidity cannot be less than an amount equal to the greater of 5% of total recourse indebtedness or $30.0 million. Under these covenants, our General CECL Allowance is added back to our tangible net worth calculation.

Senior Secured Term Loan

In May 2019, we entered into the $500.0 million senior secured term loan. During the nine months ended September 30, 2020, we repaid $3.8 million of principal related to the senior secured term loan. The senior secured term loan bears interest at LIBOR plus 2.75% and was issued at a price of 99.5%. The outstanding balance as of September 30, 2020 was $493.8 million. The senior secured term loan matures in May 2026 and contains restrictions relating to liens, asset sales, indebtedness, and investments in non-wholly owned entities. The senior secured term loan includes the following financial covenants: (i) our ratio of total recourse debt to tangible net worth cannot be greater than 3:1; and (ii) our ratio of total unencumbered assets to total pari-passu indebtedness must be at least 1.25:1.

Convertible Senior Notes

In two separate offerings during 2017, we issued an aggregate principal amount of $345.0 million of 4.75% Convertible Senior Notes due 2022, for which we received $337.5 million, after deducting the underwriting discount and offering expenses. At September 30, 2020, the 2022 Notes had a carrying value of $339.7 million and an unamortized discount of $5.3 million.

During the fourth quarter of 2018, we issued $230.0 million of 5.375% Convertible Senior Notes due 2023, for which we received $223.7 million after deducting the underwriting discount and offering expenses. At September 30, 2020, the 2023 Notes had a carrying value of $224.9 million and an unamortized discount of $5.1 million.

Cash Generated from Equity Offerings

During the second quarter of 2019, we completed a follow-on public offering of 17,250,000 shares of our common stock, including shares issued pursuant to the underwriters' option to purchase additional shares, at a price of $18.27 per share. The aggregate net proceeds from the offering were $314.8 million after deducting offering expenses.

In March 2020, our board of directors approved a stock repurchase program for up to an aggregate of $150.0 million of our common stock. During the nine months ended September 30, 2020, we repurchased 10,834,595 shares of our common stock under this program at a weighted-average price of $8.45 per share.

Other Potential Sources of Financing

Our primary sources of cash currently consist of cash available, which was $438.2 million as of September 30, 2020, principal and interest payments we receive on our portfolio of assets, and available borrowings under our secured debt arrangements. We expect our other sources of cash to consist of cash generated from operations and prepayments of principal received on our portfolio of assets. Such prepayments are difficult to estimate in advance. Depending on market conditions, we may utilize additional borrowings as a source of cash, which may also include additional secured debt arrangements as well as other borrowings or conduct additional public and private debt and equity offerings. As of September 30, 2020 we also held $1.0 billion of unencumbered assets, consisting of $42.9 million of senior mortgages and $1.0 billion of mezzanine loans.

We maintain policies relating to our borrowings and use of leverage. See "Leverage Policies" below. In the future, we may seek to raise further equity or debt capital or engage in other forms of borrowings in order to fund future investments or to refinance expiring indebtedness.

We generally intend to hold our target assets as long-term investments, although we may sell certain of our investments in order to manage our interest rate risk and liquidity needs, meet other operating objectives and adapt to market conditions.

To maintain our qualification as a REIT under the Internal Revenue Code, we must distribute annually at least 90% of our REIT taxable income, determined without regard to the deduction for dividends paid and excluding net capital gain. These distribution requirements limit our ability to retain earnings and replenish or increase capital for operations.

43

Leverage Policies

We use leverage for the sole purpose of financing our portfolio and not for the purpose of speculating on changes in interest rates. In addition to our secured debt arrangements and senior secured term loan, we access additional sources of borrowings. Our charter and bylaws do not limit the amount of indebtedness we can incur; however, we are subject to and carefully monitor the limits placed on us by our credit providers and those that assign ratings on our Company.

At September 30, 2020, our debt-to-equity ratio was 1.7 and our portfolio was comprised of $5.4 billion of commercial mortgage loans and $1.0 billion of subordinate loans and other lending assets. In order to achieve our return on equity, we generally finance our mortgage loans with 2.0 to 3.0 turns of leverage and generally do not finance our subordinate loan portfolio given built-in inherent structural leverage. Consequently, depending on our portfolio mix, our debt-to-equity ratio may exceed our previously disclosed thresholds.

Investment Guidelines

Our current investment guidelines, approved by our board of directors, are comprised of the following:

•no investment will be made that would cause us to fail to qualify as a REIT for U.S. federal income tax purposes;

•no investment will be made that would cause us to register as an investment company under the 1940 Act;

•investments will be predominantly in our target assets;

•no more than 20% of our cash equity (on a consolidated basis) will be invested in any single investment at the time of the investment; and

•until appropriate investments can be identified, the Manager may invest the proceeds of any offering in interest bearing, short-term investments, including money market accounts and/or funds, that are consistent with our intention to qualify as a REIT.

The board of directors must approve any change in or waiver to these investment guidelines.

Contractual Obligations and Commitments

Our contractual obligations including expected interest payments as of September 30, 2020 are summarized as follows ($ in thousands):

	Less than 1 year (1)		1 to 2 years(1)		2 to 3 years (1)		3 to 5 years (1)		More than 5 years (1)		Total
Secured debt arrangements(1)(2)	$	575,514	$	924,928	$	904,842	$	1,248,750	$	—	$	3,654,034
Senior secured term loan(2)	19,465		19,317		19,170		37,938		477,267		573,157
Convertible senior notes	28,750		372,172		12,363		231,030		—		644,315
Unfunded loan commitments (3)	573,344		429,516		302,134		66,328		—		1,371,322
Total	$	1,197,073	$	1,745,933	$	1,238,509	$	1,584,046	$	477,267	$	6,242,828

———————

(1)     Assumes underlying assets are financed through the fully extended maturity date of the secured debt arrangement.

(2)     Based on the applicable benchmark rates as of September 30, 2020 on the floating rate debt for interest payments due.

(3)     Based on fully extended maturity and our expected funding schedule, which is based upon the Manager’s estimates based upon the best information available to the Manager at the time. There is no assurance that the payments will occur in accordance with these estimates or at all, which could affect our operating results. Refer to "Note 15– Commitments and Contingencies" for further detail regarding unfunded loan commitments.

Loan Commitments. As of September 30, 2020, we had $1.4 billion of unfunded loan commitments, comprised of $1.4 billion related to our commercial mortgage loan portfolio, and $32.9 million related to our subordinate loan portfolio.

Management Agreement. On September 23, 2009, we entered into the Management Agreement with the Manager pursuant to which the Manager is entitled to receive a management fee and the reimbursement of certain expenses. The table above does not include amounts due under the Management Agreement as those obligations do not have fixed and determinable payments. Pursuant to the Management Agreement, the Manager is entitled to a base management fee calculated and payable quarterly in arrears in an amount equal to 1.5% of our stockholders’ equity (as defined in the Management Agreement), per annum. The Manager will use the proceeds from its management fee in part to pay

44

compensation to its officers and personnel. We do not reimburse the Manager or its affiliates for the salaries and other compensation of their personnel, except for the allocable share of the compensation of (1) our Chief Financial Officer based on the percentage of time spent on our affairs and (2) other corporate finance, tax, accounting, internal audit, legal, risk management, operations, compliance and other non-investment professional personnel of the Manager or its affiliates who spend all or a portion of their time managing our affairs based on the percentage of time devoted by such personnel to our affairs. We are also required to reimburse the Manager for operating expenses related to us incurred by the Manager, including expenses relating to legal, accounting, due diligence and other services. Expense reimbursements to the Manager are made in cash on a monthly basis following the end of each month. Our reimbursement obligation is not subject to any dollar limitation.

The current term of the Management Agreement will expire on September 29, 2021. Absent certain action by the independent directors of our board of directors, as described below, the Management Agreement will automatically renew on each anniversary for a one-year term. The Management Agreement may be terminated upon expiration of the one-year term only upon the affirmative vote of at least two-thirds of our independent directors, based upon (1) unsatisfactory performance by the Manager that is materially detrimental to us or (2) a determination that the management fee payable to the Manager is not fair, subject to the Manager’s right to prevent such a termination based on unfair fees by accepting a mutually acceptable reduction of management fees agreed to by at least two-thirds of our independent directors. The Manager must be provided with written notice of any such termination at least 180 days prior to the expiration of the then existing term and will be paid a termination fee equal to three times the sum of the average annual base management fee during the 24-month period immediately preceding the date of termination, calculated as of the end of the most recently completed fiscal quarter prior to the date of termination. Amounts payable under the Management Agreement are not fixed and determinable. Following a meeting by our independent directors in February 2020, which included a discussion of the Manager’s performance and the level of the management fees thereunder, we determined not to terminate the Management Agreement.

Forward Currency Contracts. We use forward currency contracts to economically hedge interest and principal payments due under our loans denominated in currencies other than U.S. dollars. We have entered into a series of forward contracts to sell an amount of foreign currency (GBP and EUR) for an agreed upon amount of USD at various dates through December 2024. These forward contracts were executed to economically fix the USD amounts of foreign denominated cash flows expected to be received by us related to foreign denominated loan investments. Refer to "Note 10- Derivatives, Net" to the accompanying condensed consolidated financial statements for details regarding our forward currency contracts.

Interest Rate Swap and Cap. In connection with the senior secured term loan, we previously entered into an interest rate swap to fix LIBOR at 2.12%, effectively fixing our all-in coupon on the senior secured term loan at 4.87%. During the second quarter of 2020 we terminated our interest rate swap due to significant decrease in LIBOR and recognized a realized loss on the accompanying condensed consolidated statement of operations. Subsequently, in June 2020, we entered into an interest rate cap for approximately $1.1 million. We use our interest rate cap to manage exposure to variable cash flows on our borrowings under our senior secured term loan by effectively limiting LIBOR from exceeding 0.75%. Refer to "Note 10- Derivatives, Net" to the accompanying condensed consolidated financial statements for details regarding our interest rate cap.

Off-balance Sheet Arrangements

We do not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured investment vehicles, or special purpose or variable interest entities, established to facilitate off-balance sheet arrangements or other contractually narrow or limited purposes. Further, we have not guaranteed any obligations of unconsolidated entities or entered into any commitment to provide additional funding to any such entities.

Dividends

We intend to continue to make regular quarterly distributions to holders of our common stock. U.S. federal income tax law generally requires that a REIT distribute annually at least 90% of our REIT taxable income, without regard to the deduction for dividends paid and excluding net capital gains, and that we pay tax at regular corporate rates to the extent that we annually distribute less than 100% of our net taxable income. We generally intend over time to pay dividends to our stockholders in an amount equal to our net taxable income, if and to the extent authorized by our board of directors. Any distributions we make are at the discretion of our board of directors and depend upon, among other things, our actual results of operations. These results and our ability to pay distributions are affected by various factors, including the net interest and other income from our portfolio, our operating expenses and any other expenditures. If our cash available for distribution is less than our net taxable income, we could be required to sell assets or borrow funds to make cash distributions or we may make a portion of the required distribution in the form of a taxable stock distribution or

45

distribution of debt securities.

As of September 30, 2020, we had 6,770,393 shares of Series B Preferred Stock outstanding, which entitles holders to receive dividends that are payable quarterly in arrears. The Series B Preferred Stock pay cumulative cash dividends, which are payable quarterly in equal amounts in arrears on the 15th day of each January, April, July and October: (i) from, and including, the original date of issuance of the Series B Preferred Stock to, but excluding, September 20, 2020, at an initial rate of 8.00% per annum of the $25.00 per share liquidation preference; and (ii) from, and including, September 20, 2020, at the rate per annum equal to the greater of (a) 8.00% and (b) a floating rate equal to the 3-month LIBOR rate as calculated on each applicable date of determination plus 6.46% of the $25.00 liquidation preference. Except under certain limited circumstances, the Series B Preferred Stock is generally not convertible into or exchangeable for any other property or any other of our securities at the election of the holders. We may, at our option, redeem the shares at a redemption price of $25.00, plus any accrued unpaid distribution through the date of the redemption.

In June 2019, we redeemed all 6,900,000 shares of Series C Preferred Stock outstanding. Holders of the Series C Preferred Stock received the redemption price of $25.00 plus accumulated but unpaid dividends to the redemption date of $0.2223.

Non-GAAP Financial Measures

Operating Earnings

For the three and nine months ended September 30, 2020, our Operating Earnings were $52.9 million, or $0.36 per share, and $104.3 million, or $0.68 per share, respectively, as compared to $72.6 million, or $0.47 per share, and $197.6 million, or $1.35 per share, respectively, for the same periods in the prior year. Operating Earnings is a non-GAAP financial measure that we define as net income available to common stockholders, computed in accordance with GAAP, adjusted for (i) equity-based compensation expense (a portion of which may become cash-based upon final vesting and settlement of awards should the holder elect net share settlement to satisfy income tax withholding), (ii) any unrealized gains or losses or other non-cash items included in net income available to common stockholders, (iii) unrealized income from unconsolidated joint ventures, (iv) foreign currency gains (losses), other than (a) realized gains/(losses) related to interest income, and (b) forward point gains/(losses) realized on our foreign currency hedges, (v) the non-cash amortization expense related to the reclassification of a portion of the Notes to stockholders’ equity in accordance with GAAP, and (vi) provision for loan losses. Operating Earnings may also be adjusted to exclude certain other non-cash items, as determined by the Manager and approved by a majority of our independent directors.

The table below summarizes the reconciliation from weighted-average basic and diluted shares under GAAP to the weighted-average diluted shares used for Operating Earnings ($ in thousands):

	Three months ended September 30,		Nine months ended September 30,
	2020	2019	2020	2019
Weighted-Averages	Shares	Shares	Shares	Shares
Weighted-average basic and diluted shares - GAAP	146,612,313	153,531,678	150,679,773	144,638,237
Unvested RSUs	2,051,311	1,839,631	2,028,573	1,845,086
Weighted-average diluted shares - Operating Earnings	148,663,624	155,371,309	152,708,346	146,483,323

In order to evaluate the effective yield of the portfolio, we use Operating Earnings to reflect the net investment income of our portfolio as adjusted to include the net interest income or expense related to our derivative instruments. Forward points effectively convert our foreign rate exposure to USD LIBOR, which we believe is a better reflection of our operating results and we believe the inclusion of the resulting gain or loss in Operating Earnings is useful to our investors. Operating Earnings allows us to isolate the net interest income or expense associated with our swaps and caps in order to monitor and project our full cost of borrowings.

As discussed in “Note 10 - Derivatives” we terminated our interest rate swap, which we used to manage exposure to variable cash flows on our borrowings under our senior secured term loan, in the second quarter of 2020 and recorded a realized loss in our condensed consolidated statement of operations. As of September 30, 2020, there are no interest rate swaps on our condensed consolidated balance sheet. In addition, as discussed in “Note 4 - Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net,” we recorded a net realized loss on the sale of a residential-for-sale: inventory loan, three construction loans and, in connection with a troubled debt restructuring, on one hotel loan.

46

We believe it is useful to our investors to also present Operating Earnings excluding realized loss on investments and realized loss on interest rate swap to reflect our operating results because our operating results are primarily comprised of earning interest income on our investments net of borrowing and administrative costs, which are our ongoing operations. We believe that our investors use Operating Earnings and Operating Earnings excluding realized loss on investments and realized loss on interest rate swap, or a comparable supplemental performance measure, to evaluate and compare the performance of our company and our peers and, as such, we believe that the disclosure of Operating Earnings and Operating Earnings excluding realized loss on investments and realized loss on interest rate swap is useful to our investors.

A significant limitation associated with Operating Earnings as a measure of our financial performance over any period is that it excludes unrealized gains (losses) from investments. In addition, our presentation of Operating Earnings may not be comparable to similarly-titled measures of other companies, that use different calculations. As a result, Operating Earnings should not be considered as a substitute for our GAAP net income as a measure of our financial performance or any measure of our liquidity under GAAP.

    The table below summarizes the reconciliation from net income (loss) available to common stockholders to Operating Earnings and Operating Earnings excluding realized loss on investments and realized loss on interest rate swap ($ in thousands):

	Three months ended September 30,				Nine months ended September 30,
	2020		2019		2020		2019
Net income (loss) available to common stockholders	$	45,953	$	25,704	$	(28,458)	$	143,132
Adjustments:
Equity-based compensation expense	4,212		3,889		12,726		12,084
Unrealized (gain) loss on interest rate swap	—		10,307		(14,470)		23,420
(Gain) loss on currency forwards	34,537		(24,153)		(32,959)		(28,619)
Foreign currency (gain) loss, net	(27,002)		19,129		8,388		20,012
Unrealized (gain) loss on interest rate cap	564		—		(174)		—
Realized gains (losses) relating to interest income on foreign currency hedges, net	(90)		870		1,254		1,614
Realized gains relating to forward points on foreign currency hedges, net	244		1,076		3,733		3,552
Amortization of the convertible senior notes related to equity reclassification	777		732		2,296		2,362
Provision for (reversal of) loan losses	(6,342)		35,000		151,954		20,000
Total adjustments:	6,900		46,850		132,748		54,425
Operating Earnings	$	52,853	$	72,554	$	104,290	$	197,557
Realized loss on investments	1,037		—		17,442		12,513
Realized loss on interest rate swap	—		—		53,851		—
Operating Earnings excluding realized loss on investments and realized loss on interest rate swap	$	53,890	$	72,554	$	175,583	$	210,070
Diluted Operating Earnings per share of common stock	$	0.36	$	0.47	$	0.68	$	1.35
Diluted Operating Earnings excluding realized loss on investments and realized loss on interest rate swap	$	0.36	$	0.47	$	1.15	$	1.43
Basic weighted-average shares of common stock outstanding	146,612,313		153,531,678		150,679,773		144,638,237
Weighted-average diluted shares - Operating Earnings	148,663,624		155,371,309		152,708,346		146,483,323

47

Book Value Per Share

The table below calculates our book value per share ($ in thousands, except per share data):

	September 30, 2020		December 31, 2019
Stockholders' Equity	$	2,319,281	$	2,629,975
Series B Preferred Stock (Liquidation Preference)	(169,260)		(169,260)
Common Stockholders' Equity	$	2,150,021	$	2,460,715
Common Stock	143,288,347		153,537,296
Book value per share	$	15.00	$	16.03

The table below shows the changes in our book value per share:

	Book value per share
Book value per share at December 31, 2019	$	16.03
Net unrealized gain on currency hedges	0.15
Repurchase of common stock	0.45
Decrease in fair value on interest rate swap	(0.27)
Vesting and delivery of RSUs	(0.07)
Other	(0.01)
Book value per share at September 30, 2020 prior to CECL Allowances	$	16.28
Specific CECL Allowance	$	(0.98)
Book value per share at September 30, 2020 prior to General CECL Allowance	$	15.30
General CECL Allowance	$	(0.30)
Book value per share at September 30, 2020	$	15.00

We believe that presenting book value per share with sub-totals prior to the CECL Allowances is useful for investors for various reasons, including, among other things, analyzing our compliance with financial covenants related to tangible net worth and debt-to-equity under our secured debt arrangements and senior secured term loan permit us to add the General CECL Allowance to our GAAP stockholders' equity. Given that our lenders consider book value per share prior to the General CECL Allowance as an important metric related to our debt covenants, we believe disclosing book value per share prior to the General CECL Allowance is important to investors such that they have the same visibility.

48

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We seek to manage our risks related to the credit quality of our assets, interest rates, liquidity, prepayment speeds and market value, while, at the same time, seeking to provide an opportunity to stockholders to realize attractive risk-adjusted returns through ownership of our capital stock. While risks are inherent in any business enterprise, we seek to quantify and justify risks in light of available returns and to maintain capital levels consistent with the risks we undertake.

Credit Risk

One of our strategic focuses is acquiring assets that we believe to be of high credit quality. We believe this strategy will generally keep our credit losses and financing costs low. However, we are subject to varying degrees of credit risk in connection with our other target assets. We seek to mitigate this risk by seeking to acquire high quality assets, at appropriate prices given anticipated and unanticipated losses, and by deploying a value-driven approach to underwriting and diligence, consistent with the Manager’s historical investment strategy, with a focus on current cash flows and potential risks to cash flow. The Manager seeks to enhance its due diligence and underwriting efforts by accessing the Manager’s knowledge base and industry contacts. Nevertheless, unanticipated credit losses could occur, which could adversely impact our operating results.

Interest Rate Risk

Interest rates are highly sensitive to many factors, including fiscal and monetary policies and domestic and international economic and political considerations, as well as other factors beyond our control. We are subject to interest rate risk in connection with our target assets and our related financing obligations.

To the extent consistent with maintaining our REIT qualification, we seek to manage risk exposure to protect our portfolio of financial assets against the effects of major interest rate changes. We generally seek to manage this risk by:

•attempting to structure our financing agreements to have a range of different maturities, terms, amortizations and interest rate adjustment periods;

•using hedging instruments, interest rate swaps; and

•to the extent available, using securitization financing to better match the maturity of our financing with the duration of our assets.

The following table estimates the hypothetical impact on our net interest income for the twelve-month period following September 30, 2020, assuming an immediate increase or decrease of 50 basis points in the applicable interest rate benchmark by currency ($ in thousands, except per share data):

			50 basis point increase				50 basis point decrease
Currency	Net floating rate assets subject to interest rate sensitivity		Increase (Decrease) to net interest income (1)(2)		Decrease to net interest income (per share) (1)(2)		Increase (Decrease) to net interest income (1)(2)		Increase to net interest income (per share) (1)(2)
USD	$	1,036,853	$	(10,867)	$	(0.08)	$	3,127	$	0.02
GBP	428,213		(58)		—		69		—
EUR	307,899		—		—		—		—
Total:	$	1,772,965	$	(10,925)	$	(0.08)	$	3,196	$	0.02

———————

(1)Any such hypothetical impact on interest rates on our variable rate borrowings does not consider the effect of any change in overall economic activity that could occur in a rising or falling interest rate environment. Further, in the event of a change in interest rates of that magnitude, we may take actions to further mitigate our exposure to such a change. However, due to the uncertainty of the specific actions that would be taken and their possible effects, this analysis assumes no changes in our financial structure.

(2)Certain of our floating rate loans are subject to a LIBOR floor.

Prepayment Risk

Prepayment risk is the risk that principal will be repaid at a different rate than anticipated, causing the return on an asset to be less than expected. In certain cases, we adapt to prepayment risk by stating prepayment penalties in loan agreements.

49

Market Risk

Commercial mortgage assets are subject to volatility and may be affected adversely by a number of factors, including, but not limited to, national, regional and local economic conditions (which may be adversely affected by industry slowdowns and other factors); local real estate conditions; changes or continued weakness in specific industry segments; construction quality, age and design; demographic factors; retroactive changes to building or similar codes; pandemics; natural disasters and other acts of god. In addition, decreases in property values reduce the value of the collateral and the potential proceeds available to a borrower to repay the underlying loans or loans, as the case may be, which could also cause us to suffer losses. Market volatility has been particularly heightened due to the COVID-19 global pandemic. COVID-19 has disrupted economic activities and could have a continued significant adverse effect on economic and market conditions including limited lending from financial institutions, depressed asset values, and limited market liquidity.

Inflation

Virtually all of our assets and liabilities are interest rate sensitive in nature. As a result, interest rates and other factors influence our performance far more so than does inflation. Changes in interest rates do not necessarily correlate with inflation rates or changes in inflation rates. Our financial statements are prepared in accordance with GAAP and distributions are determined by our board of directors consistent with our obligation to distribute to our stockholders at least 90% of our REIT taxable income, excluding net capital gains and determined without regard to the dividends paid deduction, on an annual basis in order to maintain our REIT qualification. In each case, our activities and balance sheet are measured with reference to historical cost and/or fair market value without considering inflation.

Currency Risk

Some of our loans and secured debt arrangements are denominated in a foreign currency and subject to risks related to fluctuations in currency rates. We seek to mitigate this exposure through foreign currency forward contracts, which match the net principal and interest of our foreign currency loans and secured debt arrangements.

50

Item 4. Controls and Procedures.

    Our Chief Executive Officer and Chief Financial Officer, based on their evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) required by paragraph (b) of Rule 13a-15 or Rule 15d-15, have concluded that as of the end of the period covered by this report, our disclosure controls and procedures were effective to give reasonable assurances to the timely collection, evaluation and disclosure of information relating to ARI that would potentially be subject to disclosure under the Exchange Act, and the rules and regulations promulgated thereunder.

    During the period ended September 30, 2020, there was no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

    Notwithstanding the foregoing, a control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that it will detect or uncover failures within ARI to disclose material information otherwise required to be set forth in our periodic reports.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

     From time to time, we may be involved in various claims and legal actions arising in the ordinary course of business. On June 28, 2018, AmBase Corporation, 111 West 57th Street Manager Funding LLC and 111 West 57th Investment LLC commenced an action captioned AmBase Corporation et al v. ACREFI Mortgage Lending, LLC et al (No 653251/2018) in New York Supreme Court. The complaint names as defendants (i) ACREFI Mortgage Lending, LLC, a subsidiary of the Company, (ii) the Company, and (iii) certain funds managed by Apollo, which are co-lenders on a mezzanine loan against the development of a residential condominium building in Manhattan, New York. The plaintiffs allege that the defendants tortiously interfered with the contractual equity put right in the plaintiffs’ joint venture agreement with the developers of the project, and that the defendants aided and abetted breaches of fiduciary duty by the developers of the project. The plaintiffs allege the loss of a $70.0 million investment as part of total damages of $700.0 million, which includes punitive damages. The defendants' motion to dismiss was granted on October 23, 2019 and the Court entered judgment dismissing the complaint in its entirety on November 8, 2019. Plaintiffs filed a timely notice of appeal on December 6, 2019 and, as of September 28, 2020, the parties have now fully briefed the appeal. We are awaiting scheduling of oral argument. We believe the claims are without merit and do not believe this will have a material adverse effect on our condensed consolidated financial statements.

Item 1A. Risk Factors

For information regarding factors that could affect our results of operations, financial condition and liquidity, see the risk factors discussed in "Item 1A. Risk Factors" in our Annual Report.

In light of developments relating to the COVID-19 pandemic occurring subsequent to the filing of our Annual Report, we are supplementing the risk factors discussed in our Annual Report with the following risk factor, which should be read in conjunction with the risk factors contained in our Annual Report.

Major public health issues, including the current outbreak of COVID-19, and related disruptions in the U.S. and global economy and financial markets have and continue to adversely impact or disrupt our financial condition and results of operations.

The recent outbreak of COVID-19 in many countries continues to adversely impact global economic activity and has contributed to significant volatility in financial markets. On March 11, 2020, the World Health Organization publicly characterized COVID-19 as a pandemic. On March 13, 2020, the President of the United States declared the COVID-19 outbreak a national emergency. The global impact of the outbreak has been rapidly evolving, and as cases of the virus increased around the world, governments and organizations have implemented a variety of actions to mobilize efforts to mitigate the ongoing and expected impact. Many governments, including where real estate is located that secures or underlies a significant portion of our mortgage and other real estate-related loans, have reacted by instituting quarantines, restrictions on travel, school closures, bans on public events and on public gatherings, “shelter in place”, “stay at home” and "safer-at-home" rules, restrictions on types of business that may continue to operate, with exceptions, in certain cases, available for certain essential operations and businesses, and/or restrictions on types of construction projects that may continue. Further, such actions have created, and expect to continue to create disruption in real estate financing transactions and the commercial real estate market and adversely impact a number of industries. The outbreak could have a continued adverse impact on economic and market conditions and continue to cause regional, national and global economic slowdowns and potentially trigger recessions in any or all of these areas.

51

In the United States, there have been a number of federal, state and local government initiatives applicable to a significant number of mortgage loans, to manage the spread of the virus and its impact on the economy, financial markets and continuity of businesses of all sizes and industries. On March 27, 2020, the U.S. Congress approved the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), and President Trump signed it into law. The CARES Act provides approximately $2 trillion in financial assistance to individuals and businesses resulting from the outbreak of COVID-19. The CARES Act, among other things, provides certain measures to support individuals and businesses in maintaining solvency through monetary relief, including in the form of financing and loan forgiveness and/or forbearance. Although this action by the federal government, together with other actions taken at the federal, regional and local levels are intended to support these economies, there is no guarantee that such measures will provide sufficient relief to avoid continued adverse effects on the economy and potentially a recession. Similar actions have been taken by governments around the globe but as is the case in the United States there is no assurance that such measures will prevent further economic disruptions, which may be significant, around the world.

We believe that our and the Manager's ability to operate, our level of business activity and the profitability of our business, as well as the values of, and the cash flows from, the assets we own have been, and will continue to be impacted by the effects of COVID-19 and could in the future be impacted by another pandemic or other major public health issues. While we have implemented risk management and contingency plans and taken preventive measures and other precautions, no predictions of specific scenarios can be made with respect to the COVID-19 pandemic and such measures may not adequately predict the impact on our business from such events.

The effects of COVID-19 have adversely impacted the value of our assets, business, financial condition, results of operations and cash flows, and our ability to operate successfully. Some of the factors that impacted us to date and may continue to affect us include the following:

•difficulty accessing debt and equity capital on attractive terms, or at all, and a severe disruption and instability in the financial markets or deteriorations in credit and financing conditions may affect our ability and our borrowers’ ability to make regular payments of principal and interest (whether due to an inability to make such payments, an unwillingness to make such payments, or a waiver of the requirement to make such payments on a timely basis or at all);

•the extent the value of commercial real estate declines, which would also likely negatively impact the value of the loans we own, which could lead to additional margin calls;

•our ability to continue to satisfy any additional margin calls from our lenders and to the extent we are unable to satisfy any such margin calls, any acceleration of our indebtedness, increase in the interest rate on advanced funds, termination of our ability to borrow funds from them, or foreclosure by our lenders on our assets;

•our ability to remain in compliance with the financial covenants in our financing agreements with our lenders in the event of impairments in the value of the loans we own;

•disruptions to the efficient function of our operations because of, among other factors, any inability to access short-term or long-term financing for the mortgage loans and other real estate-related loans we make;

•our need to sell assets, including at a loss;

•to the extent we elect or are forced to reduce our loan origination activities;

•inability of borrowers under our construction loans to continue or complete construction as planned for their operations, which may affect their ability to complete construction and collect rent and, consequently, their ability to pay principal or interest on our construction loans;

•inability by loan servicers to operate in affected areas or at all, including due to the bankruptcy of one or more servicers, or the inability of the Manager to effectively oversee servicers in certain of their activities or perform certain loan administration functions;

•inability of other third-party vendors we rely on to conduct our business to operate effectively and continue to support our business and operations, including vendors that provide IT services, legal and accounting services, or other operational support services;

•decreases in observable market activity or unavailability of information, resulting in restricted access to key inputs used to derive certain estimates and assumptions made in connection with financial reporting or otherwise, including valuing the loans we own, including estimated impairments, and estimates and changes in long term macro-economic assumptions relating to accounting for CECL Allowances;

•effects of legal and regulatory responses to concerns about the COVID-19 pandemic and related public health issues, which could result in additional regulation or restrictions affecting the conduct of our business; and

•our ability to ensure operational continuity in the event our business continuity plan is not effective or ineffectually implemented or deployed during a disruption.

The rapid development and fluidity of the circumstances resulting from this pandemic precludes any prediction as to the ultimate adverse impact of COVID-19. There are no comparable recent events which provide guidance as to the effect of the spread of COVID-19 and a pandemic on our business. Nevertheless, COVID-19 and the current financial, economic and capital

52

markets environment, and future developments in these and other areas present material uncertainty and risk with respect to our performance, financial condition, volume of business, results of operations and cash flows. Moreover, many risk factors set forth in our Annual Report should be interpreted as heightened risks as a result of the impact of the COVID-19 pandemic.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

The following table sets forth the Company's repurchases of common stock during the three months ended September 30, 2020 ($ in thousands, except per share data):

Period	Total Number of Shares Purchased(1)	Weighted Average Price Paid per Share		Total Number of Shares of Common Stock Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
July 2020	688,762	$	8.93	688,762	$	97,557
August 2020	1,529,015	9.21		1,529,015	83,443
September 2020	2,820,842	8.93		2,820,842	58,199
Total	5,038,619	$	9.01	5,038,619	$	58,199

———————

(1)On March 16, 2020, we announced that our board of directors approved a stock repurchase program to authorize the Company to repurchase up to an aggregate of $150.0 million of our common stock. This repurchase program has no expiration date and may be suspended or terminated by us at any time without prior notice. This $150.0 million program replaced the previous program authorized in November 2013, which was terminated.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not Applicable.

Item 5. Other Information

None.

Item 6. Exhibits

3.1	Articles of Amendment and Restatement of Apollo Commercial Real Estate Finance, Inc., incorporated by reference to Exhibit 3.1 of the Registrant’s Form S-11, as amended (Registration No. 333-160533).
3.2	Articles Supplementary designating Apollo Commercial Real Estate Finance, Inc.’s 8.00% Fixed-to-Floating Series B Cumulative Redeemable Perpetual Preferred Stock, liquidation preference $25.00 per share, par value $0.01 per share, incorporated by reference to Exhibit 3.1 of the Registrant’s Form 8-K filed on September 23, 2015 (File No.: 001-34452).
3.3	By-laws of Apollo Commercial Real Estate Finance, Inc., incorporated by reference to Exhibit 3.2 of the Registrant’s Form S-4 (Registration No. 333-210632).
4.1	Specimen Stock Certificate of Apollo Commercial Real Estate Finance, Inc., incorporated by reference to Exhibit 4.1 of the Registrant’s Form S-11, as amended (Registration No. 333-160533).
4.2	Specimen Stock Certificate of Apollo Commercial Real Estate Finance, Inc.’s 8.00% Fixed-to-Floating Series B Cumulative Redeemable Perpetual Preferred Stock, liquidation preference $25.00 per share, par value $0.01 per share, incorporated by reference to Exhibit 4.1 of the Registrant’s Current Report on Form 8-K filed on September 23, 2015.

53

4.3	Indenture, dated as of March 17, 2014, between the Registrant and Wells Fargo Bank, National Association, as Trustee, incorporated by reference to Exhibit 4.1 of the Registrant’s Form 8-K filed on March 21, 2014 (File No.: 001-34452).
4.4	Second Supplemental Indenture, dated as of August 21, 2017, between the Registrant and Wells Fargo Bank, National Association, as Trustee (including the form of 4.75% Convertible Senior Note due 2022), incorporated by reference to Exhibit 4.2 of the Registrant’s Form 8-K filed on August 21, 2017 (File No.: 001-34452).
4.5	Third Supplemental Indenture, dated as of October 5, 2018 between the Registrant and Wells Fargo Bank, National Association, as Trustee (including the form of 5.375% Convertible Senior Note due 2023), incorporated by reference to Exhibit 4.2 of the Registrant's Form 8-K filed on October 5, 2018 (File No.: 001-34452).
31.1*	Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*	Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*	Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of 18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act of 2002. Officer and Principal Financial Officer pursuant to Section 906 of 18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act of 2002.
101.INS*	Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH*	Inline XBRL Taxonomy Extension Schema
101.CAL*	Inline XBRL Taxonomy Extension Calculation Linkbase
101.DEF*	Inline XBRL Taxonomy Extension Definition Linkbase
101.LAB*	Inline XBRL Taxonomy Extension Label Linkbase
101.PRE*	Inline XBRL Taxonomy Extension Presentation Linkbase
104*	Cover Page Interactive Data File (embedded with the Inline XBRL document)

* Filed herewith.

54

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		APOLLO COMMERCIAL REAL ESTATE FINANCE, INC.
October 26, 2020
	By:	/s/ Stuart A. Rothstein
		Stuart A. Rothstein
		President and Chief Executive Officer
		(Principal Executive Officer)
	By:	/s/ Jai Agarwal
		Jai Agarwal
		Chief Financial Officer, Treasurer and Secretary
		(Principal Financial Officer and Principal Accounting Officer)

55

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Stuart A. Rothstein, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Apollo Commercial Real Estate Finance, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 26, 2020	By:	/s/ Stuart A. Rothstein
	Name:	Stuart A. Rothstein
	Title:	President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Jai Agarwal, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Apollo Commercial Real Estate Finance, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 26, 2020	By:	/s/ Jai Agarwal
	Name:	Jai Agarwal
	Title:	Chief Financial Officer, Treasurer and Secretary

EX-32.1

Exhibit 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S. C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, the President and Chief Executive Officer of Apollo Commercial Real Estate Finance, Inc. (the "Company"), hereby certifies on the date hereof, pursuant to 18 U.S.C. 1350(a), as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q for the period ended September 30, 2020 (the "Form 10-Q"), filed concurrently herewith by the Company, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: October 26, 2020	By:	/s/ Stuart A. Rothstein
	Name:	Stuart A. Rothstein
	Title:	President and Chief Executive Officer

The undersigned, the Chief Financial Officer, Treasurer and Secretary of Apollo Commercial Real Estate Finance, Inc. (the "Company"), hereby certifies on the date hereof, pursuant to 18 U.S.C. 1350(a), as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q for the period ended September 30, 2020 (the "Form 10-Q"), filed concurrently herewith by the Company, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: October 26, 2020	By:	/s/ Jai Agarwal
	Name:	Jai Agarwal
	Title:	Chief Financial Officer, Treasurer and Secretary

Pursuant to the Securities and Exchange Commission Release 33-8238, dated June 5, 2003, this certification is being furnished and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended or incorporated by reference in any registration statement of the Company filed under the Securities Act of 1933, as amended.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover Page - shares	9 Months Ended
	Sep. 30, 2020	Oct. 25, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2020
Document Transition Report	false
Entity File Number	001-34452
Entity Registrant Name	Apollo Commercial Real Estate Finance, Inc.
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	27-0467113
Entity Address, Address Line One	9 West 57th Street
Entity Address, Address Line Two	43rd Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10019
City Area Code	212
Local Phone Number	515–3200
Title of 12(b) Security	Common Stock, $0.01 par value
Trading Symbol	ARI
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Small Business Entity	false
Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		140,296,764
Amendment flag	false
Document fiscal year focus	2020
Document fiscal period focus	Q3
Entity central index key	0001467760
Current fiscal year end date	--12-31

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)		Sep. 30, 2020	Dec. 31, 2019
Assets:
Cash and cash equivalents		$ 438,234,000	$ 452,282,000
Total carrying value, net		6,437,037,000	6,375,093,000
Derivative assets, net		13,654,000	0
Other assets		43,644,000	52,716,000
Loan proceeds held by servicer		0	8,272,000
Total Assets		6,932,569,000	6,888,363,000
Liabilities:
Secured debt arrangements, net (net of deferred financing costs of $12,746 and $17,190 in 2020 and 2019, respectively)		3,465,337,000	3,078,366,000
Convertible senior notes, net		564,611,000	561,573,000
Senior secured term loan, net (net of deferred financing costs of $7,565 and $7,277 in 2020 and 2019, respectively)		484,191,000	487,961,000
Accounts payable, accrued expenses and other liabilities	[1]	89,222,000	100,712,000
Payable to related party		9,927,000	10,430,000
Derivative liabilities		0	19,346,000
Total Liabilities		4,613,288,000	4,258,388,000
Commitments and Contingencies (see Note 15)
Stockholders’ Equity:
Preferred stock, $0.01 par value, 50,000,000 shares authorized, Series B, 6,770,393 shares issued and outstanding ($169,260 liquidation preference)		68,000	68,000
Common stock, $0.01 par value, 450,000,000 shares authorized, 143,288,347 and 153,537,296 shares issued and outstanding in 2020 and 2019, respectively		1,433,000	1,535,000
Additional paid-in-capital		2,739,851,000	2,825,317,000
Accumulated deficit		(422,071,000)	(196,945,000)
Total Stockholders’ Equity		2,319,281,000	2,629,975,000
Total Liabilities and Stockholders’ Equity		6,932,569,000	6,888,363,000
Commercial Mortgage Portfolio Segment
Assets:
Total carrying value, net	[2],[3]	5,427,945,000	5,326,967,000
Subordinate Mortgage Portfolio Segment
Assets:
Total carrying value, net	[3]	$ 1,009,092,000	$ 1,048,126,000

[1] Includes $3,595 of General CECL Allowance related to unfunded commitments on commercial mortgage loans, subordinate loans and other lending assets, net in 2020.

[2] Includes $5,405,220 and $4,852,087 pledged as collateral under secured debt arrangements in 2020 and 2019, respectively

[3] Net of $236,207 CECL Allowances in 2020, comprised of $196,931 Specific CECL Allowance and $39,276 General CECL Allowance. Net of $56,981 provision for loan loss in 2019.

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Deferred financing costs	$ 12,746	$ 17,190
Deferred financing costs	$ 7,565	$ 7,277
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	6,770,393	6,770,393
Preferred stock, shares outstanding (in shares)	6,770,393	6,770,393
Preferred stock, liquidation preference	$ 169,260	$ 169,260
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	450,000,000	450,000,000
Common stock, shares issued (in shares)	143,288,347	153,537,296
Common stock, shares outstanding (in shares)	143,288,347	153,537,296
CECL allowance	$ 236,207	$ 39,276
Loan specific reserves	196,931	56,981
General CECL allowance related to unfunded commitments	3,595	0
Commercial Mortgage Portfolio Segment
Loans pledged as collateral	$ 5,405,220	$ 4,852,087

XML

Condensed Consolidated Statement of Operations (Unaudited) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Net interest income:
Interest income from commercial mortgage loans		$ 74,522	$ 81,136	$ 232,018	$ 236,880
Interest income from subordinate loans and other lending assets		28,857	43,421	95,491	125,303
Interest expense		(34,824)	(39,341)	(113,527)	(109,147)
Net interest income		68,555	85,216	213,982	253,036
Operating expenses:
General and administrative expenses (includes equity-based compensation of $4,212 and $12,727 in 2020 and $3,889 and $12,084 in 2019, respectively)		(6,624)	(5,839)	(19,580)	(18,564)
Management fees to related party		(9,927)	(10,434)	(30,152)	(30,306)
Total operating expenses		(16,551)	(16,273)	(49,732)	(48,870)
Other income		128	429	1,479	1,431
Realized loss on investments		(1,037)	0	(17,442)	(12,513)
Reversal of (provision for) loan losses	[1]	6,342	(35,000)	(151,954)	(20,000)
Foreign currency translation gain (loss)		27,002	(19,129)	(8,388)	(20,012)
Gain (loss) on sale of derivatives		(564)	(10,307)	(39,207)	(23,420)
Net income (loss)		49,338	29,089	(18,303)	158,271
Preferred dividends		(3,385)	(3,385)	(10,155)	(15,139)
Net income (loss) available to common stockholders		$ 45,953	$ 25,704	$ (28,458)	$ 143,132
Net income (loss) per share of common stock:
Basic (in dollars per share)		$ 0.31	$ 0.16	$ (0.20)	$ 0.97
Diluted (in dollars per share)		$ 0.31	$ 0.16	$ (0.20)	$ 0.97
Basic weighted-average shares of common stock outstanding (in shares)		146,612,313	153,531,678	150,679,773	144,638,237
Diluted weighted-average shares of common stock outstanding (in shares)		146,612,313	153,531,678	150,679,773	144,638,237
Dividend declared per share of common stock (in dollars per share)		$ 0.35	$ 0.46	$ 1.10	$ 1.38
Forward currency contracts
Operating expenses:
Gain (loss) on sale of derivatives		$ (34,537)	$ 24,153	$ 32,959	$ 28,619
Interest rate cap and swaps
Operating expenses:
Gain (loss) on sale of derivatives		$ (564)	$ (10,307)	$ (39,207)	$ (23,420)

[1] Comprised of $550 and $(139,950) of Specific CECL Reversal (Allowance) and $5,792 and $(12,004) of General CECL Reversal (Allowance) for the three and nine months ended September 30, 2020, respectively.

XML

Condensed Consolidated Statement of Operations (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020
General and administrative expenses, equity-based compensation	$ 4,212	$ 12,727
Unrealized gain (loss) on derivatives		33,000
Specific CECL allowance	550	(139,950)
General CECL Allowance (Reversal)	5,792	(12,004)
Foreign currency forward, net
Unrealized gain (loss) on derivatives	(35,076)	18,356
Interest rate cap and swaps
Unrealized gain (loss) on derivatives	$ (564)	$ 14,644

XML

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid-In-Capital	Accumulated Deficit	Adjustment due to Adoption of ASU	Adjustment due to Adoption of ASU Accumulated Deficit
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2018		13,670,393	133,853,565
Stockholders' equity, beginning balance at Dec. 31, 2018	$ 2,509,747	$ 137	$ 1,339	$ 2,638,441	$ (130,170)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Capital increase (decrease) related to Equity Incentive Plan (in shares)			433,426
Capital increase (decrease) related to Equity Incentive Plan	(1,095)		$ 4	(1,099)
Conversions of convertible senior notes for common stock (in shares)			1,967,361
Conversions of convertible senior notes for common stock	33,778		$ 20	33,758
Net income (loss)	67,758				67,758
Dividends declared on preferred stock	(6,835)				(6,835)
Dividends declared on common stock	(63,529)				(63,529)
Stockholders' equity, ending balance (in shares) at Mar. 31, 2019		13,670,393	136,254,352
Stockholders' equity, ending balance at Mar. 31, 2019	2,539,824	$ 137	$ 1,363	2,671,100	(132,776)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2018		13,670,393	133,853,565
Stockholders' equity, beginning balance at Dec. 31, 2018	2,509,747	$ 137	$ 1,339	2,638,441	(130,170)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	158,271
Stockholders' equity, ending balance (in shares) at Sep. 30, 2019		6,770,393	153,531,756
Stockholders' equity, ending balance at Sep. 30, 2019	2,629,510	$ 68	$ 1,535	2,821,419	(193,512)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2018		13,670,393	133,853,565
Stockholders' equity, beginning balance at Dec. 31, 2018	2,509,747	$ 137	$ 1,339	2,638,441	(130,170)
Stockholders' equity, ending balance (in shares) at Dec. 31, 2019		6,770,393	153,537,296
Stockholders' equity, ending balance at Dec. 31, 2019	$ 2,629,975	$ 68	$ 1,535	2,825,317	(196,945)	$ (30,867)	$ (30,867)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	us-gaap:AccountingStandardsUpdate201613Member
Stockholders' equity, beginning balance (in shares) at Mar. 31, 2019		13,670,393	136,254,352
Stockholders' equity, beginning balance at Mar. 31, 2019	$ 2,539,824	$ 137	$ 1,363	2,671,100	(132,776)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Capital increase (decrease) related to Equity Incentive Plan (in shares)			27,245
Capital increase (decrease) related to Equity Incentive Plan	4,294			4,294
Issuance of common stock (in shares)			17,250,000
Issuance of common stock	315,157		$ 172	314,985
Redemption of preferred stock (in shares)		(6,900,000)
Redemption of preferred stock	(172,500)	$ (69)		(172,431)
Offering costs	(406)			(406)
Net income (loss)	61,424				61,424
Dividends declared on preferred stock	(4,919)				(4,919)
Dividends declared on common stock	(71,475)				(71,475)
Stockholders' equity, ending balance (in shares) at Jun. 30, 2019		6,770,393	153,531,597
Stockholders' equity, ending balance at Jun. 30, 2019	2,671,399	$ 68	$ 1,535	2,817,542	(147,746)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Capital increase (decrease) related to Equity Incentive Plan (in shares)			159
Capital increase (decrease) related to Equity Incentive Plan	3,889			3,889
Offering costs	(12)			(12)
Net income (loss)	29,089				29,089
Dividends declared on preferred stock	(3,385)				(3,385)
Dividends declared on common stock	(71,470)				(71,470)
Stockholders' equity, ending balance (in shares) at Sep. 30, 2019		6,770,393	153,531,756
Stockholders' equity, ending balance at Sep. 30, 2019	2,629,510	$ 68	$ 1,535	2,821,419	(193,512)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2019		6,770,393	153,537,296
Stockholders' equity, beginning balance at Dec. 31, 2019	2,629,975	$ 68	$ 1,535	2,825,317	(196,945)	(30,867)	(30,867)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Capital increase (decrease) related to Equity Incentive Plan (in shares)			503,251
Capital increase (decrease) related to Equity Incentive Plan	(2,231)		$ 5	(2,236)
Repurchase of common stock (in shares)			(300,000)
Repurchase of common stock	(2,441)		$ (3)	(2,438)
Net income (loss)	(127,842)				(127,842)
Dividends declared on preferred stock	(3,385)				(3,385)
Dividends declared on common stock	(62,298)				(62,298)
Stockholders' equity, ending balance (in shares) at Mar. 31, 2020		6,770,393	153,740,547
Stockholders' equity, ending balance at Mar. 31, 2020	2,400,911	$ 68	$ 1,537	2,820,643	(421,337)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2019		6,770,393	153,537,296
Stockholders' equity, beginning balance at Dec. 31, 2019	2,629,975	$ 68	$ 1,535	2,825,317	(196,945)	$ (30,867)	$ (30,867)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(18,303)
Stockholders' equity, ending balance (in shares) at Sep. 30, 2020		6,770,393	143,288,347
Stockholders' equity, ending balance at Sep. 30, 2020	2,319,281	$ 68	$ 1,433	2,739,851	(422,071)
Stockholders' equity, beginning balance (in shares) at Mar. 31, 2020		6,770,393	153,740,547
Stockholders' equity, beginning balance at Mar. 31, 2020	2,400,911	$ 68	$ 1,537	2,820,643	(421,337)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Capital increase (decrease) related to Equity Incentive Plan (in shares)			82,235
Capital increase (decrease) related to Equity Incentive Plan	4,252		$ 1	4,251
Repurchase of common stock (in shares)			(5,495,976)
Repurchase of common stock	(43,838)		$ (55)	(43,783)
Net income (loss)	60,201				60,201
Dividends declared on preferred stock	(3,385)				(3,385)
Dividends declared on common stock	(52,635)				(52,635)
Stockholders' equity, ending balance (in shares) at Jun. 30, 2020		6,770,393	148,326,806
Stockholders' equity, ending balance at Jun. 30, 2020	2,365,506	$ 68	$ 1,483	2,781,111	(417,156)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Capital increase (decrease) related to Equity Incentive Plan (in shares)			160
Capital increase (decrease) related to Equity Incentive Plan	4,212			4,212
Repurchase of common stock (in shares)			(5,038,619)
Repurchase of common stock	(45,522)		$ (50)	(45,472)
Net income (loss)	49,338				49,338
Dividends declared on preferred stock	(3,385)				(3,385)
Dividends declared on common stock	(50,868)				(50,868)
Stockholders' equity, ending balance (in shares) at Sep. 30, 2020		6,770,393	143,288,347
Stockholders' equity, ending balance at Sep. 30, 2020	$ 2,319,281	$ 68	$ 1,433	$ 2,739,851	$ (422,071)

XML

Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) (Parenthetical) - $ / shares	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Stockholders' Equity [Abstract]
Dividends declared on preferred stock (in dollars per share)	$ 0.50	$ 0.50	$ 0.50	$ 0.50	$ 0.50	$ 0.50
Dividends declared on common stock (in dollars per share)	$ 0.35	$ 0.35	$ 0.40	$ 0.46	$ 0.46	$ 0.46	$ 1.10	$ 1.38

XML

Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Thousands		9 Months Ended
		Sep. 30, 2020	Sep. 30, 2019
Cash flows provided by operating activities:
Net income (loss)		$ (18,303)	$ 158,271
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Amortization of discount/premium and PIK		(53,670)	(61,949)
Amortization of deferred financing costs		9,652	8,535
Equity-based compensation		12,721	7,084
Provision for loan losses	[1]	151,954	20,000
Foreign currency loss		34,225	22,111
Unrealized (gain) loss on derivative instruments		(33,000)	11,391
Realized loss on investments		17,442	12,513
Changes in operating assets and liabilities:
Proceeds received from PIK		0	11,469
Other assets		(6,251)	(4,216)
Accounts payable, accrued expenses and other liabilities		(1,233)	2,462
Payable to related party		(503)	630
Net cash provided by operating activities		113,034	188,301
Cash flows used in investing activities:
New funding of commercial mortgage loans		(457,449)	(1,277,606)
Add-on funding of commercial mortgage loans		(262,193)	(271,720)
New funding of subordinate loans and other lending assets		0	(493,017)
Add-on funding of subordinate loans and other lending assets		(47,627)	(18,323)
Proceeds received from the repayment and sale of commercial mortgage loans		528,782	570,305
Proceeds received from the repayment of subordinate loans and other lending assets		5,122	254,019
Origination and exit fees received on commercial mortgage loans, and subordinate loans and other lending assets, net		6,420	24,524
Increase (decrease) in collateral held related to derivative contracts, net		25,130	(19,830)
Net cash (used in) provided by investing activities		(201,815)	(1,231,648)
Cash flows from financing activities:
Proceeds from issuance of common stock		0	315,157
Redemption of preferred stock		0	(172,500)
Repurchase of common stock		(91,801)	0
Payment of offering costs		0	(153)
Proceeds from secured debt arrangements		1,465,757	1,948,037
Repayments of secured debt arrangements		(1,083,849)	(1,264,223)
Repayments of senior secured term loan principal		(3,750)	(1,250)
Proceeds from issuance of senior secured term loan		0	497,500
Exchanges of convertible senior notes		0	(704)
Payment of deferred financing costs		(8,092)	(11,043)
Other financing activities		(6,494)	0
Dividends on common stock		(186,883)	(197,757)
Dividends on preferred stock		(10,155)	(18,589)
Net cash (used in) provided by financing activities		74,733	1,094,475
Net increase in cash and cash equivalents		(14,048)	51,128
Cash and cash equivalents, beginning of period		452,282	109,806
Cash and cash equivalents, end of period		438,234	160,934
Supplemental disclosure of cash flow information:
Interest paid		100,573	96,201
Supplemental disclosure of non-cash financing activities:
Exchange of convertible senior notes for common stock		0	33,778
Dividend declared, not yet paid		54,254	74,855
Offering costs payable		0	200
Loan proceeds held by servicer		0	3,323
Deferred financing costs, not yet paid		2,596	5,420
Transfer of proceeds borrowed under secured credit facilities to Barclays Private Securitization		782,006	0
Restructuring of subordinate loan to commercial mortgage loan		$ 68,500	$ 0

[1] Comprised of $550 and $(139,950) of Specific CECL Reversal (Allowance) and $5,792 and $(12,004) of General CECL Reversal (Allowance) for the three and nine months ended September 30, 2020, respectively.

XML

Organization

9 Months Ended

Sep. 30, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization

Organization

Apollo Commercial Real Estate Finance, Inc. (together with its consolidated subsidiaries, is referred to throughout this report as the "Company," "ARI," "we," "us" and "our") is a corporation that has elected to be taxed as a real estate investment trust ("REIT") for U.S. federal income tax purposes and primarily originates, acquires, invests in and manages performing commercial first mortgage loans, subordinate financings, and other commercial real estate-related debt investments. These asset classes are referred to as our target assets.

We were formed in Maryland on June 29, 2009, commenced operations on September 29, 2009 and are externally managed and advised by ACREFI Management, LLC (the "Manager"), an indirect subsidiary of Apollo Global Management, Inc. (together with its subsidiaries, "Apollo").

We elected to be taxed as a REIT under the Internal Revenue Code of 1986, as amended, commencing with the taxable year ended December 31, 2009. To maintain our tax qualification as a REIT, we are required to distribute at least 90% of our taxable income, excluding net capital gains, to stockholders and meet certain other asset, income, and ownership tests.

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2020

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed consolidated financial statements include our accounts and those of our consolidated subsidiaries. All intercompany amounts have been eliminated. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Our most significant estimates include loan loss allowances. Actual results could differ from those estimates.

These unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019 ("Annual Report"), as filed with the Securities and Exchange Commission (the "SEC"). In the opinion of management, all adjustments (consisting only of normal recurring adjustments) necessary to present fairly our financial position, results of operations and cash flows have been included. Our results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the full year or any other future period.

We currently operate in one reporting segment.

Risks and Uncertainties

During the first quarter of 2020, there was a global outbreak of a novel coronavirus ("COVID-19"), which was declared by the World Health Organization as a pandemic. In response to COVID-19, the United States and numerous other countries have declared national emergencies, which has led to large scale quarantines as well as restrictions to business deemed non-essential. These responses to COVID-19 have disrupted economic activities and could have a continued significant adverse effect on economic and market conditions. As we are still in the midst of the COVID-19 pandemic we are not in a position to estimate the ultimate impact this will have on our business and the economy as a whole. We believe the estimates used in preparing our financial statements and related footnotes are reasonable and supportable based on the best information available to us as of September 30, 2020. The uncertainty surrounding COVID-19 may materially impact the accuracy of the estimates and assumptions used in the financial statements and related footnotes and, as a result, actual results may vary significantly from estimates.

Current Expected Credit Losses ("CECL")

In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-13 "Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments" ("ASU 2016-13"), which we refer to as the "CECL Standard." This update has changed how entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value. The CECL Standard replaced the "incurred loss" approach under existing guidance with an "expected loss" model for instruments measured at amortized cost. The CECL Standard requires entities to record allowances for held-to-maturity debt securities that are deducted from the carrying amount of the assets to present the net carrying value at the amounts expected to be collected on the assets. We continue to record loan specific allowances as a practical expedient under the CECL Standard ("Specific CECL Allowance"), which we apply to assets that are collateral

dependent and where the borrower or sponsor is experiencing financial difficulty. In addition, we now record a general allowance in accordance with the CECL Standard on the remainder of the loan portfolio ("General CECL Allowance", and together with the Specific CECL Allowance, "CECL Allowances") on a collective basis by assets with similar risk characteristics.

The CECL Standard requires us to record an allowance for credit losses that are deducted from the carrying amount of our loan portfolio to present the net carrying value at the amounts expected to be collected on the assets. We adopted the CECL Standard through a cumulative-effect adjustment to retained earnings on January 1, 2020. Subsequent changes to the General CECL Allowance are recognized through net income (loss) on our condensed consolidated statement of operations.

The CECL Standard requires an entity to consider historical loss experience, current conditions, and a reasonable and supportable forecast of the macroeconomic environment. The FASB recognizes the weighted average remaining maturity ("WARM") method as an acceptable approach for computing current expected credit losses. We have adopted the WARM method to comply with the CECL Standard in determining a General CECL Allowance for a majority of our portfolio. In the future, we may use other acceptable methods, such as a probability-of-default/loss-given-default method. For loans where we have deemed the borrower/sponsor to be experiencing financial difficulty, we have elected to apply a practical expedient in which the fair value of the underlying collateral is compared to the amortized cost of the loan in determining a Specific CECL Allowance.

In accordance with the WARM method, an annual historical loss rate is applied to the amortized cost of an asset or pool of assets over the remaining expected life. The WARM method requires consideration of the timing of expected future fundings of existing commitments and repayments over each asset’s remaining life. An annual loss factor, adjusted for macroeconomic estimates, is applied over each subsequent period and aggregated to arrive at the General CECL Allowance.

In determining the General CECL Allowance, we considered various factors including (i) historical loss experience in the commercial real estate lending market, (ii) timing of expected repayments and satisfactions, (iii) expected future funding, (iv) capital subordinate to us when we are the senior lender, (v) capital senior to us when we are the subordinate lender, and (vi) our current and future view of the macroeconomic environment. The standard requires the use of significant judgment to arrive at an estimated credit loss. There is significant uncertainty related to future macroeconomic conditions as the result of COVID-19.

We derived an annual historical loss rate based on a commercial mortgage backed securities ("CMBS") database with historical losses from 1998 through the third quarter of 2020 provided by a third party, Trepp LLC. We applied various filters to arrive at a CMBS dataset most analogous to our current portfolio from which to determine an appropriate historical loss rate. The annual historical loss rate was further adjusted to reflect our expectations of the macroeconomic environment for a reasonable and supportable forecast period which we have determined to be one year.

The General CECL Allowance on subordinate loans is calculated by incorporating both the loan balance of the position(s) of the structurally senior third-party lender(s) and the balance of our subordinate loan(s). The subordinate loans, by virtue of being the first loss position, are required to absorb losses prior to the senior position(s) being impacted, resulting in a higher percentage allowance attributable to the subordinate loan. The General CECL Allowance on unfunded loan commitments is time-weighted based on our expected commitment to fund such obligations. The General CECL Allowance on unfunded commitments is recorded as a liability on our condensed consolidated balance sheet within accounts payable, accrued expenses and other liabilities. At adoption, the General CECL Allowance was $30.9 million and was recorded in our condensed consolidated statement of changes in stockholders’ equity.

Refer to "Note 4 - Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net" for further information regarding CECL.

Secured Debt Arrangements

Secured debt arrangements are accounted for as financing transactions, unless they meet the criteria for sale accounting. Loans financed through a secured debt arrangement remain on our balance sheet as an asset and cash received from the purchaser is recorded on our condensed consolidated balance sheet as a liability. Interest incurred in accordance with secured debt arrangements is recorded as interest expense.

During the second quarter of 2020, we entered into a private securitization with Barclays Bank, plc (the "Barclays Private Securitization"). We have determined that the issuer of this securitization, ACRE Debt 2 PLC, is a Variable Interest Entity ("VIE") of which we were deemed to be the primary beneficiary and therefore, we consolidated the operations of this entity for GAAP. The collateral assets of the securitization are included in commercial mortgage loans, net on our condensed consolidated balance sheet. The liabilities of the securitization to the senior noteholders, excluding the notes held by us, are included in secured debt arrangements, net on our condensed consolidated balance sheet.

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06 "Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity" ("ASU 2020-06"). The intention of ASU 2020-06 is to address the complexities in accounting for certain financial instruments with a debt and equity component. Under ASU 2020-06, the number of accounting models for convertible notes will be reduced and entities that issue convertible debt will be required to use the if-converted method for the computation of diluted "Earnings per share" under ASC 260. ASC 2020-06 is effective for fiscal years beginning after December 15, 2021 and may be adopted through either a modified retrospective method of transition or a fully retrospective method of transition. We are currently assessing the impact this guidance will have on our condensed consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04 “Reference Rate Reform (Topic 848) – Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional expedients and exceptions for applying GAAP to debt instruments, derivatives, and other contracts that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform. This guidance is optional and may be elected through December 31, 2022 using a prospective application on all eligible contract modifications. We have loan agreements, debt agreements, and an interest rate cap that incorporate LIBOR as a referenced interest rate. It is difficult to predict what effect, if any, the phase-out of LIBOR and the use of alternative benchmarks may have on our business or on the overall financial markets. We have not adopted any of the optional expedients or exceptions through September 30, 2020, but will continue to evaluate the possible adoption of any such expedients or exceptions.

XML

Fair Value Disclosure

9 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Fair Value Disclosure

Fair Value Disclosure

GAAP establishes a hierarchy of valuation techniques based on the observability of the inputs utilized in measuring financial instruments at fair values. Market-based or observable inputs are the preferred source of values, followed by valuation models using management's assumptions in the absence of market-based or observable inputs. The three levels of the hierarchy as noted in ASC 820 "Fair Value Measurements and Disclosures" are described below:

Level I — Quoted prices in active markets for identical assets or liabilities.

Level II — Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants would use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others.

Level III — Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used.

While we anticipate that our valuation methods will be appropriate and consistent with valuation methods used by other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date. We will use inputs that are current as of the measurement date, which may include periods of market dislocation, during which price transparency may be reduced.

The estimated fair values of our derivative instruments are determined using a discounted cash flow analysis on the expected cash flows of each instrument. Our derivative instruments are classified as Level II in the fair value hierarchy.

The fair values of foreign exchange forwards are determined by comparing the contracted forward exchange rate to the current market exchange rate. The current market exchange rates are determined by using market spot rates, forward rates and interest rate curves for the underlying countries.

The fair value of interest rate swaps is determined by comparing the present value of remaining fixed payments to the present value of expected floating rate payments based on the forward one-month London Inter-bank Offered Rate ("LIBOR") curve. As of September 30, 2020, we had no interest rate swaps on our condensed consolidated balance sheet.

The fair value of our interest rate cap is determined by using the market standard methodology of discounting the future expected cash receipts that would occur if variable interest rates rise above the strike rate of the interest rate cap. The variable interest rates used in the calculation of projected receipts on the interest rate cap are based on a third party expert's expectation of future interest rates derived from observable market interest rate curves and volatilities.

The following table summarizes the levels in the fair value hierarchy into which our derivative assets were categorized as of September 30, 2020 and December 31, 2019 ($ in thousands): 

	Fair Value as of September 30, 2020								Fair Value as of December 31, 2019
	Level I		Level II		Level III		Total		Level I		Level II		Level III		Total
Foreign currency forward, net	$	—	$	13,481	$	—	$	13,481	$	—	$	—	$	—	$	—
Interest rate cap	—		173		—		173		—		—		—		—
Total financial instruments assets	$	—	$	13,654	$	—	$	13,654	$	—	$	—	$	—	$	—

The following table summarizes the levels in the fair value hierarchy into which our derivative liabilities were categorized as of September 30, 2020 and December 31, 2019 ($ in thousands): 

	Fair Value as of September 30, 2020								Fair Value as of December 31, 2019
	Level I		Level II		Level III		Total		Level I		Level II		Level III		Total
Foreign currency forward, net	$	—	$	—	$	—	$	—	$	—	$	4,876	$	—	$	4,876
Interest rate swap liability	—		—		—		—		—		14,470		—		14,470
Total financial instrument liabilities	$	—	$	—	$	—	$	—	$	—	$	19,346	$	—	$	19,346

XML

Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net

9 Months Ended

Sep. 30, 2020

Receivables [Abstract]

Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net

Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net

Our loan portfolio was comprised of the following at September 30, 2020 and December 31, 2019 ($ in thousands):

Loan Type	September 30, 2020		December 31, 2019
Commercial mortgage loans, net (1)	$	5,427,945	$	5,326,967
Subordinate loans and other lending assets, net	1,009,092		1,048,126
Carrying value, net	$	6,437,037	$	6,375,093

  ———————

(1)Includes $156.4 million and $126.7 million in 2020 and 2019, respectively, of contiguous financing structured as subordinate loans.

Our loan portfolio consisted of 95% floating rate loans, based on amortized cost, as of September 30, 2020 and December 31, 2019, respectively.

Activity relating to our loan portfolio, for the nine months ended September 30, 2020, was as follows ($ in thousands):

	Principal Balance		Deferred Fees/Other Items (1)		Specific Provision for Loan Loss		Carrying Value, Net
December 31, 2019	$	6,467,842	$	(35,768)	$	(56,981)	$	6,375,093
New loan fundings	457,449		—		—		457,449
Add-on loan fundings (2)	309,820		—		—		309,820
Loan repayments and sales	(543,535)		—		—		(543,535)
Gain (loss) on foreign currency translation	(15,060)		543		—		(14,517)
Specific CECL Allowance	—		—		(139,950)		(139,950)
Realized loss on investment	(20,569)		3,127		—		(17,442)
Deferred fees	—		(6,027)		—		(6,027)
PIK interest and amortization of fees	38,197		17,225		—		55,422
September 30, 2020	$	6,694,144	$	(20,900)	$	(196,931)	$	6,476,313
General CECL Allowance (3)							(39,276)
Carrying value, net							$	6,437,037

———————

(1)Other items primarily consist of purchase discounts or premiums, cost recovery interest, exit fees and deferred origination expenses.

(2)Represents fundings for loans closed prior to 2020.

(3)$3.6 million of the General CECL Allowance is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheet.

The following table details overall statistics for our loan portfolio at the dates indicated ($ in thousands):

	September 30, 2020			December 31, 2019
Number of loans	70			72
Principal balance	$	6,694,144		$	6,467,842
Carrying value, net	$	6,437,037		$	6,375,093
Unfunded loan commitments (1)	$	1,426,404		$	1,952,887
Weighted-average cash coupon (2)	5.6		%	6.5		%
Weighted-average remaining fully-extended term (3)	2.9 years			3.3 years
Weighted-average expected term (4)	2.0 years			1.8 years

———————

(1)Unfunded loan commitments are funded to finance construction costs, tenant improvements, leasing commissions, or carrying costs. These future commitments are funded over the term of each loan, subject in certain cases to an expiration date.

(2)For floating rate loans, based on applicable benchmark rates as of the specified dates. For loans placed on non-accrual or cost recovery the interest rate used in calculating weighted-average cash coupon is 0%.

(3)Assumes all extension options are exercised.

(4)Expected term represents our estimated timing of repayments as of September 30, 2020 and December 31, 2019, respectively.

Property Type

The table below details the property type of the properties securing the loans in our portfolio at the dates indicated ($ in thousands):

	September 30, 2020				December 31, 2019
Property Type	Carrying Value		% of Portfolio(1)		Carrying Value		% of Portfolio
Office	$	1,832,607	28.3	%	$	1,401,400	22.0	%
Hotel	1,578,614		24.4		1,660,162		26.0
Residential-for-sale: construction	894,610		13.8		692,816		10.9
Residential-for-sale: inventory	150,015		2.3		321,673		5.1
Urban Retail	636,308		9.8		643,706		10.1
Urban Predevelopment	295,728		4.6		409,864		6.4
Healthcare	363,170		5.6		371,423		5.8
Industrial	228,674		3.5		227,940		3.6
Other	496,587		7.7		646,109		10.1
Total	$	6,476,313	100.0	%	$	6,375,093	100.0	%
General CECL Allowance (2)	(39,276)
Carrying value, net	$	6,437,037

———————

(1)Percentage of portfolio calculations are made prior to consideration of General CECL Allowance.

(2)$3.6 million of the General CECL Allowance is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheet.

Geography

The table below details the geographic distribution of the properties securing the loans in our portfolio at the dates indicated ($ in thousands):

	September 30, 2020				December 31, 2019
Geographic Location	Carrying Value		% of Portfolio(1)		Carrying Value		% of Portfolio
New York City	$	2,393,012	37.0	%	$	2,167,487	34.0	%
Northeast	138,448		2.1		110,771		1.7
United Kingdom	1,179,761		18.2		1,274,390		20.0
West	741,971		11.5		728,182		11.4
Midwest	556,011		8.6		614,337		9.6
Southeast	576,420		8.9		564,166		8.9
Other	890,690		13.7		915,760		14.4
Total	$	6,476,313	100.0	%	$	6,375,093	100.0	%
General CECL Allowance (2)	(39,276)
Carrying value, net	$	6,437,037

———————

(1)Percentage of portfolio calculations are made prior to consideration of General CECL Allowance.

(2)$3.6 million of the General CECL Allowance is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheet.

Risk Rating

We assess the risk factors of each loan and assign a risk rating based on a variety of factors, including, without limitation, loan-to-value ratio ("LTV"), debt yield, property type, geographic and local market dynamics, physical

condition, cash flow volatility, leasing and tenant profile, loan structure and exit plan, and project sponsorship. This review is performed quarterly. Based on a 5-point scale, our loans are rated "1" through "5," from less risk to greater risk, which ratings are defined as follows:

    1.    Very low risk

    2.    Low risk

    3. Moderate/average risk

    4. High risk/potential for loss: a loan that has a risk of realizing a principal loss

    5. Impaired/loss likely: a loan that has a high risk of realizing principal loss, has incurred principal loss or an impairment has been recorded

The following tables allocate the carrying value of our loan portfolio based on our internal risk ratings and date of origination at the dates indicated ($ in thousands):

September 30, 2020
						Year Originated
Risk Rating	Number of Loans	Total		% of Portfolio		2020		2019		2018		2017		2016		Prior
1	—	$	—	—	%	$	—	$	—	$	—	$	—	$	—	$	—
2	1	32,000		0.5	%	—		—		—		—		—		32,000
3	62	6,035,647		93.2	%	450,119		2,685,060		1,350,949		815,789		88,685		645,045
4	—	—		—	%	—		—		—		—		—		—
5	7	408,666		6.3	%	—		—		28,872		137,798		114,910		127,086
Total	70	$	6,476,313	100.0	%	$	450,119	$	2,685,060	$	1,379,821	$	953,587	$	203,595	$	804,131
General CECL Allowance		(39,276)
Total carrying value, net		$	6,437,037
Weighted Average Risk Rating		3.1

December 31, 2019
						Year Originated
Risk Rating	Number of Loans	Total		% of Portfolio		2019		2018		2017		2016		2015		Prior
1	—	$	—	—	%	$	—	$	—	$	—	$	—	$	—	$	—
2	8	348,324		5.5	%	—		241,676		—		36,250		24,546		45,852
3	61	5,707,555		89.5	%	2,736,825		1,355,014		912,636		72,540		499,700		130,840
4	1	182,910		2.9	%	—		—		—		182,910		—		—
5	2	136,304		2.1	%	—		—		—		—		—		136,304
Total	72	$	6,375,093	100.0	%	$	2,736,825	$	1,596,690	$	912,636	$	291,700	$	524,246	$	312,996
Weighted Average Risk Rating		3.0

Current Expected Credit Losses

Refer to the following schedule of the General CECL Allowance as of September 30, 2020, and as of the date of adoption, January 1, 2020 ($ in thousands):

	September 30, 2020		January 1, 2020(1)
Commercial mortgage loans, net	$	20,161	$	12,149
Subordinate loans and other lending assets, net	19,115		15,630
Unfunded commitments(2)	3,595		3,088
Total General CECL Allowance	$	42,871	$	30,867

 ———————

(1)As of January 1, 2020, we adopted the CECL Standard through a cumulative-effect adjustment to retained earnings

(2)The General CECL Allowance on unfunded commitments is recorded as a liability on our condensed consolidated balance sheet within accounts payable, accrued expenses and other liabilities

In assessing the General CECL Allowance, we consider macroeconomic factors, including unemployment rate, commercial real estate prices, and market liquidity. We compared the historical data for each metric to historical commercial real estate losses in order to determine the correlation of the data. We used projections, obtained from third-party service providers, of each factor to approximate the impact the macroeconomic outlook may have on our loss rate.

The General CECL Allowance increased by $12.0 million from initial adoption on January 1, 2020, to September 30, 2020. The increase is primarily related to a change in our view of estimated future macroeconomic conditions in the backdrop of the global COVID-19 pandemic and an increase in our view of the remaining expected term of our loan portfolio as of September 30, 2020.

The General CECL Allowance decreased by $5.8 million in the quarter ended September 30, 2020. The decrease is primarily related to an improved view of estimated future macroeconomic conditions since the prior quarter end.

Although our secured debt obligations and senior secured term loan financing have a minimum tangible net worth maintenance covenant, the General CECL Allowance has no impact on these covenants as we are permitted to add back the General CECL Allowance for the computation of tangible net worth as defined in the respective agreements.

We have made an accounting policy election to exclude $38.4 million accrued interest receivable, included in Other Assets on our condensed consolidated balance sheet, from the amortized cost basis of the related commercial mortgage loans and subordinate loans and other lending assets in determining the General CECL Allowance as any uncollected accrued interest receivable is written off in a timely manner. We discontinue accruing interest on loans if we deem the interest to be uncollectible with any previously accrued uncollected interest on the loan charged to interest income in the same period. Under certain circumstances, we may apply the cost recovery method under which interest collected on a loan is a reduction to its amortized cost. The amortized cost basis for loans on cost recovery was $408.7 million and $136.3 million as of September 30, 2020 and December 31, 2019, respectively. For the three and nine months ended September 30, 2020, we received $0.3 million and $1.6 million, respectively, in interest that reduced amortized cost under the cost recovery method. Accrued interest is past due for 90 or more days for loans with an amortized cost basis of $408.7 million and $136.3 million as of September 30, 2020 and December 31, 2019, respectively.

The following schedule illustrates the quarterly changes in the CECL Allowance since we adopted the CECL Standard on January 1, 2020 ($ in thousands):

		Specific CECL Allowance(1)		General CECL Allowance						Total CECL Allowance		CECL Allowance as % of Amortized Cost
				Funded		Unfunded		Total				General		Total
December 31, 2019		$56,981		$	—	$	—	$	—	$	56,981	—	%	—	%
Changes:
	January 1, 2020 - Adoption of CECL Standard	—		27,779		3,088		30,867		30,867
	Q1 Allowances	150,000		30,494		2,971		33,465		183,465
March 31, 2020		$	206,981	$	58,273	$	6,059	$	64,332	$	271,313	1.08	%	4.05	%
Changes:
	Q2 Allowances (Reversals)	5,500		(13,729)		(1,940)		(15,669)		(10,169)
	Realized Loss	(15,000)		—		—		—		(15,000)
June 30, 2020		$	197,481	$	44,544	$	4,119	$	48,663	$	246,144	0.81	%	3.71	%
Changes:
	Q3 Reversals	(550)		(5,268)		(524)		(5,792)		(6,342)
September 30, 2020		$	196,931	$	39,276	$	3,595	$	42,871	$	239,802	0.71	%	3.59	%

 ———————

(1)As of December 31, 2019, amount represents specific loan loss provisions recorded on assets before the adoption of the CECL Standard. After the adoption of the CECL Standard on January 1, 2020, amounts represent Specific CECL Allowances.

Specific CECL Allowance

We regularly evaluate the extent and impact of any credit migration associated with the performance and/or value of the underlying collateral property as well as the financial and operating capability of the borrower/sponsor on a loan by loan basis. Specifically, a property’s operating results and any cash reserves are analyzed and used to assess (i) whether cash from operations is sufficient to cover the debt service requirements currently and into the future, (ii) the ability of the borrower to refinance the loan and/or (iii) the liquidation value of the underlying collateral. We also evaluate the financial wherewithal of any loan guarantors as well as the borrower’s competency in managing and operating the properties. In addition, we consider the overall economic environment, real estate sector and geographic sub-market in which the borrower operates. Such impairment analysis is completed and reviewed by asset management and finance personnel who utilize various data sources, including (i) periodic financial data such as debt service coverage ratio, property occupancy, tenant profile, rental rates, operating expenses, the borrower’s exit plan, and capitalization and discount rates, (ii) site inspections and (iii) current credit spreads and discussions with market participants.

We evaluate our loans on a quarterly basis. For loans where we have deemed the borrower/sponsor to be experiencing financial difficulty, we have elected to apply a practical expedient in accordance with the CECL Standard. In accordance with the practical expedient approach, we determine the loan loss provision to be the difference between the fair value of the underlying collateral and the carrying value of the loan (prior to the loan loss provision). When the repayment or satisfaction of a loan is dependent on a sale, rather than operations, of the collateral, the fair value is adjusted for the estimated cost to sell the collateral. The fair value of the underlying collateral is determined by using method(s) such as discounted cash flow, the market approach, or direct capitalization approach. The key unobservable inputs used to determine the fair value of the underlying collateral may vary depending on the information available to us and market conditions as of the valuation date.

We evaluate modifications to our loan portfolio to determine if the modifications constitute a troubled debt restructuring ("TDR") and/or substantial modification, under ASC Topic 310 "Receivables". During the second quarter of 2020, one commercial mortgage loan, secured by a hotel in New York City, was restructured and was deemed to be a TDR. In connection with this restructuring, the borrower contributed additional equity of $15.0 million and concurrently we wrote down our principal on this loan by $15.0 million, which had been previously recorded as a Specific CECL Allowance. As of September 30, 2020, the loan had a principal balance and amortized cost of $142.8 million and $144.5 million, respectively, has a risk rating of 3, and is on accrual status. During the three months ended June 30, 2020, the CECL Allowance of $15.0 million was reversed through reversal of loan losses, while the write-down was recorded in realized loss on investments in our condensed consolidated statement of operations.

The following table summarizes the specific provision for loan losses that has been recorded on our portfolio as of September 30, 2020 ($ in thousands):

Type	Property type	Location	Amortized cost(1)		Interest recognition status/ as of date
Mortgage
	Urban Predevelopment(3)	Brooklyn, NY	128,418		Cost Recovery/ 3/1/2020
	Urban Predevelopment(3)	Miami, FL	114,910		Cost Recovery/ 3/1/2020
	Retail Center(4)(5)	Cincinnati, OH	105,561		Cost Recovery/ 10/1/2019
	Hotel(2)	Pittsburgh, PA	28,872		Cost Recovery/ 3/31/2020
	Residential-for-sale: inventory(6)(7)	Bethesda, MD	3,095		Cost Recovery/ 1/1/2018
Mortgage total:			$	380,856
Mezzanine
	Hotel(2)	Washington, DC	18,430		Cost Recovery/ 3/31/2020
	Hotel(8)	Anaheim, CA	9,380		Cost Recovery/ 9/30/2020
Mezzanine total:			$	27,810
Grand total:			$	408,666

———————

(1)Amortized cost is shown net of $196.9 million of net loan loss provisions. During the three and nine months ended September 30, 2020, there was $(0.6) million and $140.0 million in (reversals)/provisions taken due to factors including COVID-19. See Note 2 for additional information regarding COVID-19.

(2)The fair value of hotel collateral was determined by applying a discount rate ranging from 8.5% to 11.0% and a capitalization rate ranging from 7.0% to 9.0%. For the hotel located in Washington, DC, during the three and nine months ended September 30, 2020, there was $0 and $0.2 million of interest paid applied towards reducing the carrying value of the loan, respectively.

(3)The fair value of urban predevelopment collateral was determined by assuming rent per square foot ranging from $48 to $225 and a capitalization rate ranging from 5.0% to 5.5%.

(4)The fair value of retail collateral was determined by applying a capitalization rate of 8.3%.

(5)The entity in which we own an interest and which owns the underlying property was deemed to be a VIE and we determined that we are not the primary beneficiary of that VIE. During the three and nine months ended September 30, 2020, $0.4 million and $1.1 million, respectively, of interest paid was applied towards reducing the carrying value of the loan.

(6)Subsequent to September 30, 2020, the remaining collateral on this loan was sold. In connection with the sale of the underlying collateral, a $1.9 million reversal of the previously recognized specific CECL Allowance was recorded during the three months ended September 30, 2020. Refer to "Note 18 - Subsequent Events" for more information.

(7)A $3.0 million portion of this provision was recorded on an investment previously recorded under other assets on our condensed consolidated balance sheet.

(8)The fair value of the hotel, located in Anaheim, California, was determined using the market approach where the fair market value of the underlying collateral, less projected closing costs, was compared to the amortized cost of the loan.

Other Loan and Lending Assets Activity

We recognized payment-in-kind ("PIK") interest of $12.5 million and $37.3 million for the three and nine months ended September 30, 2020, respectively, and $13.7 million and $42.8 million for the three and nine months ended September 30, 2019, respectively.

We recognized $0 and $0.2 million in pre-payment penalties and accelerated fees for the three and nine months ended September 30, 2020, respectively, and $0.3 million and $4.0 million for the three and nine months ended September 30, 2019, respectively.

Our portfolio includes two other lending assets, which are subordinate risk retention interests in securitization vehicles. The underlying mortgages related to our subordinate risk retention interests are secured by a portfolio of properties located throughout the United States. Our maximum exposure to loss from the subordinate risk retention interests is limited to the book value of such interests of $68.1 million as of September 30, 2020. These interests have a weighted average maturity of 6.07 years. We are not obligated to provide, and do not intend to provide financial support to these subordinate risk retention interests. Both interests are accounted for as held-to-maturity and recorded at amortized cost on our condensed consolidated balance sheet.

In January 2020, we sold £62.2 million ($81.3 million assuming conversion into U.S. dollars) in a mezzanine loan and £50.0 million ($65.3 million assuming conversion into U.S. dollars) unfunded commitment of a senior mortgage secured by a mixed-use property in London, UK to a fund managed by an affiliate of the Manager, that was originated by us in December 2019. This transaction was evaluated under ASC 860 - Transfers and Servicing, and we determined that it qualifies as a sale and accounted for it as such. We recorded no gain or loss related to this sale.

In the second quarter of 2020, we sold interests in three construction loans, with aggregate commitments of $376.9 million (of which approximately $127 million was funded at the time of sale). The sales were to entities managed by affiliates of the Manager. In connection with these sales, we agreed to indemnify each buyer on a limited basis for realized losses of up to 10% of the committed amount on each of the loans provided that; (i) the loan is in default on or prior to December 15, 2020 and (ii) the buyer realized a loss from an enforcement action pursuant to the underlying loan agreement on or prior to June 15, 2021. The limited indemnity does not cover a loss on sale of the loan or an unrealized mark-to-market loss. We recorded a loss of approximately $1.4 million in connection with these sales. These transactions were evaluated under ASC 860 - Transfers and Servicing, and we determined that they qualify as sales and accounted for them as such.

In July 2020, we sold our interest in a foreign residential-for-sale inventory loan, with outstanding principal of £97.5 million ($124.2 million assuming conversion into USD). We recorded a loss of approximately $1.0 million in connection with this sale. This transaction was evaluated under ASC 860 - Transfers and Servicing, and we determined that it qualifies as a sale and accounted for it as such.

Loan Proceeds Held by Servicer Loan proceeds held by servicer represents principal payments held by our third-party loan servicer as of the balance sheet date which were remitted to us subsequent to the balance sheet date. There were no loan proceeds held by servicer as of September 30, 2020. Loan proceeds held by servicer were $8.3 million as of December 31, 2019.

XML

Loan Proceeds Held by Servicer

9 Months Ended

Sep. 30, 2020

Receivables [Abstract]

Loan Proceeds Held by Servicer

Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net

Our loan portfolio was comprised of the following at September 30, 2020 and December 31, 2019 ($ in thousands):

Loan Type	September 30, 2020		December 31, 2019
Commercial mortgage loans, net (1)	$	5,427,945	$	5,326,967
Subordinate loans and other lending assets, net	1,009,092		1,048,126
Carrying value, net	$	6,437,037	$	6,375,093

  ———————

(1)Includes $156.4 million and $126.7 million in 2020 and 2019, respectively, of contiguous financing structured as subordinate loans.

Our loan portfolio consisted of 95% floating rate loans, based on amortized cost, as of September 30, 2020 and December 31, 2019, respectively.

Activity relating to our loan portfolio, for the nine months ended September 30, 2020, was as follows ($ in thousands):

	Principal Balance		Deferred Fees/Other Items (1)		Specific Provision for Loan Loss		Carrying Value, Net
December 31, 2019	$	6,467,842	$	(35,768)	$	(56,981)	$	6,375,093
New loan fundings	457,449		—		—		457,449
Add-on loan fundings (2)	309,820		—		—		309,820
Loan repayments and sales	(543,535)		—		—		(543,535)
Gain (loss) on foreign currency translation	(15,060)		543		—		(14,517)
Specific CECL Allowance	—		—		(139,950)		(139,950)
Realized loss on investment	(20,569)		3,127		—		(17,442)
Deferred fees	—		(6,027)		—		(6,027)
PIK interest and amortization of fees	38,197		17,225		—		55,422
September 30, 2020	$	6,694,144	$	(20,900)	$	(196,931)	$	6,476,313
General CECL Allowance (3)							(39,276)
Carrying value, net							$	6,437,037

———————

(1)Other items primarily consist of purchase discounts or premiums, cost recovery interest, exit fees and deferred origination expenses.

(2)Represents fundings for loans closed prior to 2020.

(3)$3.6 million of the General CECL Allowance is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheet.

The following table details overall statistics for our loan portfolio at the dates indicated ($ in thousands):

	September 30, 2020			December 31, 2019
Number of loans	70			72
Principal balance	$	6,694,144		$	6,467,842
Carrying value, net	$	6,437,037		$	6,375,093
Unfunded loan commitments (1)	$	1,426,404		$	1,952,887
Weighted-average cash coupon (2)	5.6		%	6.5		%
Weighted-average remaining fully-extended term (3)	2.9 years			3.3 years
Weighted-average expected term (4)	2.0 years			1.8 years

———————

(1)Unfunded loan commitments are funded to finance construction costs, tenant improvements, leasing commissions, or carrying costs. These future commitments are funded over the term of each loan, subject in certain cases to an expiration date.

(2)For floating rate loans, based on applicable benchmark rates as of the specified dates. For loans placed on non-accrual or cost recovery the interest rate used in calculating weighted-average cash coupon is 0%.

(3)Assumes all extension options are exercised.

(4)Expected term represents our estimated timing of repayments as of September 30, 2020 and December 31, 2019, respectively.

Property Type

The table below details the property type of the properties securing the loans in our portfolio at the dates indicated ($ in thousands):

	September 30, 2020				December 31, 2019
Property Type	Carrying Value		% of Portfolio(1)		Carrying Value		% of Portfolio
Office	$	1,832,607	28.3	%	$	1,401,400	22.0	%
Hotel	1,578,614		24.4		1,660,162		26.0
Residential-for-sale: construction	894,610		13.8		692,816		10.9
Residential-for-sale: inventory	150,015		2.3		321,673		5.1
Urban Retail	636,308		9.8		643,706		10.1
Urban Predevelopment	295,728		4.6		409,864		6.4
Healthcare	363,170		5.6		371,423		5.8
Industrial	228,674		3.5		227,940		3.6
Other	496,587		7.7		646,109		10.1
Total	$	6,476,313	100.0	%	$	6,375,093	100.0	%
General CECL Allowance (2)	(39,276)
Carrying value, net	$	6,437,037

———————

(1)Percentage of portfolio calculations are made prior to consideration of General CECL Allowance.

(2)$3.6 million of the General CECL Allowance is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheet.

Geography

The table below details the geographic distribution of the properties securing the loans in our portfolio at the dates indicated ($ in thousands):

	September 30, 2020				December 31, 2019
Geographic Location	Carrying Value		% of Portfolio(1)		Carrying Value		% of Portfolio
New York City	$	2,393,012	37.0	%	$	2,167,487	34.0	%
Northeast	138,448		2.1		110,771		1.7
United Kingdom	1,179,761		18.2		1,274,390		20.0
West	741,971		11.5		728,182		11.4
Midwest	556,011		8.6		614,337		9.6
Southeast	576,420		8.9		564,166		8.9
Other	890,690		13.7		915,760		14.4
Total	$	6,476,313	100.0	%	$	6,375,093	100.0	%
General CECL Allowance (2)	(39,276)
Carrying value, net	$	6,437,037

———————

(1)Percentage of portfolio calculations are made prior to consideration of General CECL Allowance.

(2)$3.6 million of the General CECL Allowance is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheet.

Risk Rating

We assess the risk factors of each loan and assign a risk rating based on a variety of factors, including, without limitation, loan-to-value ratio ("LTV"), debt yield, property type, geographic and local market dynamics, physical

condition, cash flow volatility, leasing and tenant profile, loan structure and exit plan, and project sponsorship. This review is performed quarterly. Based on a 5-point scale, our loans are rated "1" through "5," from less risk to greater risk, which ratings are defined as follows:

    1.    Very low risk

    2.    Low risk

    3. Moderate/average risk

    4. High risk/potential for loss: a loan that has a risk of realizing a principal loss

    5. Impaired/loss likely: a loan that has a high risk of realizing principal loss, has incurred principal loss or an impairment has been recorded

The following tables allocate the carrying value of our loan portfolio based on our internal risk ratings and date of origination at the dates indicated ($ in thousands):

September 30, 2020
						Year Originated
Risk Rating	Number of Loans	Total		% of Portfolio		2020		2019		2018		2017		2016		Prior
1	—	$	—	—	%	$	—	$	—	$	—	$	—	$	—	$	—
2	1	32,000		0.5	%	—		—		—		—		—		32,000
3	62	6,035,647		93.2	%	450,119		2,685,060		1,350,949		815,789		88,685		645,045
4	—	—		—	%	—		—		—		—		—		—
5	7	408,666		6.3	%	—		—		28,872		137,798		114,910		127,086
Total	70	$	6,476,313	100.0	%	$	450,119	$	2,685,060	$	1,379,821	$	953,587	$	203,595	$	804,131
General CECL Allowance		(39,276)
Total carrying value, net		$	6,437,037
Weighted Average Risk Rating		3.1

December 31, 2019
						Year Originated
Risk Rating	Number of Loans	Total		% of Portfolio		2019		2018		2017		2016		2015		Prior
1	—	$	—	—	%	$	—	$	—	$	—	$	—	$	—	$	—
2	8	348,324		5.5	%	—		241,676		—		36,250		24,546		45,852
3	61	5,707,555		89.5	%	2,736,825		1,355,014		912,636		72,540		499,700		130,840
4	1	182,910		2.9	%	—		—		—		182,910		—		—
5	2	136,304		2.1	%	—		—		—		—		—		136,304
Total	72	$	6,375,093	100.0	%	$	2,736,825	$	1,596,690	$	912,636	$	291,700	$	524,246	$	312,996
Weighted Average Risk Rating		3.0

Current Expected Credit Losses

Refer to the following schedule of the General CECL Allowance as of September 30, 2020, and as of the date of adoption, January 1, 2020 ($ in thousands):

	September 30, 2020		January 1, 2020(1)
Commercial mortgage loans, net	$	20,161	$	12,149
Subordinate loans and other lending assets, net	19,115		15,630
Unfunded commitments(2)	3,595		3,088
Total General CECL Allowance	$	42,871	$	30,867

 ———————

(1)As of January 1, 2020, we adopted the CECL Standard through a cumulative-effect adjustment to retained earnings

(2)The General CECL Allowance on unfunded commitments is recorded as a liability on our condensed consolidated balance sheet within accounts payable, accrued expenses and other liabilities

In assessing the General CECL Allowance, we consider macroeconomic factors, including unemployment rate, commercial real estate prices, and market liquidity. We compared the historical data for each metric to historical commercial real estate losses in order to determine the correlation of the data. We used projections, obtained from third-party service providers, of each factor to approximate the impact the macroeconomic outlook may have on our loss rate.

The General CECL Allowance increased by $12.0 million from initial adoption on January 1, 2020, to September 30, 2020. The increase is primarily related to a change in our view of estimated future macroeconomic conditions in the backdrop of the global COVID-19 pandemic and an increase in our view of the remaining expected term of our loan portfolio as of September 30, 2020.

The General CECL Allowance decreased by $5.8 million in the quarter ended September 30, 2020. The decrease is primarily related to an improved view of estimated future macroeconomic conditions since the prior quarter end.

Although our secured debt obligations and senior secured term loan financing have a minimum tangible net worth maintenance covenant, the General CECL Allowance has no impact on these covenants as we are permitted to add back the General CECL Allowance for the computation of tangible net worth as defined in the respective agreements.

We have made an accounting policy election to exclude $38.4 million accrued interest receivable, included in Other Assets on our condensed consolidated balance sheet, from the amortized cost basis of the related commercial mortgage loans and subordinate loans and other lending assets in determining the General CECL Allowance as any uncollected accrued interest receivable is written off in a timely manner. We discontinue accruing interest on loans if we deem the interest to be uncollectible with any previously accrued uncollected interest on the loan charged to interest income in the same period. Under certain circumstances, we may apply the cost recovery method under which interest collected on a loan is a reduction to its amortized cost. The amortized cost basis for loans on cost recovery was $408.7 million and $136.3 million as of September 30, 2020 and December 31, 2019, respectively. For the three and nine months ended September 30, 2020, we received $0.3 million and $1.6 million, respectively, in interest that reduced amortized cost under the cost recovery method. Accrued interest is past due for 90 or more days for loans with an amortized cost basis of $408.7 million and $136.3 million as of September 30, 2020 and December 31, 2019, respectively.

The following schedule illustrates the quarterly changes in the CECL Allowance since we adopted the CECL Standard on January 1, 2020 ($ in thousands):

		Specific CECL Allowance(1)		General CECL Allowance						Total CECL Allowance		CECL Allowance as % of Amortized Cost
				Funded		Unfunded		Total				General		Total
December 31, 2019		$56,981		$	—	$	—	$	—	$	56,981	—	%	—	%
Changes:
	January 1, 2020 - Adoption of CECL Standard	—		27,779		3,088		30,867		30,867
	Q1 Allowances	150,000		30,494		2,971		33,465		183,465
March 31, 2020		$	206,981	$	58,273	$	6,059	$	64,332	$	271,313	1.08	%	4.05	%
Changes:
	Q2 Allowances (Reversals)	5,500		(13,729)		(1,940)		(15,669)		(10,169)
	Realized Loss	(15,000)		—		—		—		(15,000)
June 30, 2020		$	197,481	$	44,544	$	4,119	$	48,663	$	246,144	0.81	%	3.71	%
Changes:
	Q3 Reversals	(550)		(5,268)		(524)		(5,792)		(6,342)
September 30, 2020		$	196,931	$	39,276	$	3,595	$	42,871	$	239,802	0.71	%	3.59	%

 ———————

(1)As of December 31, 2019, amount represents specific loan loss provisions recorded on assets before the adoption of the CECL Standard. After the adoption of the CECL Standard on January 1, 2020, amounts represent Specific CECL Allowances.

Specific CECL Allowance

We regularly evaluate the extent and impact of any credit migration associated with the performance and/or value of the underlying collateral property as well as the financial and operating capability of the borrower/sponsor on a loan by loan basis. Specifically, a property’s operating results and any cash reserves are analyzed and used to assess (i) whether cash from operations is sufficient to cover the debt service requirements currently and into the future, (ii) the ability of the borrower to refinance the loan and/or (iii) the liquidation value of the underlying collateral. We also evaluate the financial wherewithal of any loan guarantors as well as the borrower’s competency in managing and operating the properties. In addition, we consider the overall economic environment, real estate sector and geographic sub-market in which the borrower operates. Such impairment analysis is completed and reviewed by asset management and finance personnel who utilize various data sources, including (i) periodic financial data such as debt service coverage ratio, property occupancy, tenant profile, rental rates, operating expenses, the borrower’s exit plan, and capitalization and discount rates, (ii) site inspections and (iii) current credit spreads and discussions with market participants.

We evaluate our loans on a quarterly basis. For loans where we have deemed the borrower/sponsor to be experiencing financial difficulty, we have elected to apply a practical expedient in accordance with the CECL Standard. In accordance with the practical expedient approach, we determine the loan loss provision to be the difference between the fair value of the underlying collateral and the carrying value of the loan (prior to the loan loss provision). When the repayment or satisfaction of a loan is dependent on a sale, rather than operations, of the collateral, the fair value is adjusted for the estimated cost to sell the collateral. The fair value of the underlying collateral is determined by using method(s) such as discounted cash flow, the market approach, or direct capitalization approach. The key unobservable inputs used to determine the fair value of the underlying collateral may vary depending on the information available to us and market conditions as of the valuation date.

We evaluate modifications to our loan portfolio to determine if the modifications constitute a troubled debt restructuring ("TDR") and/or substantial modification, under ASC Topic 310 "Receivables". During the second quarter of 2020, one commercial mortgage loan, secured by a hotel in New York City, was restructured and was deemed to be a TDR. In connection with this restructuring, the borrower contributed additional equity of $15.0 million and concurrently we wrote down our principal on this loan by $15.0 million, which had been previously recorded as a Specific CECL Allowance. As of September 30, 2020, the loan had a principal balance and amortized cost of $142.8 million and $144.5 million, respectively, has a risk rating of 3, and is on accrual status. During the three months ended June 30, 2020, the CECL Allowance of $15.0 million was reversed through reversal of loan losses, while the write-down was recorded in realized loss on investments in our condensed consolidated statement of operations.

The following table summarizes the specific provision for loan losses that has been recorded on our portfolio as of September 30, 2020 ($ in thousands):

Type	Property type	Location	Amortized cost(1)		Interest recognition status/ as of date
Mortgage
	Urban Predevelopment(3)	Brooklyn, NY	128,418		Cost Recovery/ 3/1/2020
	Urban Predevelopment(3)	Miami, FL	114,910		Cost Recovery/ 3/1/2020
	Retail Center(4)(5)	Cincinnati, OH	105,561		Cost Recovery/ 10/1/2019
	Hotel(2)	Pittsburgh, PA	28,872		Cost Recovery/ 3/31/2020
	Residential-for-sale: inventory(6)(7)	Bethesda, MD	3,095		Cost Recovery/ 1/1/2018
Mortgage total:			$	380,856
Mezzanine
	Hotel(2)	Washington, DC	18,430		Cost Recovery/ 3/31/2020
	Hotel(8)	Anaheim, CA	9,380		Cost Recovery/ 9/30/2020
Mezzanine total:			$	27,810
Grand total:			$	408,666

———————

(1)Amortized cost is shown net of $196.9 million of net loan loss provisions. During the three and nine months ended September 30, 2020, there was $(0.6) million and $140.0 million in (reversals)/provisions taken due to factors including COVID-19. See Note 2 for additional information regarding COVID-19.

(2)The fair value of hotel collateral was determined by applying a discount rate ranging from 8.5% to 11.0% and a capitalization rate ranging from 7.0% to 9.0%. For the hotel located in Washington, DC, during the three and nine months ended September 30, 2020, there was $0 and $0.2 million of interest paid applied towards reducing the carrying value of the loan, respectively.

(3)The fair value of urban predevelopment collateral was determined by assuming rent per square foot ranging from $48 to $225 and a capitalization rate ranging from 5.0% to 5.5%.

(4)The fair value of retail collateral was determined by applying a capitalization rate of 8.3%.

(5)The entity in which we own an interest and which owns the underlying property was deemed to be a VIE and we determined that we are not the primary beneficiary of that VIE. During the three and nine months ended September 30, 2020, $0.4 million and $1.1 million, respectively, of interest paid was applied towards reducing the carrying value of the loan.

(6)Subsequent to September 30, 2020, the remaining collateral on this loan was sold. In connection with the sale of the underlying collateral, a $1.9 million reversal of the previously recognized specific CECL Allowance was recorded during the three months ended September 30, 2020. Refer to "Note 18 - Subsequent Events" for more information.

(7)A $3.0 million portion of this provision was recorded on an investment previously recorded under other assets on our condensed consolidated balance sheet.

(8)The fair value of the hotel, located in Anaheim, California, was determined using the market approach where the fair market value of the underlying collateral, less projected closing costs, was compared to the amortized cost of the loan.

Other Loan and Lending Assets Activity

We recognized payment-in-kind ("PIK") interest of $12.5 million and $37.3 million for the three and nine months ended September 30, 2020, respectively, and $13.7 million and $42.8 million for the three and nine months ended September 30, 2019, respectively.

We recognized $0 and $0.2 million in pre-payment penalties and accelerated fees for the three and nine months ended September 30, 2020, respectively, and $0.3 million and $4.0 million for the three and nine months ended September 30, 2019, respectively.

Our portfolio includes two other lending assets, which are subordinate risk retention interests in securitization vehicles. The underlying mortgages related to our subordinate risk retention interests are secured by a portfolio of properties located throughout the United States. Our maximum exposure to loss from the subordinate risk retention interests is limited to the book value of such interests of $68.1 million as of September 30, 2020. These interests have a weighted average maturity of 6.07 years. We are not obligated to provide, and do not intend to provide financial support to these subordinate risk retention interests. Both interests are accounted for as held-to-maturity and recorded at amortized cost on our condensed consolidated balance sheet.

In January 2020, we sold £62.2 million ($81.3 million assuming conversion into U.S. dollars) in a mezzanine loan and £50.0 million ($65.3 million assuming conversion into U.S. dollars) unfunded commitment of a senior mortgage secured by a mixed-use property in London, UK to a fund managed by an affiliate of the Manager, that was originated by us in December 2019. This transaction was evaluated under ASC 860 - Transfers and Servicing, and we determined that it qualifies as a sale and accounted for it as such. We recorded no gain or loss related to this sale.

In the second quarter of 2020, we sold interests in three construction loans, with aggregate commitments of $376.9 million (of which approximately $127 million was funded at the time of sale). The sales were to entities managed by affiliates of the Manager. In connection with these sales, we agreed to indemnify each buyer on a limited basis for realized losses of up to 10% of the committed amount on each of the loans provided that; (i) the loan is in default on or prior to December 15, 2020 and (ii) the buyer realized a loss from an enforcement action pursuant to the underlying loan agreement on or prior to June 15, 2021. The limited indemnity does not cover a loss on sale of the loan or an unrealized mark-to-market loss. We recorded a loss of approximately $1.4 million in connection with these sales. These transactions were evaluated under ASC 860 - Transfers and Servicing, and we determined that they qualify as sales and accounted for them as such.

In July 2020, we sold our interest in a foreign residential-for-sale inventory loan, with outstanding principal of £97.5 million ($124.2 million assuming conversion into USD). We recorded a loss of approximately $1.0 million in connection with this sale. This transaction was evaluated under ASC 860 - Transfers and Servicing, and we determined that it qualifies as a sale and accounted for it as such.

Loan Proceeds Held by Servicer Loan proceeds held by servicer represents principal payments held by our third-party loan servicer as of the balance sheet date which were remitted to us subsequent to the balance sheet date. There were no loan proceeds held by servicer as of September 30, 2020. Loan proceeds held by servicer were $8.3 million as of December 31, 2019.

XML

Other Assets

9 Months Ended

Sep. 30, 2020

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Other Assets

Other Assets

The following table details the components of our other assets at the dates indicated ($ in thousands):

	September 30, 2020		December 31, 2019
Interest receivable	$	38,401	$	35,581
Collateral deposited under derivative agreements	1,810		17,090
Other	3,433		45
Total	$	43,644	$	52,716

XML

Secured Debt Arrangements, Net

9 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Secured Debt Arrangements, Net

Secured Debt Arrangements, Net

At September 30, 2020 and December 31, 2019, our borrowings included the following secured debt arrangements, maturities and weighted-average interest rates ($ in thousands):

	September 30, 2020					December 31, 2019
	Maximum Amount of Borrowings(1)		Borrowings Outstanding(1)		Maturity (2)	Maximum Amount of Borrowings(1)		Borrowings Outstanding(1)		Maturity (2)
JPMorgan (USD)	$	1,132,013	$	989,278	June 2024	$	1,154,109	$	1,090,160	June 2024
JPMorgan (GBP)	97,661		97,661		June 2024	51,702		50,410		June 2024
JPMorgan (EUR)	70,326		70,326		June 2024	94,189		94,189		June 2024
DB (USD)	1,000,000		526,743		March 2023	1,250,000		513,876		March 2021
Goldman (USD)	500,000		362,139		November 2021	500,000		322,170		November 2021
CS - USD	378,903		378,781		January 2023(3)	226,068		218,644		June 2020
CS - GBP	—		—		N/A(4)	93,915		93,915		June 2020
HSBC - USD	47,223		47,223		January 2021	50,625		50,625		October 2020
HSBC - GBP	—		—		N/A	34,634		34,634		June 2020
HSBC - EUR	157,148		157,148		July 2021	154,037		154,037		January 2021
Barclays (USD)	200,000		35,192		March 2024	N/A		N/A		N/A
Barclays (GBP)	—		—		N/A(4)	538,916		290,347		February 2024(5)
Barclays (EUR)	—		—		N/A(4)	182,549		182,549		November 2020
Total Secured Credit Facilities	3,583,274		2,664,491			4,330,744		3,095,556
Barclays Private Securitization	813,592		813,592		March 2024(5)	N/A		N/A		N/A
Total Secured Debt Arrangements	4,396,866		3,478,083			4,330,744		3,095,556
less: deferred financing costs	N/A		(12,746)			N/A		(17,190)
Total Secured Debt Arrangements, net(6)(7)(8)	$	4,396,866	$	3,465,337		$	4,330,744	$	3,078,366

———————

(1)As of September 30, 2020, British Pound Sterling ("GBP") and Euros ("EUR") borrowings were converted to U.S. Dollars ("USD") at a rate of 1.29 and 1.17, respectively. As of December 31, 2019, GBP and EUR borrowings were converted at a rate of 1.33 and 1.12, respectively.

(2)Maturity date assumes extensions at our option are exercised with consent of financing providers, where applicable.

(3)Assumes financings are extended in line with the underlying loans.

(4)As of September 30, 2020, there are no loans pledged to this facility.

(5)Represents weighted average maturity across various financings with the counterparty. See below for additional details.

(6)Weighted-average borrowing costs as of September 30, 2020 and December 31, 2019 were USD L + 2.15% / GBP L + 1.82% / EUR L + 1.46% and USD L + 2.07% / GBP L + 1.75% / EUR L + 1.36%, respectively.

(7)Weighted average advance rates based on cost as of September 30, 2020 and December 31, 2019 were 64.3% (63.8% (USD) / 67.9% (GBP) / 61.3% (EUR)) and 63.8% (66.7% (USD) / 47.1% (GBP) / 76.1% (EUR)).

(8)As of September 30, 2020 and December 31, 2019, approximately 55% and 54% of the outstanding balance under these secured borrowings were recourse to us.

Each of our existing secured debt arrangements include "credit based and other mark-to-market" features. "Credit mark-to-market" provisions in repurchase facilities are designed to keep the lenders' credit exposure generally constant as a percentage of the underlying collateral value of the assets pledged as security to them. If the credit of the underlying collateral value decreases, the amount of leverage available to us will be reduced as our assets are marked-to-market, which would reduce our liquidity. Generally, the lender under the applicable secured debt arrangement calls for and/or sets the valuation and any revaluation of the collateral assets in its sole, good faith discretion. If it is determined (subject to certain conditions) that the market value of the underlying collateral has decreased by more than a defined minimum amount, the lender may require us to provide additional collateral or may make margin calls, which may require us to repay all or a portion of the funds advanced. We closely monitor our liquidity and intend to maintain sufficient liquidity on our balance sheet in order to meet any margin calls in the event of any significant decreases in asset values. As of September 30, 2020 and December 31, 2019, the weighted average haircut under our secured debt arrangements was approximately 35.7% and 36.2%, respectively. In addition, our existing secured debt arrangements are not entirely term-matched financings and may mature before our commercial real estate debt investments that represent underlying collateral to those financings. We are in frequent dialogue with the lenders under our secured debt arrangements regarding our management of their collateral assets and as we negotiate renewals and extensions of these liabilities, we may experience lower advance rates and higher pricing under the renewed or extended agreements.

JPMorgan Facility

In November 2019, through three indirect wholly-owned subsidiaries, we entered into a Sixth Amended and Restated Master Repurchase Agreement with JPMorgan Chase Bank, National Association (as amended, the "JPMorgan Facility"). The JPMorgan Facility allows for $1.3 billion of maximum borrowings (with amounts borrowed in British pounds and Euros converted to USD for purposes of calculating availability based on the greater of the spot rate as of the initial financing under the corresponding mortgage loan and the then-current spot rate) and matures in June 2022 and has two one-year extensions available at our option, which are subject to certain conditions. The JPMorgan Facility enables us to elect to receive advances in USD, GBP, or EUR. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $1.2 billion (including £75.6 million and €60.0 million assuming conversion into USD) of borrowings outstanding under the JPMorgan Facility secured by certain of our commercial mortgage loans.

DB Facility

In March 2020, through an indirect wholly-owned subsidiary, we entered into a Third Amended and Restated Master Repurchase Agreement with Deutsche Bank AG, Cayman Islands Branch, London Branch (as amended, the "DB Facility"), which provides for advances of up to $1.0 billion for the sale and repurchase of eligible first mortgage loans secured by commercial or multifamily properties located in the United States, United Kingdom and the European Union, and enables us to elect to receive advances in USD, GBP, or EUR. The repurchase facility matures in March 2021, and has two one-year extensions available at our option, subject to certain conditions. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $526.7 million of borrowings outstanding under the DB Facility secured by certain of our commercial mortgage loans.

Goldman Facility

In November 2017, through an indirect wholly-owned subsidiary, we entered into a master repurchase and securities contract agreement with Goldman Sachs Bank USA (the "Goldman Facility"), which provides advances up to $500.0 million and matures in November 2020, and has one one-year extension available at our option, subject to certain conditions. Margin calls may occur any time at specified margin deficit thresholds.

As of September 30, 2020, we had $362.1 million of borrowings outstanding under the Goldman Facility secured by certain of our commercial mortgage loans.

CS Facility - USD

In July 2018, through an indirect wholly-owned subsidiary, we entered into a Master Repurchase Agreement with Credit Suisse AG, acting through its Cayman Islands Branch and Alpine Securitization Ltd (the "CS Facility - USD"), which provides for advances for the sale and repurchase of eligible commercial mortgage loans secured by real estate. The CS Facility - USD has an "evergreen" feature such that the facility continues unless terminated at any time by Credit Suisse with six months' notice. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $378.8 million of borrowings outstanding under the CS Facility - USD secured by certain of our commercial mortgage loans.

CS Facility - GBP

In June 2018, through an indirect wholly-owned subsidiary, we entered into a Global Master Repurchase Agreement with Credit Suisse Securities (Europe) Limited (the "CS Facility - GBP"). During the third quarter of 2020, the facility was repaid in connection with the sale of the underlying loan.

HSBC Facility - USD    

In October 2019, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement with HSBC Bank plc (the "HSBC Facility - USD"), which provides for a single asset financing. The facility is scheduled to mature in January 2021. Margin calls may occur any time at specified aggregate margin thresholds.

As of September 30, 2020, we had $47.2 million of borrowings under the HSBC Facility - USD secured by one commercial mortgage loan.

HSBC Facility - GBP

In September 2018, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement with HSBC Bank plc (the "HSBC Facility - GBP"), which provided for a single asset financing. The facility matured and was repaid in June 2020 in connection with the repayment of the underlying loan.

HSBC Facility - EUR

In July 2019, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement with HSBC Bank plc (the "HSBC Facility - EUR"), which provides for a single asset financing. The facility matures in July 2021. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $157.1 million (€134.1 million assuming conversion into USD) of borrowings outstanding under the HSBC Facility - EUR secured by one commercial mortgage loan.

Barclays Facility - USD

In March 2020, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement pursuant to a Master Repurchase Agreement with Barclays Bank plc ("Barclays Facility - USD"). The Barclays Facility - USD allows for $200.0 million of maximum borrowings and initially matures in March 2023 with extensions available at our option, subject to certain conditions. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $35.2 million of borrowings outstanding under the Barclays Facility - USD secured by one commercial mortgage loan.

Barclays Facility - GBP/EUR

Beginning in October 2019, through an indirect wholly-owned subsidiary, we entered into five secured debt arrangements pursuant to a Global Master Repurchase Agreement with Barclays Bank plc (the "Barclays Facility - GBP/EUR"). In June 2020, all assets previously financed pursuant to this facility were refinanced under the Barclays Private Securitization.

Barclays Private Securitization

In June 2020, through a newly formed entity, we entered into a private securitization with Barclays Bank plc, of which Barclays Bank plc retained $782.0 million of senior notes. This Barclays Private Securitization finances the loans that were previously financed under the Barclays Facility - GBP/EUR. In addition, we pledged an additional commercial mortgage loan with an outstanding principal balance of £26.0 million and pledged additional collateral of a financed loan of €5.3 million as of June 30, 2020.

The securitization eliminates daily margining provisions and grants us significant discretion to modify certain terms of the underlying collateral including waiving certain loan-level covenant breaches and deferring or waiving of debt service payments for up to 18 months. The securitization includes LTV based covenants with significant headroom to existing levels that are also subject to a six-month holiday through December 2020. These deleveraging requirements are based on significant declines in the value of the collateral as determined by an annual third-party (engaged by us) appraisal process tied to the provisions of the underlying loan agreements. We believe this provides us with both cushion and predictability to avoid sudden unexpected outcomes and material repayment requirements. In addition to the pledge of the additional collateral noted above, we paid down the previous financing by €16.5 million (totaling $18.5 million in USD) and agreed to increase the financing spreads by 0.25%.

The table below provides the borrowings outstanding (on an as converted basis) and weighted-average fully-extended maturities by currency for the assets financed under the Barclays Private Securitization as of September 30, 2020 ($ in thousands):

	Borrowings outstanding	Fully-Extended Maturity(1)
Total/Weighted-Average GBP	$670,024	January 2024
Total/Weighted-Average EUR	143,568	August 2021(2)
Total/Weighted-Average Securitization	$813,592	March 2024

———————

(1)Assumes underlying loans extend to fully extended maturity and extensions at our option are exercised.

(2)The EUR portion of the Barclays Private Securitization has an "evergreen" feature such that the facility continues for one year and can be terminated by either party on certain dates with, depending on the date of notice, a minimum of nine to twelve months' notice.

    The table below provides the assets and liabilities of the Barclays Private Securitization VIE included in our condensed consolidated balance sheet ($ in thousands):

	September 30, 2020
Assets:
Cash	$	921
Commercial mortgage loans, net(1)	1,224,154
Other Assets	9,401
Total Assets	$	1,234,476
Liabilities:
Secured debt arrangements, net (net of deferred financing costs of $0.2 million)	$	813,431
Accounts payable, accrued expenses and other liabilities(2)	1,084
Total Liabilities	$	814,515

———————

(1)Net of the General CECL Allowance of $6.1 million.

(2)Represents General CECL Allowance related to unfunded commitments on commercial mortgage loans, net of $0.3 million.

	Three months ended
	September 30, 2020
Net Interest Income:
Interest income from commercial mortgage loans	$	15,075
Interest expense	(4,278)
Net interest income	$	10,797
Provision for loan losses and impairments	$	(2,318)
Foreign currency gain	17,078
Net Income	$	25,557

As of September 30, 2020, we had $813.6 million (£518.6 million and €122.5 million assuming conversion into USD) of borrowings outstanding under the Barclays Private Securitization secured by certain of our commercial mortgage loans.

At September 30, 2020, our borrowings had the following remaining maturities ($ in thousands):

	Less than 1 year		1 to 3 years		3 to 5 years		More than 5 years		Total
JPMorgan	$	45,918	$	432,440	$	678,907	$	—	$	1,157,265
DB	15,594		511,149		—		—		526,743
Goldman	—		362,139		—		—		362,139
CS - USD	94,299		146,994		137,488		—		378,781
HSBC - USD	47,223		—		—		—		47,223
HSBC - EUR	157,148		—		—		—		157,148
Barclays - USD	—		—		35,192		—		35,192
Barclays Private Securitization	143,568		289,769		380,255		—		813,592
Total	$	503,750	$	1,742,491	$	1,231,842	$	—	$	3,478,083

The table above reflects the fully extended maturity date of the facility and assumes facilities with an "evergreen" feature continue to extend through the fully-extended maturity of the underlying asset and assumes underlying loans are extended with consent of financing providers.

The table below summarizes the outstanding balances at September 30, 2020, as well as the maximum and average month-end balances for the nine months ended September 30, 2020 for our borrowings under secured debt arrangements ($ in thousands).

	As of September 30, 2020				For the nine months ended September 30, 2020
	Balance		Amortized Cost of Collateral		Maximum Month-End Balance		Average Month-End Balance
JPMorgan	$	1,157,265	$	1,976,965	$	1,192,288	$	1,106,461
DB	526,743		804,835		526,743		501,470
Goldman	362,139		548,671		362,139		343,882
CS - USD	378,781		523,272		378,781		339,425
CS - GBP	—		—		90,111		57,459
HSBC - USD	47,223		67,203		50,625		48,357
HSBC - GBP	—		—		34,500		32,900
HSBC - EUR	157,148		204,040		160,034		152,982
Barclays - USD	35,192		49,929		35,193		27,372
Barclays - GBP	—		—		666,810		347,590

Barclays - EUR	—		—		180,595	94,028
Barclays Private Securitization	813,592		1,230,305		839,563	814,844
Total	$	3,478,083	$	5,405,220

The table below summarizes the outstanding balances at December 31, 2019, as well as the maximum and average month-end balances for the year ended December 31, 2019 for our borrowings under secured debt arrangements ($ in thousands).

	As of December 31, 2019				For the year ended December 31, 2019
	Balance		Amortized Cost of Collateral		Maximum Month-End Balance		Average Month-End Balance
JPMorgan	$	1,234,759	$	1,845,400	$	1,234,759	$	947,400
DB	513,876		766,676		757,117		604,067
Goldman	322,170		513,559		324,821		246,318
CS - USD	218,644		308,884		218,644		182,646
CS - GBP	93,915		129,723		150,811		134,694
HSBC - USD	50,625		66,960		50,625		50,625
HSBC - GBP	34,634		49,976		50,784		42,296
HSBC - EUR	154,037		190,780		154,037		151,889
Barclays - GBP	290,347		738,455		290,347		139,004
Barclays - EUR	182,549		241,674		182,549		181,159
Total	$	3,095,556	$	4,852,087

We were in compliance with the covenants under each of our secured debt arrangements at September 30, 2020 and December 31, 2019.

XML

Senior Secured Term Loan, Net

9 Months Ended

Sep. 30, 2020

Senior Secured Term Loan, Net

Secured Debt Arrangements, Net

At September 30, 2020 and December 31, 2019, our borrowings included the following secured debt arrangements, maturities and weighted-average interest rates ($ in thousands):

	September 30, 2020					December 31, 2019
	Maximum Amount of Borrowings(1)		Borrowings Outstanding(1)		Maturity (2)	Maximum Amount of Borrowings(1)		Borrowings Outstanding(1)		Maturity (2)
JPMorgan (USD)	$	1,132,013	$	989,278	June 2024	$	1,154,109	$	1,090,160	June 2024
JPMorgan (GBP)	97,661		97,661		June 2024	51,702		50,410		June 2024
JPMorgan (EUR)	70,326		70,326		June 2024	94,189		94,189		June 2024
DB (USD)	1,000,000		526,743		March 2023	1,250,000		513,876		March 2021
Goldman (USD)	500,000		362,139		November 2021	500,000		322,170		November 2021
CS - USD	378,903		378,781		January 2023(3)	226,068		218,644		June 2020
CS - GBP	—		—		N/A(4)	93,915		93,915		June 2020
HSBC - USD	47,223		47,223		January 2021	50,625		50,625		October 2020
HSBC - GBP	—		—		N/A	34,634		34,634		June 2020
HSBC - EUR	157,148		157,148		July 2021	154,037		154,037		January 2021
Barclays (USD)	200,000		35,192		March 2024	N/A		N/A		N/A
Barclays (GBP)	—		—		N/A(4)	538,916		290,347		February 2024(5)
Barclays (EUR)	—		—		N/A(4)	182,549		182,549		November 2020
Total Secured Credit Facilities	3,583,274		2,664,491			4,330,744		3,095,556
Barclays Private Securitization	813,592		813,592		March 2024(5)	N/A		N/A		N/A
Total Secured Debt Arrangements	4,396,866		3,478,083			4,330,744		3,095,556
less: deferred financing costs	N/A		(12,746)			N/A		(17,190)
Total Secured Debt Arrangements, net(6)(7)(8)	$	4,396,866	$	3,465,337		$	4,330,744	$	3,078,366

———————

(1)As of September 30, 2020, British Pound Sterling ("GBP") and Euros ("EUR") borrowings were converted to U.S. Dollars ("USD") at a rate of 1.29 and 1.17, respectively. As of December 31, 2019, GBP and EUR borrowings were converted at a rate of 1.33 and 1.12, respectively.

(2)Maturity date assumes extensions at our option are exercised with consent of financing providers, where applicable.

(3)Assumes financings are extended in line with the underlying loans.

(4)As of September 30, 2020, there are no loans pledged to this facility.

(5)Represents weighted average maturity across various financings with the counterparty. See below for additional details.

(6)Weighted-average borrowing costs as of September 30, 2020 and December 31, 2019 were USD L + 2.15% / GBP L + 1.82% / EUR L + 1.46% and USD L + 2.07% / GBP L + 1.75% / EUR L + 1.36%, respectively.

(7)Weighted average advance rates based on cost as of September 30, 2020 and December 31, 2019 were 64.3% (63.8% (USD) / 67.9% (GBP) / 61.3% (EUR)) and 63.8% (66.7% (USD) / 47.1% (GBP) / 76.1% (EUR)).

(8)As of September 30, 2020 and December 31, 2019, approximately 55% and 54% of the outstanding balance under these secured borrowings were recourse to us.

Each of our existing secured debt arrangements include "credit based and other mark-to-market" features. "Credit mark-to-market" provisions in repurchase facilities are designed to keep the lenders' credit exposure generally constant as a percentage of the underlying collateral value of the assets pledged as security to them. If the credit of the underlying collateral value decreases, the amount of leverage available to us will be reduced as our assets are marked-to-market, which would reduce our liquidity. Generally, the lender under the applicable secured debt arrangement calls for and/or sets the valuation and any revaluation of the collateral assets in its sole, good faith discretion. If it is determined (subject to certain conditions) that the market value of the underlying collateral has decreased by more than a defined minimum amount, the lender may require us to provide additional collateral or may make margin calls, which may require us to repay all or a portion of the funds advanced. We closely monitor our liquidity and intend to maintain sufficient liquidity on our balance sheet in order to meet any margin calls in the event of any significant decreases in asset values. As of September 30, 2020 and December 31, 2019, the weighted average haircut under our secured debt arrangements was approximately 35.7% and 36.2%, respectively. In addition, our existing secured debt arrangements are not entirely term-matched financings and may mature before our commercial real estate debt investments that represent underlying collateral to those financings. We are in frequent dialogue with the lenders under our secured debt arrangements regarding our management of their collateral assets and as we negotiate renewals and extensions of these liabilities, we may experience lower advance rates and higher pricing under the renewed or extended agreements.

JPMorgan Facility

In November 2019, through three indirect wholly-owned subsidiaries, we entered into a Sixth Amended and Restated Master Repurchase Agreement with JPMorgan Chase Bank, National Association (as amended, the "JPMorgan Facility"). The JPMorgan Facility allows for $1.3 billion of maximum borrowings (with amounts borrowed in British pounds and Euros converted to USD for purposes of calculating availability based on the greater of the spot rate as of the initial financing under the corresponding mortgage loan and the then-current spot rate) and matures in June 2022 and has two one-year extensions available at our option, which are subject to certain conditions. The JPMorgan Facility enables us to elect to receive advances in USD, GBP, or EUR. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $1.2 billion (including £75.6 million and €60.0 million assuming conversion into USD) of borrowings outstanding under the JPMorgan Facility secured by certain of our commercial mortgage loans.

DB Facility

In March 2020, through an indirect wholly-owned subsidiary, we entered into a Third Amended and Restated Master Repurchase Agreement with Deutsche Bank AG, Cayman Islands Branch, London Branch (as amended, the "DB Facility"), which provides for advances of up to $1.0 billion for the sale and repurchase of eligible first mortgage loans secured by commercial or multifamily properties located in the United States, United Kingdom and the European Union, and enables us to elect to receive advances in USD, GBP, or EUR. The repurchase facility matures in March 2021, and has two one-year extensions available at our option, subject to certain conditions. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $526.7 million of borrowings outstanding under the DB Facility secured by certain of our commercial mortgage loans.

Goldman Facility

In November 2017, through an indirect wholly-owned subsidiary, we entered into a master repurchase and securities contract agreement with Goldman Sachs Bank USA (the "Goldman Facility"), which provides advances up to $500.0 million and matures in November 2020, and has one one-year extension available at our option, subject to certain conditions. Margin calls may occur any time at specified margin deficit thresholds.

As of September 30, 2020, we had $362.1 million of borrowings outstanding under the Goldman Facility secured by certain of our commercial mortgage loans.

CS Facility - USD

In July 2018, through an indirect wholly-owned subsidiary, we entered into a Master Repurchase Agreement with Credit Suisse AG, acting through its Cayman Islands Branch and Alpine Securitization Ltd (the "CS Facility - USD"), which provides for advances for the sale and repurchase of eligible commercial mortgage loans secured by real estate. The CS Facility - USD has an "evergreen" feature such that the facility continues unless terminated at any time by Credit Suisse with six months' notice. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $378.8 million of borrowings outstanding under the CS Facility - USD secured by certain of our commercial mortgage loans.

CS Facility - GBP

In June 2018, through an indirect wholly-owned subsidiary, we entered into a Global Master Repurchase Agreement with Credit Suisse Securities (Europe) Limited (the "CS Facility - GBP"). During the third quarter of 2020, the facility was repaid in connection with the sale of the underlying loan.

HSBC Facility - USD    

In October 2019, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement with HSBC Bank plc (the "HSBC Facility - USD"), which provides for a single asset financing. The facility is scheduled to mature in January 2021. Margin calls may occur any time at specified aggregate margin thresholds.

As of September 30, 2020, we had $47.2 million of borrowings under the HSBC Facility - USD secured by one commercial mortgage loan.

HSBC Facility - GBP

In September 2018, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement with HSBC Bank plc (the "HSBC Facility - GBP"), which provided for a single asset financing. The facility matured and was repaid in June 2020 in connection with the repayment of the underlying loan.

HSBC Facility - EUR

In July 2019, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement with HSBC Bank plc (the "HSBC Facility - EUR"), which provides for a single asset financing. The facility matures in July 2021. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $157.1 million (€134.1 million assuming conversion into USD) of borrowings outstanding under the HSBC Facility - EUR secured by one commercial mortgage loan.

Barclays Facility - USD

In March 2020, through an indirect wholly-owned subsidiary, we entered into a secured debt arrangement pursuant to a Master Repurchase Agreement with Barclays Bank plc ("Barclays Facility - USD"). The Barclays Facility - USD allows for $200.0 million of maximum borrowings and initially matures in March 2023 with extensions available at our option, subject to certain conditions. Margin calls may occur any time at specified aggregate margin deficit thresholds.

As of September 30, 2020, we had $35.2 million of borrowings outstanding under the Barclays Facility - USD secured by one commercial mortgage loan.

Barclays Facility - GBP/EUR

Beginning in October 2019, through an indirect wholly-owned subsidiary, we entered into five secured debt arrangements pursuant to a Global Master Repurchase Agreement with Barclays Bank plc (the "Barclays Facility - GBP/EUR"). In June 2020, all assets previously financed pursuant to this facility were refinanced under the Barclays Private Securitization.

Barclays Private Securitization

In June 2020, through a newly formed entity, we entered into a private securitization with Barclays Bank plc, of which Barclays Bank plc retained $782.0 million of senior notes. This Barclays Private Securitization finances the loans that were previously financed under the Barclays Facility - GBP/EUR. In addition, we pledged an additional commercial mortgage loan with an outstanding principal balance of £26.0 million and pledged additional collateral of a financed loan of €5.3 million as of June 30, 2020.

The securitization eliminates daily margining provisions and grants us significant discretion to modify certain terms of the underlying collateral including waiving certain loan-level covenant breaches and deferring or waiving of debt service payments for up to 18 months. The securitization includes LTV based covenants with significant headroom to existing levels that are also subject to a six-month holiday through December 2020. These deleveraging requirements are based on significant declines in the value of the collateral as determined by an annual third-party (engaged by us) appraisal process tied to the provisions of the underlying loan agreements. We believe this provides us with both cushion and predictability to avoid sudden unexpected outcomes and material repayment requirements. In addition to the pledge of the additional collateral noted above, we paid down the previous financing by €16.5 million (totaling $18.5 million in USD) and agreed to increase the financing spreads by 0.25%.

The table below provides the borrowings outstanding (on an as converted basis) and weighted-average fully-extended maturities by currency for the assets financed under the Barclays Private Securitization as of September 30, 2020 ($ in thousands):

	Borrowings outstanding	Fully-Extended Maturity(1)
Total/Weighted-Average GBP	$670,024	January 2024
Total/Weighted-Average EUR	143,568	August 2021(2)
Total/Weighted-Average Securitization	$813,592	March 2024

———————

(1)Assumes underlying loans extend to fully extended maturity and extensions at our option are exercised.

(2)The EUR portion of the Barclays Private Securitization has an "evergreen" feature such that the facility continues for one year and can be terminated by either party on certain dates with, depending on the date of notice, a minimum of nine to twelve months' notice.

    The table below provides the assets and liabilities of the Barclays Private Securitization VIE included in our condensed consolidated balance sheet ($ in thousands):

	September 30, 2020
Assets:
Cash	$	921
Commercial mortgage loans, net(1)	1,224,154
Other Assets	9,401
Total Assets	$	1,234,476
Liabilities:
Secured debt arrangements, net (net of deferred financing costs of $0.2 million)	$	813,431
Accounts payable, accrued expenses and other liabilities(2)	1,084
Total Liabilities	$	814,515

———————

(1)Net of the General CECL Allowance of $6.1 million.

(2)Represents General CECL Allowance related to unfunded commitments on commercial mortgage loans, net of $0.3 million.

	Three months ended
	September 30, 2020
Net Interest Income:
Interest income from commercial mortgage loans	$	15,075
Interest expense	(4,278)
Net interest income	$	10,797
Provision for loan losses and impairments	$	(2,318)
Foreign currency gain	17,078
Net Income	$	25,557

As of September 30, 2020, we had $813.6 million (£518.6 million and €122.5 million assuming conversion into USD) of borrowings outstanding under the Barclays Private Securitization secured by certain of our commercial mortgage loans.

At September 30, 2020, our borrowings had the following remaining maturities ($ in thousands):

	Less than 1 year		1 to 3 years		3 to 5 years		More than 5 years		Total
JPMorgan	$	45,918	$	432,440	$	678,907	$	—	$	1,157,265
DB	15,594		511,149		—		—		526,743
Goldman	—		362,139		—		—		362,139
CS - USD	94,299		146,994		137,488		—		378,781
HSBC - USD	47,223		—		—		—		47,223
HSBC - EUR	157,148		—		—		—		157,148
Barclays - USD	—		—		35,192		—		35,192
Barclays Private Securitization	143,568		289,769		380,255		—		813,592
Total	$	503,750	$	1,742,491	$	1,231,842	$	—	$	3,478,083

The table above reflects the fully extended maturity date of the facility and assumes facilities with an "evergreen" feature continue to extend through the fully-extended maturity of the underlying asset and assumes underlying loans are extended with consent of financing providers.

The table below summarizes the outstanding balances at September 30, 2020, as well as the maximum and average month-end balances for the nine months ended September 30, 2020 for our borrowings under secured debt arrangements ($ in thousands).

	As of September 30, 2020				For the nine months ended September 30, 2020
	Balance		Amortized Cost of Collateral		Maximum Month-End Balance		Average Month-End Balance
JPMorgan	$	1,157,265	$	1,976,965	$	1,192,288	$	1,106,461
DB	526,743		804,835		526,743		501,470
Goldman	362,139		548,671		362,139		343,882
CS - USD	378,781		523,272		378,781		339,425
CS - GBP	—		—		90,111		57,459
HSBC - USD	47,223		67,203		50,625		48,357
HSBC - GBP	—		—		34,500		32,900
HSBC - EUR	157,148		204,040		160,034		152,982
Barclays - USD	35,192		49,929		35,193		27,372
Barclays - GBP	—		—		666,810		347,590

Barclays - EUR	—		—		180,595	94,028
Barclays Private Securitization	813,592		1,230,305		839,563	814,844
Total	$	3,478,083	$	5,405,220

The table below summarizes the outstanding balances at December 31, 2019, as well as the maximum and average month-end balances for the year ended December 31, 2019 for our borrowings under secured debt arrangements ($ in thousands).

	As of December 31, 2019				For the year ended December 31, 2019
	Balance		Amortized Cost of Collateral		Maximum Month-End Balance		Average Month-End Balance
JPMorgan	$	1,234,759	$	1,845,400	$	1,234,759	$	947,400
DB	513,876		766,676		757,117		604,067
Goldman	322,170		513,559		324,821		246,318
CS - USD	218,644		308,884		218,644		182,646
CS - GBP	93,915		129,723		150,811		134,694
HSBC - USD	50,625		66,960		50,625		50,625
HSBC - GBP	34,634		49,976		50,784		42,296
HSBC - EUR	154,037		190,780		154,037		151,889
Barclays - GBP	290,347		738,455		290,347		139,004
Barclays - EUR	182,549		241,674		182,549		181,159
Total	$	3,095,556	$	4,852,087

We were in compliance with the covenants under each of our secured debt arrangements at September 30, 2020 and December 31, 2019.

Senior Debt

Senior Secured Term Loan, Net

Senior Secured Term Loan, Net

In May 2019, we entered into a $500.0 million senior secured term loan. The senior secured term loan bears interest at LIBOR plus 2.75% and was issued at a price of 99.5%. The senior secured term loan matures in May 2026 and contains restrictions relating to liens, asset sales, indebtedness, and investments in non-wholly owned entities.

During the three and nine months ended September 30, 2020, we repaid $1.3 million and $3.8 million of principal related to the senior secured term loan, respectively. The outstanding principal balance as of September 30, 2020 and December 31, 2019 was $493.8 million and $497.5 million, respectively. As of September 30, 2020, the senior secured term loan had a carrying value of $484.2 million net of deferred financing costs of $7.6 million and an unamortized discount of $2.0 million. As of December 31, 2019, the senior secured term loan had a carrying value of $488.0 million net of deferred financing costs of $7.3 million and an unamortized discount of $2.3 million.

Covenants

The senior secured term loan includes the following financial covenants: (i) our ratio of total recourse debt to tangible net worth cannot be greater than 3:1; and (ii) our ratio of total unencumbered assets to total pari-passu indebtedness must be at least 1.25:1.

We were in compliance with the covenants under the senior secured term loan at September 30, 2020 and December 31, 2019.

Interest Rate Swap

In connection with the senior secured term loan, we previously entered into an interest rate swap to fix LIBOR at 2.12% effectively fixing our all-in coupon on the senior secured term loan at 4.87%. During the second quarter of 2020 we terminated the interest rate swap and recognized a realized loss of $53.9 million.

Interest Rate Cap

During the second quarter of 2020, we entered into a three-year interest rate cap to cap LIBOR at 0.75%. This effectively limits the maximum all-in coupon on our senior secured term loan to 3.50%. In connection with the interest rate cap, we incurred up-front fees of $1.1 million, which we recorded as a deferred financing cost on our condensed consolidated balance

sheet and interest expense will be recognized over the duration of the interest rate cap in our condensed consolidated statement of operations

XML

Convertible Senior Notes, Net

9 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Convertible Senior Notes, Net

Convertible Senior Notes, Net

In two separate offerings during 2014, we issued an aggregate principal amount of $254.8 million of 5.50% Convertible Senior Notes due 2019 (the "2019 Notes"), for which we received $248.6 million, after deducting the underwriting discount and offering expenses. The 2019 Notes were exchanged or converted for shares of our common stock and cash as follows:

(i) On August 2, 2018, we entered into privately negotiated exchange agreements with a limited number of holders of the 2019 Notes pursuant to which we exchanged $206.2 million of the 2019 Notes for an aggregate of (a) 10,020,328 newly issued shares of our common stock, and (b) $39.3 million in cash. We recorded $166.0 million of additional paid-in-capital in our condensed consolidated statement of changes in stockholders' equity in connection with these transactions,

(ii) Certain holders elected to convert $47.9 million of the 2019 Notes, which were settled for an aggregate of (a) 2,775,509 newly issued shares of our common stock, and (b) $0.2 million in cash. We recorded $13.9 million of additional paid-in-capital in our condensed consolidated statement of changes in stockholders' equity in connection with these transactions. These conversions occurred from August 2018 through maturity.

The remaining $0.7 million in principal amount of the 2019 Notes was repaid at maturity on March 15, 2019.

In two separate offerings during 2017, we issued an aggregate principal amount of $345.0 million of 4.75% Convertible Senior Notes due 2022 (the "2022 Notes"), for which we received $337.5 million, after deducting the underwriting discount and offering expenses. At September 30, 2020, the 2022 Notes had a carrying value of $339.7 million and an unamortized discount of $5.3 million.

During the fourth quarter of 2018, we issued $230.0 million of 5.375% Convertible Senior Notes due 2023 (the "2023 Notes" and, together with the 2022 Notes, the "Notes"), for which we received $223.7 million after deducting the underwriting discount and offering expenses. At September 30, 2020, the 2023 Notes had a carrying value of $224.9 million and an unamortized discount of $5.1 million.

The following table summarizes the terms of the Notes ($ in thousands):

	Principal Amount		Coupon Rate		Effective Rate (1)		Conversion Rate (2)	Maturity Date	Remaining Period of Amortization
2022 Notes	$	345,000	4.75	%	5.60	%	50.2260	8/23/2022	1.90
2023 Notes	230,000		5.38	%	6.16	%	48.7187	10/15/2023	3.04
Total	$	575,000

———————

(1)Effective rate includes the effect of the adjustment for the conversion option (See footnote (2) below), the value of which reduced the initial liability and was recorded in additional paid-in-capital.

(2)We have the option to settle any conversions in cash, shares of common stock or a combination thereof. The conversion rate represents the number of shares of common stock issuable per one thousand principal amount of the Notes converted, and includes adjustments relating to cash dividend payments made by us to stockholders that have been deferred and carried-forward in accordance with, and are not yet required to be made pursuant to, the terms of the applicable supplemental indenture.

We may not redeem the Notes prior to maturity except in limited circumstances. The closing price of our common

stock on September 30, 2020 of $9.01 was less than the per share conversion price of the Notes.

In accordance with ASC 470 "Debt," the liability and equity components of convertible debt instruments that may be settled in cash upon conversion (including partial cash settlement) are to be separately accounted for in a manner that reflects the issuer’s nonconvertible debt borrowing rate. GAAP requires that the initial proceeds from the sale of the Notes be allocated between a liability component and an equity component in a manner that reflects interest expense at the interest rate of similar nonconvertible debt that could have been issued by us at such time. We measured the fair value of the debt components of the Notes as of their issuance date based on effective interest rates. As a result, we attributed approximately $15.4 million of the proceeds to the equity component of the Notes ($11.0 million to the 2022 Notes and $4.4 million to the 2023 Notes), which represents the excess proceeds received over the fair value of the liability component of the Notes at the date of issuance. The equity component of the Notes has been reflected within additional paid-in capital in our condensed consolidated balance sheet

as of September 30, 2020. The resulting debt discount is being amortized over the period during which the Notes are expected to be outstanding (the maturity date) as additional non-cash interest expense. The additional non-cash interest expense attributable to each of the Notes will increase in subsequent reporting periods through the maturity date as the Notes accrete to their par value over the same period.The aggregate contractual interest expense was approximately $7.2 million and $21.6 million for the three and nine months ended September 30, 2020, respectively, as compared to $7.2 million and $21.9 million for the three and nine months ended September 30, 2019, respectively. With respect to the amortization of the discount on the liability component of the Notes as well as the amortization of deferred financing costs, we reported additional non-cash interest expense of approximately $1.5 million and $4.5 million for the three and nine months ended September 30, 2020, respectively, as compared to $1.5 million and $4.6 million for the three and nine months ended September 30, 2019, respectively.

XML

Derivatives

9 Months Ended

Sep. 30, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives

Derivatives

We use forward currency contracts to economically hedge interest and principal payments due under our loans denominated in currencies other than USD.

We have entered into a series of forward contracts to sell an amount of foreign currency (GBP and EUR) for an agreed upon amount of USD at various dates through December 2024. These forward contracts were executed to economically fix the USD amounts of foreign denominated cash flows expected to be received by us related to foreign denominated loan investments.

    The following table summarizes our non-designated foreign exchange ("Fx") forwards and our interest rate cap as of September 30, 2020:

	September 30, 2020
	Number of Contracts	Aggregate Notional Amount (in thousands)	Notional Currency	Maturity	Weighted-Average Years to Maturity
Fx contracts - GBP	106	422,585	GBP	October 2020 - December 2024	2.16
Fx contracts - EUR	70	238,817	EUR	November 2020 - August 2024	2.79
Interest rate cap	1	500,000	USD	June 2023	2.71

The following table summarizes our non-designated Fx forwards and our interest rate swap as of December 31, 2019:

	December 31, 2019
	Number of Contracts	Aggregate Notional Amount (in thousands)	Notional Currency	Maturity	Weighted-Average Years to Maturity
Fx contracts - GBP	156	735,349	GBP	January 2020 - December 2024	1.49
Fx contracts - EUR	44	168,879	EUR	February 2020 - August 2024	3.22
Interest rate swap	1	500,000	USD	May 2026	6.37

We have not designated any of our derivative instruments as hedges as defined in ASC 815 - Derivatives and Hedging and, therefore, changes in the fair value of our derivative instruments are recorded directly in earnings. The following table summarizes the amounts recognized on our condensed consolidated statements of operations related to our derivatives for the three and nine months ended September 30, 2020 and 2019 ($ in thousands):

		Amount of gain (loss) recognized in income
		Three months ended September 30,				Nine months ended September 30,
	Location of Gain (Loss) Recognized in Income	2020		2019		2020		2019
Forward currency contracts	Unrealized gain (loss) on derivative instruments	$	(35,076)	$	16,227	$	18,356	$	12,029
Forward currency contracts	Realized gain on derivative instruments	539		7,926		14,603		16,590
Total		$	(34,537)	$	24,153	$	32,959	$	28,619

In connection with our senior secured term loan, in May 2019, we entered into an interest rate swap to fix LIBOR at 2.12% or an all-in interest rate of 4.87%. We used our interest rate swap to manage exposure to variable cash flows on our borrowings under our senior secured term loan. Our interest rate swap allowed us to receive a variable rate cash flow based on LIBOR and pay a fixed rate cash flow, mitigating the impact of this exposure. However during the second quarter of 2020, we terminated our interest rate swap due to a significant decrease in LIBOR and recognized a realized loss on the accompanying condensed consolidated statement of operations.

In June 2020, we entered into an interest rate cap for approximately $1.1 million. We use our interest rate cap to manage exposure to variable cash flows on our borrowings under our senior secured term loan by effectively limiting LIBOR from exceeding 0.75%. This effectively limits the maximum all-in coupon on our senior secured term loan to 3.50%. Unrealized gains or losses related to the interest rate swap and cap were recorded net under interest expense in our condensed consolidated statement of operations.

		Amount of loss recognized in income
		Three months ended September 30,				Nine months ended September 30,
	Location of Loss Recognized in Income	2020		2019		2020		2019
Interest rate cap(1)	Unrealized gain (loss) on interest rate cap	$	(564)	$	—	$	174	$	—
Interest rate swap(2)	Unrealized gain (loss) on interest rate swap	—		(10,307)		14,470		(23,420)
Interest rate swap(2)	Realized loss on interest rate swap	—		—		(53,851)		—
Total		$	(564)	$	(10,307)	$	(39,207)	$	(23,420)

———————

(1)With a notional amount of $500.0 million and $0 at September 30, 2020, and 2019, respectively.

(2)With a notional amount of $0 and $500.0 million at September 30, 2020, and 2019, respectively.

The following tables summarize the gross asset and liability amounts related to our derivatives at September 30, 2020 and December 31, 2019 ($ in thousands)

	September 30, 2020						December 31, 2019
	Gross Amount of Recognized Assets		Gross Amounts Offset in our Condensed Consolidated Balance Sheet		Net Amounts of Assets Presented in our Condensed Consolidated Balance Sheet		Gross Amount of Recognized Assets		Gross Amounts Offset in our Condensed Consolidated Balance Sheet		Net Amounts of Assets Presented in our Condensed Consolidated Balance Sheet
Forward currency contracts	$	20,788	$	(7,307)	$	13,481	$	—	$	—	$	—
Interest rate cap	173		—		173		—		—		—
Total	$	20,961	$	(7,307)	$	13,654	$	—	$	—	$	—

	September 30, 2020						December 31, 2019
	Gross Amount of Recognized Liability		Gross Amounts Offset in our Condensed Consolidated Balance Sheet		Net Amounts of Liability Presented in our Condensed Consolidated Balance Sheet		Gross Amount of Recognized Liabilities		Gross Amounts Offset in our Condensed Consolidated Balance Sheet		Net Amounts of Liabilities Presented in our Condensed Consolidated Balance Sheet
Interest rate swap	$	—	$	—	$	—	$	14,470	$	—	$	14,470
Forward currency contracts	—		—		—		12,687		(7,811)		4,876
Total derivative liabilities	$	—	$	—	$	—	$	27,157	$	(7,811)	$	19,346

XML

Accounts Payable, Accrued Expenses and Other Liabilities

9 Months Ended

Sep. 30, 2020

Payables and Accruals [Abstract]

Accounts Payable, Accrued Expenses and Other Liabilities

Accounts Payable, Accrued Expenses and Other Liabilities

The following table details the components of our accounts payable, accrued expense and other liabilities ($ in thousands):

	September 30, 2020		December 31, 2019
Accrued dividends payable	$	53,689	$	74,771
Collateral deposited under derivative agreements	12,780		2,930
Accrued interest payable	13,013		16,089
Accounts payable and other liabilities	6,145		6,922
General CECL Allowance on unfunded commitments(1)	3,595		—
Total	$	89,222	$	100,712

  ———————

(1)Refer to Note 4 - Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net for additional disclosure related to the General CECL Allowance on unfunded commitments for the quarter ended September 30, 2020.

XML

Related Party Transactions

9 Months Ended

Sep. 30, 2020

Related Party Transactions [Abstract]

Related Party Transactions

Related Party Transactions

Management Agreement

In connection with our initial public offering in September 2009, we entered into a management agreement (the "Management Agreement") with the Manager, which describes the services to be provided by the Manager and its compensation for those services. The Manager is responsible for managing our day-to-day operations, subject to the direction and oversight of our board of directors.

Pursuant to the terms of the Management Agreement, the Manager is paid a base management fee equal to 1.5% per annum of our stockholders’ equity (as defined in the Management Agreement), calculated and payable (in cash) quarterly in arrears.

The current term of the Management Agreement will expire on September 29, 2021, and is automatically renewed for successive one-year terms on each anniversary thereafter. The Management Agreement may be terminated upon expiration of the one-year extension term only upon the affirmative vote of at least two-thirds of our independent directors, based upon (1) unsatisfactory performance by the Manager that is materially detrimental to ARI or (2) a determination that the management fee payable to the Manager is not fair, subject to the Manager’s right to prevent such a termination based on unfair fees by accepting a mutually acceptable reduction of management fees agreed to by at least two-thirds of our independent directors. The Manager must be provided with written notice of any such termination at least 180 days prior to the expiration of the then existing term and will be paid a termination fee equal to three times the sum of the average annual base management fee during the 24-month period immediately preceding the date of termination, calculated as of the end of the most recently completed fiscal quarter prior to the date of termination. Following a meeting by our independent directors in February 2020, which included a discussion of the Manager’s performance and the level of the management fees thereunder, we determined not to seek termination of the Management Agreement.

We incurred approximately $9.9 million and $30.2 million in base management fees under the Management Agreement for the three and nine months ended September 30, 2020, respectively, as compared to $10.4 million and $30.3 million for the three and nine months ended September 30, 2019, respectively.

In addition to the base management fee, we are also responsible for reimbursing the Manager for certain expenses paid by the Manager on our behalf or for certain services provided by the Manager to us. For the three and nine months ended September 30, 2020 we paid expenses totaling $0.6 million and $1.7 million, respectively, related to reimbursements for certain expenses paid by the Manager on our behalf under the Management Agreement as compared to $0.5 million and $2.0 million, respectively Expenses incurred by the Manager and reimbursed by us are reflected in the respective condensed consolidated statement of operations expense category or our condensed consolidated balance sheet based on the nature of the item.

Included in payable to related party on our condensed consolidated balance sheet at September 30, 2020 and December 31, 2019 are approximately $9.9 million and $10.4 million, respectively, for base management fees incurred but not yet paid under the Management Agreement.

Loans receivable

In January 2020, we sold £62.2 million ($81.3 million assuming conversion into U.S. dollars) in a mezzanine loan and £50.0 million ($65.3 million assuming conversion into U.S. dollars) unfunded commitment of a senior mortgage secured by a mixed-use property in London, UK to a fund managed by an affiliate of the Manager, that was originated by us in December 2019. This transaction was evaluated under ASC 860 - Transfers and Servicing, and we determined that it qualifies as a sale and accounted for as such.

In the second quarter of 2020, we sold our interests in three construction loans to entities managed by affiliates of the Manager. Refer to "Note 4 - Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net" for additional information related to these sales.

Term Loan

In May 2019, Apollo Global Funding, LLC, an affiliate of the Manager, served as one of the five arrangers for the issuance of our senior secured term loan and received $0.6 million of arrangement fees.

XML

Share-Based Payments

9 Months Ended

Sep. 30, 2020

Share-based Payment Arrangement [Abstract]

Share-Based Payments

Share-Based Payments

On September 23, 2009, our board of directors approved the Apollo Commercial Real Estate Finance, Inc. 2009 Equity Incentive Plan ("2009 LTIP") and on April 16, 2019, our board of directors approved the Amended and Restated Apollo Commercial Real Estate Finance, Inc. 2019 Equity Incentive Plan ("2019 LTIP," and together with the 2009 LTIP, the "LTIPs"), which amended and restated the 2009 LTIP. Following the approval of the 2019 LTIP by our stockholders at our 2019 annual meeting of stockholders on June 12, 2019, no additional awards will be granted under the 2009 LTIP and all outstanding awards granted under the 2009 LTIP remain in effect in accordance with the terms in the 2009 LTIP.

The 2019 LTIP provides for grants of restricted common stock, restricted stock units ("RSUs") and other equity-based awards up to an aggregate of 7,000,000 shares of our common stock. The LTIPs are administered by the compensation committee of our board of directors (the "Compensation Committee") and all grants under the LTIPs must be approved by the Compensation Committee.

We recognized stock-based compensation expense of $4.2 million and $12.7 million for the three and nine months ended September 30, 2020, respectively, related to restricted stock and RSU vesting, as compared to $3.9 million and $12.1 million for the three and nine months ended September 30, 2019, respectively.

The following table summarizes the grants, vesting and forfeitures of restricted common stock and RSUs during the nine months ended September 30, 2020:

	Type	Restricted Stock	RSUs	Grant Date Fair Value ($ in thousands)
Outstanding at December 31, 2019		25,356	2,007,355
	Granted	82,235	54,867	906
	Vested	(25,356)	(264)	N/A
	Forfeiture	—	(13,587)	N/A
Outstanding at September 30, 2020		82,235	2,048,371

Below is a summary of restricted stock and RSU vesting dates as of September 30, 2020: 

Vesting Year	Restricted Stock	RSU	Total Awards
2020	—	956,738	956,738
2021	82,235	699,903	782,138
2022	—	373,441	373,441
2023	—	18,289	18,289
Total	82,235	2,048,371	2,130,606

At September 30, 2020, we had unrecognized compensation expense of approximately $0.3 million and $22.9 million, respectively, related to the vesting of restricted stock awards and RSUs noted in the table above.

RSU Deliveries

During the nine months ended September 30, 2020 and 2019, we delivered 503,411 and 433,585 shares of common stock for 868,421 and 730,980 vested RSUs, respectively. We allow RSU participants to settle their tax liabilities with a reduction of their share delivery from the originally granted and vested RSUs. The amount, when agreed to by the participant, results in a cash payment to the Manager related to this tax liability and a corresponding adjustment to additional paid in capital on our condensed consolidated statement of changes in stockholders' equity. The adjustment was $6.5 million and $5.0 million for the nine months ended September 30, 2020 and 2019, respectively. The adjustment is a reduction of capital related to our equity incentive plan and is presented net of increases of capital related to our equity incentive plan in our condensed consolidated statement of changes in stockholders' equity.

XML

Stockholders' Equity

9 Months Ended

Sep. 30, 2020

Equity [Abstract]

Stockholders' Equity

Stockholders’ Equity

Our authorized capital stock consists of 450,000,000 shares of common stock, $0.01 par value per share and 50,000,000 shares of preferred stock, $0.01 par value per share. As of September 30, 2020, 143,288,347 shares of common stock were issued and outstanding, and 6,770,393 shares of 8.00% Fixed-to-Floating Series B Cumulative Redeemable Perpetual Preferred Stock ("Series B Preferred Stock") were issued and outstanding.

On June 10, 2019, we redeemed all 6,900,000 shares of 8.00% Series C Cumulative Redeemable Perpetual Preferred Stock ("Series C Preferred Stock") outstanding. Holders of the Series C Preferred Stock received the redemption price of $25.00 plus accumulated but unpaid dividends to the redemption date of $0.2223 per share.

Dividends. The following table details our dividend activity:

	Three months ended		Nine months ended
Dividend declared per share of:	September 30, 2020	September 30, 2019	September 30, 2020	September 30, 2019
Common Stock	$0.35	$0.46	$1.10	$1.38
Series B Preferred Stock	0.50	0.50	1.50	1.50
Series C Preferred Stock	N/A	N/A	N/A	0.7223

Common Stock Offerings. During the first quarter of 2019, we issued 1,967,361 shares of our common stock, at a per share conversion price of $17.17, related to conversions of the 2019 Notes, the remainder of which matured on March 15, 2019. We recorded a $33.8 million increase in additional paid in capital in our condensed consolidated statement of changes in stockholders' equity. Refer to "Note 9 - Convertible Senior Notes, Net" for a further discussion on the conversions of the 2019 Notes.

During the second quarter of 2019, we completed a follow-on public offering of 17,250,000 shares of our common stock, including shares issued pursuant to the underwriters' option to purchase additional shares, at a price of $18.27 per share. The aggregate net proceeds from the offering were $314.8 million after deducting offering expenses.

Common Stock Repurchases. The following table details our common stock repurchase activity during the nine months ended September 30, 2020:

	Three months ended
	March 31, 2020	June 30, 2020	September 30, 2020	Total
Shares Repurchased	300,000	5,495,976	5,038,619	10,834,595
Weighted Average Price	$8.12	$7.96	$9.01	$	8.45

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2020

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Legal Proceedings. From time to time, we may be involved in various claims and legal actions arising in the ordinary course of business. On June 28, 2018, AmBase Corporation, 111 West 57th Street Manager Funding LLC and 111 West 57th Investment LLC commenced an action captioned AmBase Corporation et al v. ACREFI Mortgage Lending, LLC et al (No 653251/2018) in New York Supreme Court. The complaint names as defendants (i) ACREFI Mortgage Lending, LLC, a subsidiary of the Company, (ii) the Company, and (iii) certain funds managed by Apollo, which are co-lenders on a mezzanine loan against the development of a residential condominium building in Manhattan, New York. The plaintiffs allege that the defendants tortiously interfered with the contractual equity put right in the plaintiffs’ joint venture agreement with the developers of the project, and that the defendants aided and abetted breaches of fiduciary duty by the developers of the project. The plaintiffs allege the loss of a $70.0 million investment as part of total damages of $700.0 million, which includes punitive damages. The defendants' motion to dismiss was granted on October 23, 2019 and the Court entered judgment dismissing the complaint in its entirety on November 8, 2019. Plaintiffs filed a timely notice of appeal on December 6, 2019 and, as of September 28, 2020, the parties have now fully briefed the appeal. We are awaiting scheduling of oral argument. We believe the claims are without merit and do not believe this will have a material adverse effect on our condensed consolidated financial statements.

Loan Commitments. As described in "Note 4 - Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net" at September 30, 2020, we had $1.4 billion of unfunded commitments related to our commercial mortgage and subordinate loans. The timings and amounts of fundings are uncertain as these commitments relate to loans for construction costs, capital expenditures, leasing costs, interest and carry costs, among others. As such, the timings and amounts of future fundings depend on the progress and performance of the underlying assets of our loans. Certain of our lenders are contractually obligated to fund their ratable portion of these loan commitments over time, while other lenders have some degree of discretion over future loan funding obligations. The total unfunded commitment is expected to be funded over the remaining expected 4.1 years weighted average tenor of these loans.

COVID-19. The COVID-19 global pandemic has brought forth uncertainty and disruption to the global economy. The magnitude and duration of the COVID-19 pandemic and its impact on our borrowers and their tenants, cash flows and future results of operations could be significant and will largely depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of the COVID-19 pandemic, the success of actions taken to contain or treat the pandemic, and reactions by consumers, companies, governmental entities and capital markets. The prolonged duration and impact of the COVID-19 pandemic could materially disrupt our business operations and impact our financial performance.

As of September 30, 2020, we have not recorded any contingencies on our condensed consolidated balance sheet related to COVID-19. To the extent COVID-19 continues to cause dislocations in the global economy, our financial condition, results of operations, and cash flows may continue to be adversely impacted. Refer to “Note 2 - Summary of Significant Accounting Policies” for further discussion regarding COVID-19.

XML

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial InstrumentsThe following table presents the carrying value and estimated fair value of our financial instruments not carried at fair value on our condensed consolidated balance sheet at September 30, 2020 and December 31, 2019 ($ in thousands):

	September 30, 2020				December 31, 2019
	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
Cash and cash equivalents	$	438,234	$	438,234	$	452,282	$	452,282
Commercial mortgage loans, net	5,427,945		5,337,301		5,326,967		5,380,693
Subordinate loans and other lending assets, net(1)	1,009,092		982,961		1,048,126		1,050,961
Secured debt arrangements, net	(3,465,337)		(3,465,337)		(3,078,366)		(3,078,366)
Senior secured term loan, net	(484,191)		(471,531)		(487,961)		(499,988)
2022 Notes	(339,695)		(326,867)		(337,755)		(348,060)
2023 Notes	(224,916)		(206,126)		(223,818)		(234,600)

———————

(1)Includes subordinate risk retention interests in securitization vehicles with an estimated fair value that approximates their carrying value.

To determine estimated fair values of the financial instruments listed above, market rates of interest, which include credit assumptions, are used to discount contractual cash flows. The estimated fair values are not necessarily indicative of the amount we could realize on disposition of the financial instruments. The use of different market assumptions or estimation methodologies could have a material effect on the estimated fair value amounts. Estimates of fair value for cash and cash equivalents, convertible senior notes, net and senior secured term loan, net are measured using observable Level I inputs as defined in "Note 3 - Fair Value Disclosure." Estimates of fair value for all other financial instruments in the table above are measured using significant estimates, or unobservable Level III inputs as defined in "Note 3 - Fair Value Disclosure."

XML

Net Income (Loss) per Share

9 Months Ended

Sep. 30, 2020

Earnings Per Share [Abstract]

Net Income (Loss) per Share

Net Income (Loss) per Share

ASC 260 "Earnings per share" requires the use of the two-class method of computing earnings per share for all periods presented for each class of common stock and participating security as if all earnings for the period had been distributed. Under the two-class method, during periods of net income, the net income is first reduced for dividends declared on all classes of securities to arrive at undistributed earnings. During periods of net losses, the net loss is reduced for dividends declared on participating securities only if the security has the right to participate in the earnings of the entity and an objectively determinable contractual obligation to share in net losses of the entity.

The remaining earnings are allocated to common stockholders and participating securities to the extent that each security shares in earnings as if all of the earnings for the period had been distributed. Each total is then divided by the applicable number of shares to arrive at basic earnings per share. For the diluted earnings, the denominator includes all outstanding shares of common stock and all potential shares of common stock assumed issued if they are dilutive. The numerator is adjusted for any changes in income or loss that would result from the assumed conversion of these potential shares of common stock.

The table below presents the computation of basic and diluted net income (loss) per share of common stock for the three and nine months ended September 30, 2020 and 2019 ($ in thousands except per share data): 

	For the three months ended September 30,				For the nine months ended September 30,
	2020		2019		2020		2019
Basic Earnings
Net income (loss)	$	49,338	$	29,089	$	(18,303)	$	158,271
Less: Preferred dividends	(3,385)		(3,385)		(10,155)		(15,139)
Net income (loss) available to common stockholders	$	45,953	$	25,704	$	(28,458)	$	143,132
Less: Dividends on participating securities	(717)		(847)		(2,238)		(2,547)
Basic Earnings	$	45,236	$	24,857	$	(30,696)	$	140,585
Diluted Earnings
Net income (loss) available to common stockholders	$	45,953	$	25,704	$	(28,458)	$	143,132
Less: Dividends on participating securities	(717)		—		(2,238)		—
Add: Interest expense on Notes	—		—		—		—
Diluted Earnings	$	45,236	$	25,704	$	(30,696)	$	143,132

Number of Shares:
Basic weighted-average shares of common stock outstanding	146,612,313		153,531,678		150,679,773		144,638,237
Diluted weighted-average shares of common stock outstanding	146,612,313		153,531,678		150,679,773		144,638,237
Earnings Per Share Attributable to Common Stockholders
Basic	$	0.31	$	0.16	$	(0.20)	$	0.97
Diluted	$	0.31	$	0.16	$	(0.20)	$	0.97

The dilutive effect to earnings per share is determined using the "if-converted" method whereby interest expense on the outstanding Notes is added back to the diluted earnings per share numerator and all of the potentially dilutive shares are included in the diluted earnings per share denominator. For the three and nine months ended September 30, 2020, 28,533,271 weighted-average potentially issuable shares with respect to the Notes were excluded from the calculation of diluted net income per share because the effect was anti-dilutive. For the three and nine months ended September 30, 2019, 28,533,271 and 29,041,856 weighted-average potentially issuable shares with respect to the Notes, respectively, were excluded from the calculation of diluted net income per share because the effect was anti-dilutive. Refer to "Note 9 - Convertible Senior Notes, Net" for further discussion.

For the three and nine months ended September 30, 2020, 2,051,311 and 2,028,573 weighted-average unvested RSUs, respectively, were excluded from the calculation of diluted net income per share because the effect was anti-dilutive. For the three and nine months ended September 30, 2019, 1,839,631 and 1,845,086 of weighted-average unvested RSUs, respectively, were excluded from the calculation of diluted net income per share because the effect was anti-dilutive.

XML

Subsequent Events

1 Months Ended

Oct. 26, 2020

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

Subsequent to the quarter ended September 30, 2020, the following events took place:

Investment activity: We funded approximately $33.0 million for previously closed loans.

Loan Repayments. We received approximately $1.3 million from loan repayments.

In addition, the remaining collateral of for-sale residential condominium units located in Bethesda, MD, was sold for net proceeds approximately equal to the carrying value of the loan.

Loan Sales: We sold, at par, a $25.0 million subordinate position of a residential-for-sale: construction loan with a total commitment of $110.0 million.

Unconsolidated Joint Venture: We entered into a joint venture which owns the underlying properties that secure our $180.0 million first mortgage predevelopment loan located in Miami, FL. The entity in which we own an interest, and which owns the underlying properties was deemed to be a VIE and we determined that we are not the primary beneficiary of that VIE.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2020

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying condensed consolidated financial statements include our accounts and those of our consolidated subsidiaries. All intercompany amounts have been eliminated. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Our most significant estimates include loan loss allowances. Actual results could differ from those estimates.

These unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019 ("Annual Report"), as filed with the Securities and Exchange Commission (the "SEC"). In the opinion of management, all adjustments (consisting only of normal recurring adjustments) necessary to present fairly our financial position, results of operations and cash flows have been included. Our results of operations for the three and nine months ended September 30, 2020 are not necessarily indicative of the results to be expected for the full year or any other future period.

Recent Accounting Pronouncements

Current Expected Credit Losses ("CECL")

In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-13 "Financial Instruments - Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments" ("ASU 2016-13"), which we refer to as the "CECL Standard." This update has changed how entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value. The CECL Standard replaced the "incurred loss" approach under existing guidance with an "expected loss" model for instruments measured at amortized cost. The CECL Standard requires entities to record allowances for held-to-maturity debt securities that are deducted from the carrying amount of the assets to present the net carrying value at the amounts expected to be collected on the assets. We continue to record loan specific allowances as a practical expedient under the CECL Standard ("Specific CECL Allowance"), which we apply to assets that are collateral

dependent and where the borrower or sponsor is experiencing financial difficulty. In addition, we now record a general allowance in accordance with the CECL Standard on the remainder of the loan portfolio ("General CECL Allowance", and together with the Specific CECL Allowance, "CECL Allowances") on a collective basis by assets with similar risk characteristics.

The CECL Standard requires us to record an allowance for credit losses that are deducted from the carrying amount of our loan portfolio to present the net carrying value at the amounts expected to be collected on the assets. We adopted the CECL Standard through a cumulative-effect adjustment to retained earnings on January 1, 2020. Subsequent changes to the General CECL Allowance are recognized through net income (loss) on our condensed consolidated statement of operations.

The CECL Standard requires an entity to consider historical loss experience, current conditions, and a reasonable and supportable forecast of the macroeconomic environment. The FASB recognizes the weighted average remaining maturity ("WARM") method as an acceptable approach for computing current expected credit losses. We have adopted the WARM method to comply with the CECL Standard in determining a General CECL Allowance for a majority of our portfolio. In the future, we may use other acceptable methods, such as a probability-of-default/loss-given-default method. For loans where we have deemed the borrower/sponsor to be experiencing financial difficulty, we have elected to apply a practical expedient in which the fair value of the underlying collateral is compared to the amortized cost of the loan in determining a Specific CECL Allowance.

In accordance with the WARM method, an annual historical loss rate is applied to the amortized cost of an asset or pool of assets over the remaining expected life. The WARM method requires consideration of the timing of expected future fundings of existing commitments and repayments over each asset’s remaining life. An annual loss factor, adjusted for macroeconomic estimates, is applied over each subsequent period and aggregated to arrive at the General CECL Allowance.

In determining the General CECL Allowance, we considered various factors including (i) historical loss experience in the commercial real estate lending market, (ii) timing of expected repayments and satisfactions, (iii) expected future funding, (iv) capital subordinate to us when we are the senior lender, (v) capital senior to us when we are the subordinate lender, and (vi) our current and future view of the macroeconomic environment. The standard requires the use of significant judgment to arrive at an estimated credit loss. There is significant uncertainty related to future macroeconomic conditions as the result of COVID-19.

We derived an annual historical loss rate based on a commercial mortgage backed securities ("CMBS") database with historical losses from 1998 through the third quarter of 2020 provided by a third party, Trepp LLC. We applied various filters to arrive at a CMBS dataset most analogous to our current portfolio from which to determine an appropriate historical loss rate. The annual historical loss rate was further adjusted to reflect our expectations of the macroeconomic environment for a reasonable and supportable forecast period which we have determined to be one year.

The General CECL Allowance on subordinate loans is calculated by incorporating both the loan balance of the position(s) of the structurally senior third-party lender(s) and the balance of our subordinate loan(s). The subordinate loans, by virtue of being the first loss position, are required to absorb losses prior to the senior position(s) being impacted, resulting in a higher percentage allowance attributable to the subordinate loan. The General CECL Allowance on unfunded loan commitments is time-weighted based on our expected commitment to fund such obligations. The General CECL Allowance on unfunded commitments is recorded as a liability on our condensed consolidated balance sheet within accounts payable, accrued expenses and other liabilities.

Recent Accounting Pronouncements

In August 2020, the FASB issued ASU 2020-06 "Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity" ("ASU 2020-06"). The intention of ASU 2020-06 is to address the complexities in accounting for certain financial instruments with a debt and equity component. Under ASU 2020-06, the number of accounting models for convertible notes will be reduced and entities that issue convertible debt will be required to use the if-converted method for the computation of diluted "Earnings per share" under ASC 260. ASC 2020-06 is effective for fiscal years beginning after December 15, 2021 and may be adopted through either a modified retrospective method of transition or a fully retrospective method of transition. We are currently assessing the impact this guidance will have on our condensed consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04 “Reference Rate Reform (Topic 848) – Facilitation of the Effects of Reference Rate Reform on Financial Reporting” (“ASU 2020-04”). ASU 2020-04 provides optional expedients and exceptions for applying GAAP to debt instruments, derivatives, and other contracts that reference LIBOR or other reference rates expected to be discontinued as a result of reference rate reform. This guidance is optional and may be elected through December 31, 2022 using a prospective application on all eligible contract modifications. We have loan agreements, debt agreements, and an interest rate cap that incorporate LIBOR as a referenced interest rate. It is difficult to predict what effect, if any, the phase-out of LIBOR and the use of alternative benchmarks may have on our business or on the overall financial markets. We have not adopted any of the optional expedients or exceptions through September 30, 2020, but will continue to evaluate the possible adoption of any such expedients or exceptions.

XML

Fair Value Disclosure (Tables)

9 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Schedule of Levels in Fair Value Hierarchy of Financial Instruments

The following table summarizes the levels in the fair value hierarchy into which our derivative assets were categorized as of September 30, 2020 and December 31, 2019 ($ in thousands): 

	Fair Value as of September 30, 2020								Fair Value as of December 31, 2019
	Level I		Level II		Level III		Total		Level I		Level II		Level III		Total
Foreign currency forward, net	$	—	$	13,481	$	—	$	13,481	$	—	$	—	$	—	$	—
Interest rate cap	—		173		—		173		—		—		—		—
Total financial instruments assets	$	—	$	13,654	$	—	$	13,654	$	—	$	—	$	—	$	—

The following table summarizes the levels in the fair value hierarchy into which our derivative liabilities were categorized as of September 30, 2020 and December 31, 2019 ($ in thousands): 

	Fair Value as of September 30, 2020								Fair Value as of December 31, 2019
	Level I		Level II		Level III		Total		Level I		Level II		Level III		Total
Foreign currency forward, net	$	—	$	—	$	—	$	—	$	—	$	4,876	$	—	$	4,876
Interest rate swap liability	—		—		—		—		—		14,470		—		14,470
Total financial instrument liabilities	$	—	$	—	$	—	$	—	$	—	$	19,346	$	—	$	19,346

XML

Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net (Tables)

9 Months Ended

Sep. 30, 2020

Receivables [Abstract]

Schedule of Loan Portfolio

Our loan portfolio was comprised of the following at September 30, 2020 and December 31, 2019 ($ in thousands):

Loan Type	September 30, 2020		December 31, 2019
Commercial mortgage loans, net (1)	$	5,427,945	$	5,326,967
Subordinate loans and other lending assets, net	1,009,092		1,048,126
Carrying value, net	$	6,437,037	$	6,375,093

  ———————

(1)Includes $156.4 million and $126.7 million in 2020 and 2019, respectively, of contiguous financing structured as subordinate loans.

Schedule of Activity Related to Loan Investment Portfolio

Activity relating to our loan portfolio, for the nine months ended September 30, 2020, was as follows ($ in thousands):

	Principal Balance		Deferred Fees/Other Items (1)		Specific Provision for Loan Loss		Carrying Value, Net
December 31, 2019	$	6,467,842	$	(35,768)	$	(56,981)	$	6,375,093
New loan fundings	457,449		—		—		457,449
Add-on loan fundings (2)	309,820		—		—		309,820
Loan repayments and sales	(543,535)		—		—		(543,535)
Gain (loss) on foreign currency translation	(15,060)		543		—		(14,517)
Specific CECL Allowance	—		—		(139,950)		(139,950)
Realized loss on investment	(20,569)		3,127		—		(17,442)
Deferred fees	—		(6,027)		—		(6,027)
PIK interest and amortization of fees	38,197		17,225		—		55,422
September 30, 2020	$	6,694,144	$	(20,900)	$	(196,931)	$	6,476,313
General CECL Allowance (3)							(39,276)
Carrying value, net							$	6,437,037

———————

(1)Other items primarily consist of purchase discounts or premiums, cost recovery interest, exit fees and deferred origination expenses.

(2)Represents fundings for loans closed prior to 2020.

(3)$3.6 million of the General CECL Allowance is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheet.

Schedule of Overall Statistics for the Loan Portfolio

The following table details overall statistics for our loan portfolio at the dates indicated ($ in thousands):

	September 30, 2020			December 31, 2019
Number of loans	70			72
Principal balance	$	6,694,144		$	6,467,842
Carrying value, net	$	6,437,037		$	6,375,093
Unfunded loan commitments (1)	$	1,426,404		$	1,952,887
Weighted-average cash coupon (2)	5.6		%	6.5		%
Weighted-average remaining fully-extended term (3)	2.9 years			3.3 years
Weighted-average expected term (4)	2.0 years			1.8 years

———————

(1)Unfunded loan commitments are funded to finance construction costs, tenant improvements, leasing commissions, or carrying costs. These future commitments are funded over the term of each loan, subject in certain cases to an expiration date.

(2)For floating rate loans, based on applicable benchmark rates as of the specified dates. For loans placed on non-accrual or cost recovery the interest rate used in calculating weighted-average cash coupon is 0%.

(3)Assumes all extension options are exercised.

(4)Expected term represents our estimated timing of repayments as of September 30, 2020 and December 31, 2019, respectively.

Schedule of Mortgage Loans on Real Estate

The table below details the property type of the properties securing the loans in our portfolio at the dates indicated ($ in thousands):

	September 30, 2020				December 31, 2019
Property Type	Carrying Value		% of Portfolio(1)		Carrying Value		% of Portfolio
Office	$	1,832,607	28.3	%	$	1,401,400	22.0	%
Hotel	1,578,614		24.4		1,660,162		26.0
Residential-for-sale: construction	894,610		13.8		692,816		10.9
Residential-for-sale: inventory	150,015		2.3		321,673		5.1
Urban Retail	636,308		9.8		643,706		10.1
Urban Predevelopment	295,728		4.6		409,864		6.4
Healthcare	363,170		5.6		371,423		5.8
Industrial	228,674		3.5		227,940		3.6
Other	496,587		7.7		646,109		10.1
Total	$	6,476,313	100.0	%	$	6,375,093	100.0	%
General CECL Allowance (2)	(39,276)
Carrying value, net	$	6,437,037

———————

(1)Percentage of portfolio calculations are made prior to consideration of General CECL Allowance.

(2)$3.6 million of the General CECL Allowance is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheet.

Geography

The table below details the geographic distribution of the properties securing the loans in our portfolio at the dates indicated ($ in thousands):

	September 30, 2020				December 31, 2019
Geographic Location	Carrying Value		% of Portfolio(1)		Carrying Value		% of Portfolio
New York City	$	2,393,012	37.0	%	$	2,167,487	34.0	%
Northeast	138,448		2.1		110,771		1.7
United Kingdom	1,179,761		18.2		1,274,390		20.0
West	741,971		11.5		728,182		11.4
Midwest	556,011		8.6		614,337		9.6
Southeast	576,420		8.9		564,166		8.9
Other	890,690		13.7		915,760		14.4
Total	$	6,476,313	100.0	%	$	6,375,093	100.0	%
General CECL Allowance (2)	(39,276)
Carrying value, net	$	6,437,037

———————

(1)Percentage of portfolio calculations are made prior to consideration of General CECL Allowance.

(2)$3.6 million of the General CECL Allowance is excluded from this table because it relates to unfunded commitments and has been recorded as a liability under accounts payable, accrued expenses and other liabilities in our condensed consolidated balance sheet.

Schedule of Carrying Value of Loan Portfolio Based on Internal Risk Ratings

The following tables allocate the carrying value of our loan portfolio based on our internal risk ratings and date of origination at the dates indicated ($ in thousands):

September 30, 2020
						Year Originated
Risk Rating	Number of Loans	Total		% of Portfolio		2020		2019		2018		2017		2016		Prior
1	—	$	—	—	%	$	—	$	—	$	—	$	—	$	—	$	—
2	1	32,000		0.5	%	—		—		—		—		—		32,000
3	62	6,035,647		93.2	%	450,119		2,685,060		1,350,949		815,789		88,685		645,045
4	—	—		—	%	—		—		—		—		—		—
5	7	408,666		6.3	%	—		—		28,872		137,798		114,910		127,086
Total	70	$	6,476,313	100.0	%	$	450,119	$	2,685,060	$	1,379,821	$	953,587	$	203,595	$	804,131
General CECL Allowance		(39,276)
Total carrying value, net		$	6,437,037
Weighted Average Risk Rating		3.1

December 31, 2019
						Year Originated
Risk Rating	Number of Loans	Total		% of Portfolio		2019		2018		2017		2016		2015		Prior
1	—	$	—	—	%	$	—	$	—	$	—	$	—	$	—	$	—
2	8	348,324		5.5	%	—		241,676		—		36,250		24,546		45,852
3	61	5,707,555		89.5	%	2,736,825		1,355,014		912,636		72,540		499,700		130,840
4	1	182,910		2.9	%	—		—		—		182,910		—		—
5	2	136,304		2.1	%	—		—		—		—		—		136,304
Total	72	$	6,375,093	100.0	%	$	2,736,825	$	1,596,690	$	912,636	$	291,700	$	524,246	$	312,996
Weighted Average Risk Rating		3.0

Schedule of CECL Reserves

Refer to the following schedule of the General CECL Allowance as of September 30, 2020, and as of the date of adoption, January 1, 2020 ($ in thousands):

	September 30, 2020		January 1, 2020(1)
Commercial mortgage loans, net	$	20,161	$	12,149
Subordinate loans and other lending assets, net	19,115		15,630
Unfunded commitments(2)	3,595		3,088
Total General CECL Allowance	$	42,871	$	30,867

 ———————

(1)As of January 1, 2020, we adopted the CECL Standard through a cumulative-effect adjustment to retained earnings

(2)The General CECL Allowance on unfunded commitments is recorded as a liability on our condensed consolidated balance sheet within accounts payable, accrued expenses and other liabilities

The following schedule illustrates the quarterly changes in the CECL Allowance since we adopted the CECL Standard on January 1, 2020 ($ in thousands):

		Specific CECL Allowance(1)		General CECL Allowance						Total CECL Allowance		CECL Allowance as % of Amortized Cost
				Funded		Unfunded		Total				General		Total
December 31, 2019		$56,981		$	—	$	—	$	—	$	56,981	—	%	—	%
Changes:
	January 1, 2020 - Adoption of CECL Standard	—		27,779		3,088		30,867		30,867
	Q1 Allowances	150,000		30,494		2,971		33,465		183,465
March 31, 2020		$	206,981	$	58,273	$	6,059	$	64,332	$	271,313	1.08	%	4.05	%
Changes:
	Q2 Allowances (Reversals)	5,500		(13,729)		(1,940)		(15,669)		(10,169)
	Realized Loss	(15,000)		—		—		—		(15,000)
June 30, 2020		$	197,481	$	44,544	$	4,119	$	48,663	$	246,144	0.81	%	3.71	%
Changes:
	Q3 Reversals	(550)		(5,268)		(524)		(5,792)		(6,342)
September 30, 2020		$	196,931	$	39,276	$	3,595	$	42,871	$	239,802	0.71	%	3.59	%

 ———————

(1)As of December 31, 2019, amount represents specific loan loss provisions recorded on assets before the adoption of the CECL Standard. After the adoption of the CECL Standard on January 1, 2020, amounts represent Specific CECL Allowances.

Schedule of Loans in Cost Recovery

The following table summarizes the specific provision for loan losses that has been recorded on our portfolio as of September 30, 2020 ($ in thousands):

Type	Property type	Location	Amortized cost(1)		Interest recognition status/ as of date
Mortgage
	Urban Predevelopment(3)	Brooklyn, NY	128,418		Cost Recovery/ 3/1/2020
	Urban Predevelopment(3)	Miami, FL	114,910		Cost Recovery/ 3/1/2020
	Retail Center(4)(5)	Cincinnati, OH	105,561		Cost Recovery/ 10/1/2019
	Hotel(2)	Pittsburgh, PA	28,872		Cost Recovery/ 3/31/2020
	Residential-for-sale: inventory(6)(7)	Bethesda, MD	3,095		Cost Recovery/ 1/1/2018
Mortgage total:			$	380,856
Mezzanine
	Hotel(2)	Washington, DC	18,430		Cost Recovery/ 3/31/2020
	Hotel(8)	Anaheim, CA	9,380		Cost Recovery/ 9/30/2020
Mezzanine total:			$	27,810
Grand total:			$	408,666

———————

(1)Amortized cost is shown net of $196.9 million of net loan loss provisions. During the three and nine months ended September 30, 2020, there was $(0.6) million and $140.0 million in (reversals)/provisions taken due to factors including COVID-19. See Note 2 for additional information regarding COVID-19.

(2)The fair value of hotel collateral was determined by applying a discount rate ranging from 8.5% to 11.0% and a capitalization rate ranging from 7.0% to 9.0%. For the hotel located in Washington, DC, during the three and nine months ended September 30, 2020, there was $0 and $0.2 million of interest paid applied towards reducing the carrying value of the loan, respectively.

(3)The fair value of urban predevelopment collateral was determined by assuming rent per square foot ranging from $48 to $225 and a capitalization rate ranging from 5.0% to 5.5%.

(4)The fair value of retail collateral was determined by applying a capitalization rate of 8.3%.

(5)The entity in which we own an interest and which owns the underlying property was deemed to be a VIE and we determined that we are not the primary beneficiary of that VIE. During the three and nine months ended September 30, 2020, $0.4 million and $1.1 million, respectively, of interest paid was applied towards reducing the carrying value of the loan.

(6)Subsequent to September 30, 2020, the remaining collateral on this loan was sold. In connection with the sale of the underlying collateral, a $1.9 million reversal of the previously recognized specific CECL Allowance was recorded during the three months ended September 30, 2020. Refer to "Note 18 - Subsequent Events" for more information.

(7)A $3.0 million portion of this provision was recorded on an investment previously recorded under other assets on our condensed consolidated balance sheet.

(8)The fair value of the hotel, located in Anaheim, California, was determined using the market approach where the fair market value of the underlying collateral, less projected closing costs, was compared to the amortized cost of the loan.

XML

Other Assets (Tables)

9 Months Ended

Sep. 30, 2020

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Components of Other Assets

The following table details the components of our other assets at the dates indicated ($ in thousands):

	September 30, 2020		December 31, 2019
Interest receivable	$	38,401	$	35,581
Collateral deposited under derivative agreements	1,810		17,090
Other	3,433		45
Total	$	43,644	$	52,716

XML

Secured Debt Arrangements, Net (Tables)

9 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Schedule of Weighted Average Maturities and Interest Rates of Borrowings

At September 30, 2020 and December 31, 2019, our borrowings included the following secured debt arrangements, maturities and weighted-average interest rates ($ in thousands):

	September 30, 2020					December 31, 2019
	Maximum Amount of Borrowings(1)		Borrowings Outstanding(1)		Maturity (2)	Maximum Amount of Borrowings(1)		Borrowings Outstanding(1)		Maturity (2)
JPMorgan (USD)	$	1,132,013	$	989,278	June 2024	$	1,154,109	$	1,090,160	June 2024
JPMorgan (GBP)	97,661		97,661		June 2024	51,702		50,410		June 2024
JPMorgan (EUR)	70,326		70,326		June 2024	94,189		94,189		June 2024
DB (USD)	1,000,000		526,743		March 2023	1,250,000		513,876		March 2021
Goldman (USD)	500,000		362,139		November 2021	500,000		322,170		November 2021
CS - USD	378,903		378,781		January 2023(3)	226,068		218,644		June 2020
CS - GBP	—		—		N/A(4)	93,915		93,915		June 2020
HSBC - USD	47,223		47,223		January 2021	50,625		50,625		October 2020
HSBC - GBP	—		—		N/A	34,634		34,634		June 2020
HSBC - EUR	157,148		157,148		July 2021	154,037		154,037		January 2021
Barclays (USD)	200,000		35,192		March 2024	N/A		N/A		N/A
Barclays (GBP)	—		—		N/A(4)	538,916		290,347		February 2024(5)
Barclays (EUR)	—		—		N/A(4)	182,549		182,549		November 2020
Total Secured Credit Facilities	3,583,274		2,664,491			4,330,744		3,095,556
Barclays Private Securitization	813,592		813,592		March 2024(5)	N/A		N/A		N/A
Total Secured Debt Arrangements	4,396,866		3,478,083			4,330,744		3,095,556
less: deferred financing costs	N/A		(12,746)			N/A		(17,190)
Total Secured Debt Arrangements, net(6)(7)(8)	$	4,396,866	$	3,465,337		$	4,330,744	$	3,078,366

———————

(1)As of September 30, 2020, British Pound Sterling ("GBP") and Euros ("EUR") borrowings were converted to U.S. Dollars ("USD") at a rate of 1.29 and 1.17, respectively. As of December 31, 2019, GBP and EUR borrowings were converted at a rate of 1.33 and 1.12, respectively.

(2)Maturity date assumes extensions at our option are exercised with consent of financing providers, where applicable.

(3)Assumes financings are extended in line with the underlying loans.

(4)As of September 30, 2020, there are no loans pledged to this facility.

(5)Represents weighted average maturity across various financings with the counterparty. See below for additional details.

(6)Weighted-average borrowing costs as of September 30, 2020 and December 31, 2019 were USD L + 2.15% / GBP L + 1.82% / EUR L + 1.46% and USD L + 2.07% / GBP L + 1.75% / EUR L + 1.36%, respectively.

(7)Weighted average advance rates based on cost as of September 30, 2020 and December 31, 2019 were 64.3% (63.8% (USD) / 67.9% (GBP) / 61.3% (EUR)) and 63.8% (66.7% (USD) / 47.1% (GBP) / 76.1% (EUR)).

(8)As of September 30, 2020 and December 31, 2019, approximately 55% and 54% of the outstanding balance under these secured borrowings were recourse to us.

Schedule of Assets Under The Private Barclays Securitization

The table below provides the borrowings outstanding (on an as converted basis) and weighted-average fully-extended maturities by currency for the assets financed under the Barclays Private Securitization as of September 30, 2020 ($ in thousands):

	Borrowings outstanding	Fully-Extended Maturity(1)
Total/Weighted-Average GBP	$670,024	January 2024
Total/Weighted-Average EUR	143,568	August 2021(2)
Total/Weighted-Average Securitization	$813,592	March 2024

———————

(1)Assumes underlying loans extend to fully extended maturity and extensions at our option are exercised.

(2)The EUR portion of the Barclays Private Securitization has an "evergreen" feature such that the facility continues for one year and can be terminated by either party on certain dates with, depending on the date of notice, a minimum of nine to twelve months' notice.

Schedule of Assets and Liabilities

The table below provides the assets and liabilities of the Barclays Private Securitization VIE included in our condensed consolidated balance sheet ($ in thousands):

	September 30, 2020
Assets:
Cash	$	921
Commercial mortgage loans, net(1)	1,224,154
Other Assets	9,401
Total Assets	$	1,234,476
Liabilities:
Secured debt arrangements, net (net of deferred financing costs of $0.2 million)	$	813,431
Accounts payable, accrued expenses and other liabilities(2)	1,084
Total Liabilities	$	814,515

———————

(1)Net of the General CECL Allowance of $6.1 million.

(2)Represents General CECL Allowance related to unfunded commitments on commercial mortgage loans, net of $0.3 million.

Interest Income and Interest Expense Disclosure

	Three months ended
	September 30, 2020
Net Interest Income:
Interest income from commercial mortgage loans	$	15,075
Interest expense	(4,278)
Net interest income	$	10,797
Provision for loan losses and impairments	$	(2,318)
Foreign currency gain	17,078
Net Income	$	25,557

Schedule of Remaining Maturities of Borrowings

At September 30, 2020, our borrowings had the following remaining maturities ($ in thousands):

	Less than 1 year		1 to 3 years		3 to 5 years		More than 5 years		Total
JPMorgan	$	45,918	$	432,440	$	678,907	$	—	$	1,157,265
DB	15,594		511,149		—		—		526,743
Goldman	—		362,139		—		—		362,139
CS - USD	94,299		146,994		137,488		—		378,781
HSBC - USD	47,223		—		—		—		47,223
HSBC - EUR	157,148		—		—		—		157,148
Barclays - USD	—		—		35,192		—		35,192
Barclays Private Securitization	143,568		289,769		380,255		—		813,592
Total	$	503,750	$	1,742,491	$	1,231,842	$	—	$	3,478,083

Schedule of Outstanding, Maximum and Average Balances of Debt

The table below summarizes the outstanding balances at September 30, 2020, as well as the maximum and average month-end balances for the nine months ended September 30, 2020 for our borrowings under secured debt arrangements ($ in thousands).

	As of September 30, 2020				For the nine months ended September 30, 2020
	Balance		Amortized Cost of Collateral		Maximum Month-End Balance		Average Month-End Balance
JPMorgan	$	1,157,265	$	1,976,965	$	1,192,288	$	1,106,461
DB	526,743		804,835		526,743		501,470
Goldman	362,139		548,671		362,139		343,882
CS - USD	378,781		523,272		378,781		339,425
CS - GBP	—		—		90,111		57,459
HSBC - USD	47,223		67,203		50,625		48,357
HSBC - GBP	—		—		34,500		32,900
HSBC - EUR	157,148		204,040		160,034		152,982
Barclays - USD	35,192		49,929		35,193		27,372
Barclays - GBP	—		—		666,810		347,590

Barclays - EUR	—		—		180,595	94,028
Barclays Private Securitization	813,592		1,230,305		839,563	814,844
Total	$	3,478,083	$	5,405,220

The table below summarizes the outstanding balances at December 31, 2019, as well as the maximum and average month-end balances for the year ended December 31, 2019 for our borrowings under secured debt arrangements ($ in thousands).

	As of December 31, 2019				For the year ended December 31, 2019
	Balance		Amortized Cost of Collateral		Maximum Month-End Balance		Average Month-End Balance
JPMorgan	$	1,234,759	$	1,845,400	$	1,234,759	$	947,400
DB	513,876		766,676		757,117		604,067
Goldman	322,170		513,559		324,821		246,318
CS - USD	218,644		308,884		218,644		182,646
CS - GBP	93,915		129,723		150,811		134,694
HSBC - USD	50,625		66,960		50,625		50,625
HSBC - GBP	34,634		49,976		50,784		42,296
HSBC - EUR	154,037		190,780		154,037		151,889
Barclays - GBP	290,347		738,455		290,347		139,004
Barclays - EUR	182,549		241,674		182,549		181,159
Total	$	3,095,556	$	4,852,087

XML

Convertible Senior Notes, Net (Tables)

9 Months Ended

Sep. 30, 2020

Debt Disclosure [Abstract]

Schedule of Convertible Senior Notes

The following table summarizes the terms of the Notes ($ in thousands):

	Principal Amount		Coupon Rate		Effective Rate (1)		Conversion Rate (2)	Maturity Date	Remaining Period of Amortization
2022 Notes	$	345,000	4.75	%	5.60	%	50.2260	8/23/2022	1.90
2023 Notes	230,000		5.38	%	6.16	%	48.7187	10/15/2023	3.04
Total	$	575,000

———————

(1)Effective rate includes the effect of the adjustment for the conversion option (See footnote (2) below), the value of which reduced the initial liability and was recorded in additional paid-in-capital.

(2)We have the option to settle any conversions in cash, shares of common stock or a combination thereof. The conversion rate represents the number of shares of common stock issuable per one thousand principal amount of the Notes converted, and includes adjustments relating to cash dividend payments made by us to stockholders that have been deferred and carried-forward in accordance with, and are not yet required to be made pursuant to, the terms of the applicable supplemental indenture.

XML

Derivatives (Tables)

9 Months Ended

Sep. 30, 2020

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Non-Designated Foreign Exchange Forwards

The following table summarizes our non-designated foreign exchange ("Fx") forwards and our interest rate cap as of September 30, 2020:

	September 30, 2020
	Number of Contracts	Aggregate Notional Amount (in thousands)	Notional Currency	Maturity	Weighted-Average Years to Maturity
Fx contracts - GBP	106	422,585	GBP	October 2020 - December 2024	2.16
Fx contracts - EUR	70	238,817	EUR	November 2020 - August 2024	2.79
Interest rate cap	1	500,000	USD	June 2023	2.71

The following table summarizes our non-designated Fx forwards and our interest rate swap as of December 31, 2019:

	December 31, 2019
	Number of Contracts	Aggregate Notional Amount (in thousands)	Notional Currency	Maturity	Weighted-Average Years to Maturity
Fx contracts - GBP	156	735,349	GBP	January 2020 - December 2024	1.49
Fx contracts - EUR	44	168,879	EUR	February 2020 - August 2024	3.22
Interest rate swap	1	500,000	USD	May 2026	6.37

Schedule of Amounts Recognized on Consolidated Statements of Operations Related to Company's Derivatives

The following table summarizes the amounts recognized on our condensed consolidated statements of operations related to our derivatives for the three and nine months ended September 30, 2020 and 2019 ($ in thousands): 

		Amount of gain (loss) recognized in income
		Three months ended September 30,				Nine months ended September 30,
	Location of Gain (Loss) Recognized in Income	2020		2019		2020		2019
Forward currency contracts	Unrealized gain (loss) on derivative instruments	$	(35,076)	$	16,227	$	18,356	$	12,029
Forward currency contracts	Realized gain on derivative instruments	539		7,926		14,603		16,590
Total		$	(34,537)	$	24,153	$	32,959	$	28,619

		Amount of loss recognized in income
		Three months ended September 30,				Nine months ended September 30,
	Location of Loss Recognized in Income	2020		2019		2020		2019
Interest rate cap(1)	Unrealized gain (loss) on interest rate cap	$	(564)	$	—	$	174	$	—
Interest rate swap(2)	Unrealized gain (loss) on interest rate swap	—		(10,307)		14,470		(23,420)
Interest rate swap(2)	Realized loss on interest rate swap	—		—		(53,851)		—
Total		$	(564)	$	(10,307)	$	(39,207)	$	(23,420)

———————

(1)With a notional amount of $500.0 million and $0 at September 30, 2020, and 2019, respectively.

(2)With a notional amount of $0 and $500.0 million at September 30, 2020, and 2019, respectively.

Schedule of Gross Asset and Liability Amounts Related to Derivatives

The following tables summarize the gross asset and liability amounts related to our derivatives at September 30, 2020 and December 31, 2019 ($ in thousands)

	September 30, 2020						December 31, 2019
	Gross Amount of Recognized Assets		Gross Amounts Offset in our Condensed Consolidated Balance Sheet		Net Amounts of Assets Presented in our Condensed Consolidated Balance Sheet		Gross Amount of Recognized Assets		Gross Amounts Offset in our Condensed Consolidated Balance Sheet		Net Amounts of Assets Presented in our Condensed Consolidated Balance Sheet
Forward currency contracts	$	20,788	$	(7,307)	$	13,481	$	—	$	—	$	—
Interest rate cap	173		—		173		—		—		—
Total	$	20,961	$	(7,307)	$	13,654	$	—	$	—	$	—

	September 30, 2020						December 31, 2019
	Gross Amount of Recognized Liability		Gross Amounts Offset in our Condensed Consolidated Balance Sheet		Net Amounts of Liability Presented in our Condensed Consolidated Balance Sheet		Gross Amount of Recognized Liabilities		Gross Amounts Offset in our Condensed Consolidated Balance Sheet		Net Amounts of Liabilities Presented in our Condensed Consolidated Balance Sheet
Interest rate swap	$	—	$	—	$	—	$	14,470	$	—	$	14,470
Forward currency contracts	—		—		—		12,687		(7,811)		4,876
Total derivative liabilities	$	—	$	—	$	—	$	27,157	$	(7,811)	$	19,346

XML

Accounts Payable, Accrued Expenses and Other Liabilities (Tables)

9 Months Ended

Sep. 30, 2020

Payables and Accruals [Abstract]

Schedule of Accounts Payable, Accrued Expense and Other Liabilities

The following table details the components of our accounts payable, accrued expense and other liabilities ($ in thousands):

	September 30, 2020		December 31, 2019
Accrued dividends payable	$	53,689	$	74,771
Collateral deposited under derivative agreements	12,780		2,930
Accrued interest payable	13,013		16,089
Accounts payable and other liabilities	6,145		6,922
General CECL Allowance on unfunded commitments(1)	3,595		—
Total	$	89,222	$	100,712

  ———————

(1)Refer to Note 4 - Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net for additional disclosure related to the General CECL Allowance on unfunded commitments for the quarter ended September 30, 2020.

XML

Share-Based Payments (Tables)

9 Months Ended

Sep. 30, 2020

Share-based Payment Arrangement [Abstract]

Summary of Grants, Exchanges and Forfeitures of Restricted Stock and RSUs

The following table summarizes the grants, vesting and forfeitures of restricted common stock and RSUs during the nine months ended September 30, 2020:

	Type	Restricted Stock	RSUs	Grant Date Fair Value ($ in thousands)
Outstanding at December 31, 2019		25,356	2,007,355
	Granted	82,235	54,867	906
	Vested	(25,356)	(264)	N/A
	Forfeiture	—	(13,587)	N/A
Outstanding at September 30, 2020		82,235	2,048,371

Below is a summary of restricted stock and RSU vesting dates as of September 30, 2020: 

Vesting Year	Restricted Stock	RSU	Total Awards
2020	—	956,738	956,738
2021	82,235	699,903	782,138
2022	—	373,441	373,441
2023	—	18,289	18,289
Total	82,235	2,048,371	2,130,606

XML

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2020

Equity [Abstract]

Schedule of Dividends Activity

The following table details our dividend activity:

	Three months ended		Nine months ended
Dividend declared per share of:	September 30, 2020	September 30, 2019	September 30, 2020	September 30, 2019
Common Stock	$0.35	$0.46	$1.10	$1.38
Series B Preferred Stock	0.50	0.50	1.50	1.50
Series C Preferred Stock	N/A	N/A	N/A	0.7223

Common Stock Repurchases

The following table details our common stock repurchase activity during the nine months ended September 30, 2020:

	Three months ended
	March 31, 2020	June 30, 2020	September 30, 2020	Total
Shares Repurchased	300,000	5,495,976	5,038,619	10,834,595
Weighted Average Price	$8.12	$7.96	$9.01	$	8.45

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2020

Fair Value Disclosures [Abstract]

Carrying Value and Estimated Fair Value of Company's Financial Instruments

The following table presents the carrying value and estimated fair value of our financial instruments not carried at fair value on our condensed consolidated balance sheet at September 30, 2020 and December 31, 2019 ($ in thousands):

	September 30, 2020				December 31, 2019
	Carrying Value		Estimated Fair Value		Carrying Value		Estimated Fair Value
Cash and cash equivalents	$	438,234	$	438,234	$	452,282	$	452,282
Commercial mortgage loans, net	5,427,945		5,337,301		5,326,967		5,380,693
Subordinate loans and other lending assets, net(1)	1,009,092		982,961		1,048,126		1,050,961
Secured debt arrangements, net	(3,465,337)		(3,465,337)		(3,078,366)		(3,078,366)
Senior secured term loan, net	(484,191)		(471,531)		(487,961)		(499,988)
2022 Notes	(339,695)		(326,867)		(337,755)		(348,060)
2023 Notes	(224,916)		(206,126)		(223,818)		(234,600)

———————

(1)Includes subordinate risk retention interests in securitization vehicles with an estimated fair value that approximates their carrying value.

XML

Net Income (Loss) per Share (Tables)

9 Months Ended

Sep. 30, 2020

Earnings Per Share [Abstract]

Basic and Diluted Net Income per Share of Common Stock Using Two-Class Method

The table below presents the computation of basic and diluted net income (loss) per share of common stock for the three and nine months ended September 30, 2020 and 2019 ($ in thousands except per share data): 

	For the three months ended September 30,				For the nine months ended September 30,
	2020		2019		2020		2019
Basic Earnings
Net income (loss)	$	49,338	$	29,089	$	(18,303)	$	158,271
Less: Preferred dividends	(3,385)		(3,385)		(10,155)		(15,139)
Net income (loss) available to common stockholders	$	45,953	$	25,704	$	(28,458)	$	143,132
Less: Dividends on participating securities	(717)		(847)		(2,238)		(2,547)
Basic Earnings	$	45,236	$	24,857	$	(30,696)	$	140,585
Diluted Earnings
Net income (loss) available to common stockholders	$	45,953	$	25,704	$	(28,458)	$	143,132
Less: Dividends on participating securities	(717)		—		(2,238)		—
Add: Interest expense on Notes	—		—		—		—
Diluted Earnings	$	45,236	$	25,704	$	(30,696)	$	143,132

Number of Shares:
Basic weighted-average shares of common stock outstanding	146,612,313		153,531,678		150,679,773		144,638,237
Diluted weighted-average shares of common stock outstanding	146,612,313		153,531,678		150,679,773		144,638,237
Earnings Per Share Attributable to Common Stockholders
Basic	$	0.31	$	0.16	$	(0.20)	$	0.97
Diluted	$	0.31	$	0.16	$	(0.20)	$	0.97

XML

Summary of Significant Accounting Policies - Additional Information (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2020 USD ($) segment	Jun. 30, 2020 USD ($)	Mar. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Sep. 30, 2019 USD ($)	Jun. 30, 2019 USD ($)	Mar. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)
Accounting Policies [Abstract]
Number of business segments | segment	1
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
General CECL reserve	$ (2,319,281)	$ (2,365,506)	$ (2,400,911)	$ (2,629,975)	$ (2,629,510)	$ (2,671,399)	$ (2,539,824)	$ (2,509,747)
Adjustment due to Adoption of ASU
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
General CECL reserve				$ 30,867

XML

Fair Value Disclosure (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Interest rate swap	$ 13,654,000	$ 0
Interest rate swap
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Interest rate swap	$ 0

XML

Fair Value Disclosure - Summarizes Levels in Fair Value Hierarchy of Financial Instruments (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	$ 13,654,000	$ 0
Derivative liabilities	0	19,346,000
Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	13,654,000	0
Derivative liabilities	0	19,346,000
Level I | Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	0	0
Derivative liabilities	0	0
Level II | Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	13,654,000	0
Derivative liabilities	0	19,346,000
Level III | Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	0	0
Derivative liabilities	0	0
Foreign currency forward, net | Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	13,481,000	0
Derivative liabilities	0	4,876,000
Foreign currency forward, net | Level I | Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	0	0
Derivative liabilities	0	0
Foreign currency forward, net | Level II | Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	13,481,000	0
Derivative liabilities	0	4,876,000
Foreign currency forward, net | Level III | Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	0	0
Derivative liabilities	0	0
Interest rate cap | Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	173,000	0
Interest rate cap | Level I | Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	0	0
Interest rate cap | Level II | Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	173,000	0
Interest rate cap | Level III | Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	0	0
Interest rate swap liability
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets	0
Interest rate swap liability | Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	0	14,470,000
Interest rate swap liability | Level I | Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	0	0
Interest rate swap liability | Level II | Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	0	14,470,000
Interest rate swap liability | Level III | Estimate of Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities	$ 0	$ 0

XML

Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net - Loan Portfolio (Details) - USD ($) $ in Thousands		Sep. 30, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net		$ 6,437,037	$ 6,375,093
Commercial Mortgage and Subordinated Portfolio Segment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net		156,400	126,700
Commercial Mortgage Portfolio Segment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net	[1],[2]	5,427,945	5,326,967
Subordinate Mortgage Portfolio Segment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying value, net	[2]	$ 1,009,092	$ 1,048,126

[1] Includes $5,405,220 and $4,852,087 pledged as collateral under secured debt arrangements in 2020 and 2019, respectively

[2] Net of $236,207 CECL Allowances in 2020, comprised of $196,931 Specific CECL Allowance and $39,276 General CECL Allowance. Net of $56,981 provision for loan loss in 2019.

XML

Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net - Additional Information (Details) $ in Thousands, £ in Millions	1 Months Ended					3 Months Ended			9 Months Ended		12 Months Ended
	Jul. 31, 2020 USD ($)	Jul. 31, 2020 GBP (£)	May 31, 2020 USD ($)	Jan. 31, 2020 USD ($)	Jan. 31, 2020 GBP (£)	Sep. 30, 2020 USD ($)	Jun. 30, 2020 USD ($)	Sep. 30, 2019 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2019 USD ($)	Dec. 31, 2019 USD ($)
Financing Receivable, Allowance for Credit Loss [Line Items]
Percentage of loan portfolio									100.00%		100.00%
Increase (decrease) in General CECL Allowance						$ (5,800)			$ 12,000
Interest receivable						38,401			38,401		$ 35,581
Amortized cost of loans in cost recovery						408,666			408,666		$ 136,300
Interest received for loans in cost recovery						300			1,600
Specific CECL allowance						550			(139,950)
Payment in kind interest						12,500		$ 13,700	37,300	$ 42,800
Proceeds from pre-payment penalties or accelerated fees						0		$ 300	200	$ 4,000
Sale of Mezzanine Loan
Financing Receivable, Allowance for Credit Loss [Line Items]
Proceeds from sale of loan				$ 81,300	£ 62.2
Sale of Unfunded Commitment of Senior Mortgage
Financing Receivable, Allowance for Credit Loss [Line Items]
Proceeds from sale of loan				$ 65,300	£ 50.0
Sale of Construction Loan Interests
Financing Receivable, Allowance for Credit Loss [Line Items]
Commitments sold			$ 376,900
Funded amount of interests sold			$ 127,000
Percentage agreed to indemnify each buyer on loss			10.00%
Realized loss			$ 1,400
Sale of Inventory Loan
Financing Receivable, Allowance for Credit Loss [Line Items]
Realized loss	$ 1,000
Outstanding principal on loan	$ 124,200	£ 97.5
Commercial Mortgage and Subordinated Portfolio Segment
Financing Receivable, Allowance for Credit Loss [Line Items]
Specific CECL allowance									(139,950)
Subordinate Mortgage Portfolio Segment
Financing Receivable, Allowance for Credit Loss [Line Items]
Maximum exposure to loss						68,100			$ 68,100
Maximum exposure to loss, term									6 years 25 days
Floating Rate Loan
Financing Receivable, Allowance for Credit Loss [Line Items]
Percentage of loan portfolio									95.00%		95.00%
Hotel - New York City
Financing Receivable, Allowance for Credit Loss [Line Items]
Amortized cost of loans in cost recovery						144,500			$ 144,500
Borrower contributed additional equity									15,000
Principal Amount						$ 142,800			$ 142,800
Specific CECL allowance							$ 15,000

XML

Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net - Activity Relating to Loan Investment Portfolio (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2020	Mar. 31, 2020	Jan. 01, 2020	Dec. 31, 2019
Deferred Fees/Other Items
Realized loss on investment			$ 3,127
Specific Provision for Loan Loss
Specific CECL Allowance	$ 550		(139,950)
Carrying Value, Net
Carrying value, beginning balance			6,375,093
Specific CECL Allowance	550		(139,950)
Carrying value, ending balance	6,476,313		6,476,313
General CECL allowance	(39,276)		(39,276)
Carrying value, net	6,437,037		6,437,037			$ 6,375,093
General CECL allowance related to unfunded commitments	3,595	$ 4,119	3,595	$ 6,059	$ 3,088	0
Commercial Mortgage and Subordinated Portfolio Segment
Principal Balance
Principal balance, beginning			6,467,842
New loan fundings			457,449
Add-on loan fundings			309,820
Loan repayments and sales			(543,535)
Gain (loss) on foreign currency translation			(15,060)
Realized loss on investment			(20,569)
PIK interest and amortization of fees			38,197
Principal balance, ending	6,694,144		6,694,144
Deferred Fees/Other Items
Deferred fees/other items, beginning			(35,768)
Gain (loss) on foreign currency translation			543
Deferred fees			(6,027)
PIK interest and amortization of fees			17,225
Deferred fees/other items, ending	(20,900)		(20,900)
Specific Provision for Loan Loss
Specific provision for loan loss, beginning	(197,481)	(206,981)	(56,981)
Specific CECL Allowance			(139,950)
Specific provision for loan loss, ending	(196,931)	$ (197,481)	(196,931)
Carrying Value, Net
Carrying value, beginning balance			6,375,093
New loan fundings			457,449
Add-on loan fundings			309,820
Loan repayments and sales			(543,535)
Gain (loss) on foreign currency translation			(14,517)
Specific CECL Allowance			(139,950)
Realized loss on investment			(17,442)
Deferred fees			(6,027)
PIK interest and amortization of fees			55,422
Carrying value, ending balance	6,476,313		6,476,313
Carrying value, net	156,400		156,400			$ 126,700
General CECL allowance related to unfunded commitments	$ 3,600		$ 3,600

XML

Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net - Statistics for Loan Portfolio (Details) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2020 USD ($) loan	Dec. 31, 2019 USD ($) loan
Accounts, Notes, Loans and Financing Receivable [Line Items]
Number of loans | loan	70	72
Principal balance	$ 6,476,313	$ 6,375,093
Carrying value, net	6,437,037	6,375,093
Unfunded loan commitments	$ 1,426,404	$ 1,952,887
Weighted-average cash coupon	5.60%	6.50%
Weighted-average remaining fully-extended term	2 years 10 months 24 days	3 years 3 months 18 days
Weighted-average expected term	2 years	1 year 9 months 18 days
Interest rate used in calculating weighted-average cash coupon for non-accrual or cost recovery loans	0.00%	0.00%
Principal balance
Accounts, Notes, Loans and Financing Receivable [Line Items]
Principal balance	$ 6,694,144	$ 6,467,842

XML

Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net - Schedule of Mortgage Loans by Property Type and Geographic Distribution (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019	Jun. 30, 2020	Mar. 31, 2020	Jan. 01, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 6,476,313	$ 6,375,093
% of Portfolio	100.00%	100.00%
General CECL allowance	$ (39,276)
Carrying value, net	6,437,037	$ 6,375,093
General CECL allowance related to unfunded commitments	3,595	0	$ 4,119	$ 6,059	$ 3,088
New York City
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 2,393,012	$ 2,167,487
% of Portfolio	37.00%	34.00%
Northeast
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 138,448	$ 110,771
% of Portfolio	2.10%	1.70%
United Kingdom
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 1,179,761	$ 1,274,390
% of Portfolio	18.20%	20.00%
West
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 741,971	$ 728,182
% of Portfolio	11.50%	11.40%
Midwest
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 556,011	$ 614,337
% of Portfolio	8.60%	9.60%
Southeast
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 576,420	$ 564,166
% of Portfolio	8.90%	8.90%
Other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 890,690	$ 915,760
% of Portfolio	13.70%	14.40%
Office
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 1,832,607	$ 1,401,400
% of Portfolio	28.30%	22.00%
Hotel
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 1,578,614	$ 1,660,162
% of Portfolio	24.40%	26.00%
Residential-for-sale: construction
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 894,610	$ 692,816
% of Portfolio	13.80%	10.90%
Residential-for-sale: inventory
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 150,015	$ 321,673
% of Portfolio	2.30%	5.10%
Urban Retail
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 636,308	$ 643,706
% of Portfolio	9.80%	10.10%
Urban Predevelopment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 295,728	$ 409,864
% of Portfolio	4.60%	6.40%
Healthcare
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 363,170	$ 371,423
% of Portfolio	5.60%	5.80%
Industrial
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 228,674	$ 227,940
% of Portfolio	3.50%	3.60%
Other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Carrying Value	$ 496,587	$ 646,109
% of Portfolio	7.70%	10.10%

XML

Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net - Allocation of Carrying Value of Loan Portfolio Based on Internal Risk Ratings (Details) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2020 USD ($) loan	Dec. 31, 2019 USD ($) loan
Financing Receivable, Credit Quality Indicator [Line Items]
Number of Loans | loan	70	72
Total	$ 6,476,313	$ 6,375,093
% of Portfolio	100.00%	100.00%
Year 1	$ 450,119	$ 2,736,825
Year 2	2,685,060	1,596,690
Year 3	1,379,821	912,636
Year 4	953,587	291,700
Year 5	203,595	524,246
Prior	804,131	312,996
General CECL Allowance	(39,276)
Total carrying value, net	$ 6,437,037	$ 6,375,093
Weighted Average Risk Rating	3.1	3.0
1
Financing Receivable, Credit Quality Indicator [Line Items]
Number of Loans | loan	0	0
Total	$ 0	$ 0
% of Portfolio	0.00%	0.00%
Year 1	$ 0	$ 0
Year 2	0	0
Year 3	0	0
Year 4	0	0
Year 5	0	0
Prior	$ 0	$ 0
2
Financing Receivable, Credit Quality Indicator [Line Items]
Number of Loans | loan	1	8
Total	$ 32,000	$ 348,324
% of Portfolio	0.50%	5.50%
Year 1	$ 0	$ 0
Year 2	0	241,676
Year 3	0	0
Year 4	0	36,250
Year 5	0	24,546
Prior	$ 32,000	$ 45,852
3
Financing Receivable, Credit Quality Indicator [Line Items]
Number of Loans | loan	62	61
Total	$ 6,035,647	$ 5,707,555
% of Portfolio	93.20%	89.50%
Year 1	$ 450,119	$ 2,736,825
Year 2	2,685,060	1,355,014
Year 3	1,350,949	912,636
Year 4	815,789	72,540
Year 5	88,685	499,700
Prior	$ 645,045	$ 130,840
4
Financing Receivable, Credit Quality Indicator [Line Items]
Number of Loans | loan	0	1
Total	$ 0	$ 182,910
% of Portfolio	0.00%	2.90%
Year 1	$ 0	$ 0
Year 2	0	0
Year 3	0	0
Year 4	0	182,910
Year 5	0	0
Prior	$ 0	$ 0
5
Financing Receivable, Credit Quality Indicator [Line Items]
Number of Loans | loan	7	2
Total	$ 408,666	$ 136,304
% of Portfolio	6.30%	2.10%
Year 1	$ 0	$ 0
Year 2	0	0
Year 3	28,872	0
Year 4	137,798	0
Year 5	114,910	0
Prior	$ 127,086	$ 136,304

XML

Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net - Current Expected Credit Losses (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Jan. 01, 2020	Dec. 31, 2019
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance reserve	$ 39,276
Unfunded commitments	3,595	$ 4,119	$ 6,059	$ 3,088	$ 0
Total General CECL Allowance	42,871	$ 48,663	$ 64,332	30,867	$ 0
Commercial Mortgage Portfolio Segment
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance reserve	20,161			12,149
Subordinate Mortgage Portfolio Segment
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance reserve	$ 19,115			$ 15,630

XML

Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net - CECL Allowance as Percentage of Amortized Cost and Total Commitment (Details) - USD ($) $ in Thousands		3 Months Ended				9 Months Ended
		Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Allowance and Provision for Loan Credit Loss [Abstract]
Quarter allowances (reversals), specific CECL allowance, funded	[1]	$ (6,342)			$ 35,000	$ 151,954	$ 20,000
Financing Receivable, Funded, Allowance for Credit Loss [Roll Forward]
Beginning balance, General CECL allowance, funded		44,544	$ 58,273	$ 0		0
Quarter allowances (reversals), General CECL allowance, funded		(5,268)	(13,729)	30,494
Realized loss, General CECL allowance, funded			0
Ending balance, General CECL allowance, funded		39,276	44,544	58,273		39,276
Financing Receivable, Unfunded, Allowance for Credit Loss [Roll Forward]
Beginning balance, General CECL allowance, unfunded		4,119	6,059	0		0
Quarter allowances (reversals), General CECL allowance, unfunded		(524)	(1,940)	2,971
Realized loss, General CECL allowance, unfunded			0
Ending balance, General CECL allowance, unfunded		3,595	4,119	6,059		3,595
Financing Receivable, General Allowance, Allowance for Credit Loss [Roll Forward]
General CECL Allowance		48,663	64,332	0		0
Total quarter allowances (reversals), General CECL allowance		(5,792)	(15,669)	33,465
Total, realized loss, General CECL allowance			0
General CECL Allowance		42,871	48,663	64,332		42,871
Financing Receivable, Total Allowance for Credit Loss [Roll Forward]
Total CECL Allowance		246,144	271,313	56,981		56,981
Total CECL Allowance, Quarter allowances (reversals)		(6,342)	(10,169)	183,465
Total CECL allowance, realized loss			(15,000)
Total CECL Allowance		$ 239,802	$ 246,144	$ 271,313		$ 239,802
General CECL allowance, % of amortized cost		0.71%	0.81%	1.08%		0.71%		0.00%
Total CECL allowance, % of amortized cost		3.59%	3.71%	4.05%		3.59%		0.00%
Adjustment due to Adoption of ASU
Financing Receivable, Funded, Allowance for Credit Loss [Roll Forward]
Beginning balance, General CECL allowance, funded				$ 27,779		$ 27,779
Financing Receivable, Unfunded, Allowance for Credit Loss [Roll Forward]
Beginning balance, General CECL allowance, unfunded				3,088		3,088
Financing Receivable, General Allowance, Allowance for Credit Loss [Roll Forward]
General CECL Allowance				30,867		30,867
Financing Receivable, Total Allowance for Credit Loss [Roll Forward]
Total CECL Allowance				30,867		30,867
Commercial Mortgage and Subordinated Portfolio Segment
Allowance and Provision for Loan Credit Loss [Abstract]
Beginning balance, specific CECL allowance, funded		$ 197,481	$ 206,981	56,981		56,981
Quarter allowances (reversals), specific CECL allowance, funded		(550)	5,500	150,000
Realized Loss, specific CECL allowance, funded			(15,000)
Ending balance, specific CECL allowance, funded		196,931	$ 197,481	206,981		196,931
Financing Receivable, Unfunded, Allowance for Credit Loss [Roll Forward]
Ending balance, General CECL allowance, unfunded		$ 3,600				3,600
Commercial Mortgage and Subordinated Portfolio Segment | Adjustment due to Adoption of ASU
Allowance and Provision for Loan Credit Loss [Abstract]
Beginning balance, specific CECL allowance, funded				$ 0		$ 0

[1] Comprised of $550 and $(139,950) of Specific CECL Reversal (Allowance) and $5,792 and $(12,004) of General CECL Reversal (Allowance) for the three and nine months ended September 30, 2020, respectively.

XML

Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net - Cost Recovery Loans (Details) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2020 USD ($) $ / ft²	Sep. 30, 2019 USD ($)	Sep. 30, 2020 USD ($) $ / ft²	Sep. 30, 2019 USD ($)	Dec. 31, 2019 USD ($)
Financing Receivable, Credit Quality Indicator [Line Items]
Amortized cost		$ 408,666		$ 408,666		$ 136,300
Loan specific reserves		196,931		196,931		$ 56,981
Provision for loan losses	[1]	(6,342)	$ 35,000	151,954	$ 20,000
Payment in kind interest		12,500	$ 13,700	37,300	$ 42,800
Specific CECL Allowance		$ 550		$ (139,950)
Minimum | Hotel | Discount Rate
Financing Receivable, Credit Quality Indicator [Line Items]
Loan collateral, measurement input		0.085		0.085
Minimum | Hotel | Capitalization Rate
Financing Receivable, Credit Quality Indicator [Line Items]
Loan collateral, measurement input		0.070		0.070
Minimum | Urban Predevelopment | Capitalization Rate
Financing Receivable, Credit Quality Indicator [Line Items]
Loan collateral, measurement input		0.050		0.050
Minimum | Urban Predevelopment | Dollars per Square Foot
Financing Receivable, Credit Quality Indicator [Line Items]
Loan collateral, measurement input | $ / ft²		48		48
Maximum | Hotel | Discount Rate
Financing Receivable, Credit Quality Indicator [Line Items]
Loan collateral, measurement input		0.110		0.110
Maximum | Hotel | Capitalization Rate
Financing Receivable, Credit Quality Indicator [Line Items]
Loan collateral, measurement input		0.090		0.090
Maximum | Urban Predevelopment | Capitalization Rate
Financing Receivable, Credit Quality Indicator [Line Items]
Loan collateral, measurement input		0.055		0.055
Maximum | Urban Predevelopment | Dollars per Square Foot
Financing Receivable, Credit Quality Indicator [Line Items]
Loan collateral, measurement input | $ / ft²		225		225
Retail Center - Cincinnati, OH
Financing Receivable, Credit Quality Indicator [Line Items]
Payment in kind interest		$ 400		$ 1,100
Retail Center - Cincinnati, OH | Capitalization Rate
Financing Receivable, Credit Quality Indicator [Line Items]
Loan collateral, measurement input		0.083		0.083
Residential-For-Sale - Bethesda, MD
Financing Receivable, Credit Quality Indicator [Line Items]
Specific CECL Allowance		$ 1,900
Hotel - Washington D.C.
Financing Receivable, Credit Quality Indicator [Line Items]
Payment in kind interest		200		$ 200
Mortgage, Amortized cost
Financing Receivable, Credit Quality Indicator [Line Items]
Amortized cost		380,856		380,856
Mortgage, Amortized cost | Urban Predevelopment - Brooklyn, NY
Financing Receivable, Credit Quality Indicator [Line Items]
Amortized cost		128,418		128,418
Mortgage, Amortized cost | Urban Predevelopment - Miami, FL
Financing Receivable, Credit Quality Indicator [Line Items]
Amortized cost		114,910		114,910
Mortgage, Amortized cost | Retail Center - Cincinnati, OH
Financing Receivable, Credit Quality Indicator [Line Items]
Amortized cost		105,561		105,561
Mortgage, Amortized cost | Hotel - Pittsburgh, PA
Financing Receivable, Credit Quality Indicator [Line Items]
Amortized cost		28,872		28,872
Mortgage, Amortized cost | Residential-For-Sale - Bethesda, MD
Financing Receivable, Credit Quality Indicator [Line Items]
Amortized cost		3,095		3,095
Provision previously recorded under other assets				3,000
Mezzanine, Amortized cost
Financing Receivable, Credit Quality Indicator [Line Items]
Amortized cost		27,810		27,810
Mezzanine, Amortized cost | Hotel - Washington D.C.
Financing Receivable, Credit Quality Indicator [Line Items]
Amortized cost		18,430		18,430
Mezzanine, Amortized cost | Hotel - Anaheim, CA
Financing Receivable, Credit Quality Indicator [Line Items]
Amortized cost		$ 9,380		$ 9,380

[1] Comprised of $550 and $(139,950) of Specific CECL Reversal (Allowance) and $5,792 and $(12,004) of General CECL Reversal (Allowance) for the three and nine months ended September 30, 2020, respectively.

XML

Loan Proceeds Held by Servicer (Details) - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Receivables [Abstract]
Loan proceeds held by servicer	$ 0	$ 8,272,000

XML

Other Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Interest receivable	$ 38,401	$ 35,581
Collateral deposited under derivative agreements	1,810	17,090
Other	3,433	45
Total	$ 43,644	$ 52,716

XML

Secured Debt Arrangements, Net - Weighted Average Maturities and Interest Rates of Borrowings (Details) € in Millions, £ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2020 USD ($)	Dec. 31, 2019 USD ($)	Sep. 30, 2020 GBP (£)	Sep. 30, 2020 EUR (€)	Jun. 30, 2020 USD ($)	Mar. 31, 2020 USD ($)	Nov. 30, 2017 USD ($)
Debt Instrument [Line Items]
less: deferred financing costs	$ (7,565,000)	$ (7,277,000)
Percentage of secured debt that is recourse debt	55.00%	54.00%	55.00%	55.00%
Line of Credit
Debt Instrument [Line Items]
Maximum Amount of Borrowings	$ 4,396,866,000	$ 4,330,744,000
Borrowings outstanding	3,465,337,000	3,078,366,000
less: deferred financing costs	$ (12,746,000)	$ (17,190,000)
Line of Credit | Weighted Average
Debt Instrument [Line Items]
Weighted average advance rate	64.30%	63.80%
Line of Credit | London Interbank Offered Rate (LIBOR) | Weighted Average
Debt Instrument [Line Items]
Weighted average rate	2.15%	2.07%
Line of Credit | GBP London Interbank Offered Rate (LIBOR) | Weighted Average
Debt Instrument [Line Items]
Weighted average rate	1.82%	1.75%
Line of Credit | EUR London Interbank Offered Rate (LIBOR) | Weighted Average
Debt Instrument [Line Items]
Weighted average rate	1.46%	1.36%
Line of Credit | JP Morgan Chase, DB Repurchase Facility, Goldman Sachs, Credit Suisse and HSBC Facilities
Debt Instrument [Line Items]
Maximum Amount of Borrowings	$ 3,583,274,000	$ 4,330,744,000
Borrowings outstanding	2,664,491,000	3,095,556,000
Line of Credit | Deutsche Bank Repurchase Facility
Debt Instrument [Line Items]
Maximum Amount of Borrowings						$ 1,000,000,000.0
Borrowings outstanding	526,700,000
Line of Credit | Goldman Facility
Debt Instrument [Line Items]
Maximum Amount of Borrowings							$ 500,000,000.0
Borrowings outstanding	362,100,000
Line of Credit | Barclays Securitization
Debt Instrument [Line Items]
Borrowings outstanding			£ 518.6	€ 122.5
Line of Credit | JP Morgan Chase, DB Repurchase Facility, Goldman Sachs, Credit Suisse, Barclays Facility, HSBC Facilities And Barclays Securitization
Debt Instrument [Line Items]
Maximum Amount of Borrowings	4,396,866,000	4,330,744,000
Borrowings outstanding	$ 3,478,083,000	$ 3,095,556,000
USD | Line of Credit | Weighted Average
Debt Instrument [Line Items]
Weighted average advance rate	63.80%	66.70%
USD | Line of Credit | JP Morgan Facility
Debt Instrument [Line Items]
Maximum Amount of Borrowings	$ 1,132,013,000	$ 1,154,109,000
Borrowings outstanding	989,278,000	1,090,160,000
USD | Line of Credit | Deutsche Bank Repurchase Facility
Debt Instrument [Line Items]
Maximum Amount of Borrowings	1,000,000,000	1,250,000,000
Borrowings outstanding	526,743,000	513,876,000
USD | Line of Credit | Goldman Facility
Debt Instrument [Line Items]
Maximum Amount of Borrowings	500,000,000	500,000,000
Borrowings outstanding	362,139,000	322,170,000
USD | Line of Credit | Credit Suisse Facility
Debt Instrument [Line Items]
Maximum Amount of Borrowings	378,903,000	226,068,000
Borrowings outstanding	378,781,000	218,644,000
USD | Line of Credit | HSBC Facility
Debt Instrument [Line Items]
Maximum Amount of Borrowings	47,223,000	50,625,000
Borrowings outstanding	47,223,000	$ 50,625,000
USD | Line of Credit | Barclays Facility
Debt Instrument [Line Items]
Maximum Amount of Borrowings	200,000,000.0
Borrowings outstanding	$ 35,192,000
Fx contracts - GBP | Line of Credit
Debt Instrument [Line Items]
Currency conversion rate	1.29	1.33	1.29	1.29
Fx contracts - GBP | Line of Credit | Weighted Average
Debt Instrument [Line Items]
Weighted average advance rate	61.30%	47.10%
Fx contracts - GBP | Line of Credit | JP Morgan Facility
Debt Instrument [Line Items]
Maximum Amount of Borrowings	$ 97,661,000	$ 51,702,000
Borrowings outstanding	97,661,000	50,410,000
Fx contracts - GBP | Line of Credit | Credit Suisse Facility
Debt Instrument [Line Items]
Maximum Amount of Borrowings	0	93,915,000
Borrowings outstanding	$ 0	93,915,000
Fx contracts - GBP | Line of Credit | HSBC Facility
Debt Instrument [Line Items]
Maximum Amount of Borrowings		34,634,000
Borrowings outstanding		34,634,000
Fx contracts - GBP | Line of Credit | Barclays Facility
Debt Instrument [Line Items]
Maximum Amount of Borrowings		538,916,000
Borrowings outstanding		$ 290,347,000
Fx contracts - EUR | Line of Credit
Debt Instrument [Line Items]
Currency conversion rate	1.17	1.12	1.17	1.17
Fx contracts - EUR | Line of Credit | Weighted Average
Debt Instrument [Line Items]
Weighted average advance rate	67.90%	76.10%
Fx contracts - EUR | Line of Credit | JP Morgan Facility
Debt Instrument [Line Items]
Maximum Amount of Borrowings	$ 70,326,000	$ 94,189,000
Borrowings outstanding	70,326,000	94,189,000
Fx contracts - EUR | Line of Credit | HSBC Facility
Debt Instrument [Line Items]
Maximum Amount of Borrowings	157,148,000	154,037,000
Borrowings outstanding	157,148,000	154,037,000
Fx contracts - EUR | Line of Credit | Barclays Facility
Debt Instrument [Line Items]
Maximum Amount of Borrowings		182,549,000
Borrowings outstanding		$ 182,549,000
VIE | Line of Credit | Barclays Securitization
Debt Instrument [Line Items]
Maximum Amount of Borrowings	813,592,000
Borrowings outstanding	813,592,000				$ 782,000,000.0
VIE | Line of Credit | Barclays Securitization | Weighted Average
Debt Instrument [Line Items]
Borrowings outstanding	813,592,000
VIE | Fx contracts - GBP | Line of Credit | Barclays Securitization | Weighted Average
Debt Instrument [Line Items]
Borrowings outstanding	670,024,000
VIE | Fx contracts - EUR | Line of Credit | Barclays Securitization | Weighted Average
Debt Instrument [Line Items]
Borrowings outstanding	$ 143,568,000

XML

Secured Debt Arrangements, Net - Additional Information (Details) € in Millions, £ in Millions	1 Months Ended			3 Months Ended	9 Months Ended
	Nov. 30, 2019 USD ($) subsidiary extension	Jul. 31, 2018	Nov. 30, 2017 USD ($) extension	Mar. 31, 2020 USD ($) extension	Sep. 30, 2020 USD ($)	Sep. 30, 2020 EUR (€)	Sep. 30, 2019 USD ($)	Sep. 30, 2020 GBP (£)	Sep. 30, 2020 EUR (€)	Jun. 30, 2020 USD ($)	Jun. 30, 2020 GBP (£)	Jun. 30, 2020 EUR (€)	Dec. 31, 2019 USD ($)
Debt Instrument [Line Items]
Weighted average haircut under repurchase agreements					35.70%			35.70%	35.70%				36.20%
Repayments of secured debt arrangements					$ 1,083,849,000		$ 1,264,223,000
Line of Credit
Debt Instrument [Line Items]
Maximum borrowing under facility					4,396,866,000								$ 4,330,744,000
Balance					3,478,083,000								3,095,556,000
Borrowings outstanding					3,465,337,000								3,078,366,000
Line of Credit | JP Morgan Facility
Debt Instrument [Line Items]
Balance					1,157,265,000								1,234,759,000
Line of Credit | JP Morgan Facility | USD
Debt Instrument [Line Items]
Maximum borrowing under facility					1,132,013,000								1,154,109,000
Borrowings outstanding					989,278,000								1,090,160,000
Line of Credit | JP Morgan Facility | Fx contracts - GBP
Debt Instrument [Line Items]
Maximum borrowing under facility					97,661,000								51,702,000
Borrowings outstanding					97,661,000								50,410,000
Line of Credit | JP Morgan Facility | Fx contracts - EUR
Debt Instrument [Line Items]
Maximum borrowing under facility					70,326,000								94,189,000
Borrowings outstanding					70,326,000								94,189,000
Line of Credit | DB Repurchase Facility
Debt Instrument [Line Items]
Maximum borrowing under facility				$ 1,000,000,000.0
Number of extensions available | extension				2
Extension option				1 year
Balance					526,743,000								513,876,000
Borrowings outstanding					526,700,000
Line of Credit | DB Repurchase Facility | USD
Debt Instrument [Line Items]
Maximum borrowing under facility					1,000,000,000								1,250,000,000
Borrowings outstanding					526,743,000								513,876,000
Line of Credit | Goldman Sachs Repurchase Facility
Debt Instrument [Line Items]
Maximum borrowing under facility			$ 500,000,000.0
Number of extensions available | extension			1
Extension option			1 year
Balance					362,139,000								322,170,000
Borrowings outstanding					362,100,000
Line of Credit | Goldman Sachs Repurchase Facility | USD
Debt Instrument [Line Items]
Maximum borrowing under facility					500,000,000								500,000,000
Borrowings outstanding					362,139,000								322,170,000
Line of Credit | Credit Suisse Facility | USD
Debt Instrument [Line Items]
Maximum borrowing under facility					378,903,000								226,068,000
Balance					378,781,000								218,644,000
Borrowings outstanding					378,781,000								218,644,000
Term after either party notifies the other party of intention to terminate		6 months
Line of Credit | Credit Suisse Facility | Fx contracts - GBP
Debt Instrument [Line Items]
Maximum borrowing under facility					0								93,915,000
Balance													93,915,000
Borrowings outstanding					0								93,915,000
Line of Credit | HSBC Facility | USD
Debt Instrument [Line Items]
Maximum borrowing under facility					47,223,000								50,625,000
Balance					47,223,000								50,625,000
Borrowings outstanding					47,223,000								50,625,000
Line of Credit | HSBC Facility | Fx contracts - GBP
Debt Instrument [Line Items]
Maximum borrowing under facility													34,634,000
Balance					0								34,634,000
Borrowings outstanding													34,634,000
Line of Credit | HSBC Facility | Fx contracts - EUR
Debt Instrument [Line Items]
Maximum borrowing under facility					157,148,000								154,037,000
Balance					157,148,000								154,037,000
Borrowings outstanding					157,148,000								154,037,000
Line of credit, amount outstanding					157,100,000				€ 134.1
Line of Credit | Barclays Facility
Debt Instrument [Line Items]
Repayments of secured debt arrangements | €						€ 16.5
Line of Credit | Barclays Facility | USD
Debt Instrument [Line Items]
Maximum borrowing under facility					200,000,000.0
Balance					35,192,000
Borrowings outstanding					35,192,000
Line of Credit | Barclays Facility | Fx contracts - GBP
Debt Instrument [Line Items]
Maximum borrowing under facility													538,916,000
Balance					0								290,347,000
Borrowings outstanding													290,347,000
Line of Credit | Barclays Facility | Fx contracts - EUR
Debt Instrument [Line Items]
Maximum borrowing under facility													182,549,000
Balance					0								182,549,000
Borrowings outstanding													$ 182,549,000
Line of Credit | Barclays Securitization
Debt Instrument [Line Items]
Balance					813,592,000
Borrowings outstanding								£ 518.6	122.5
Line of Credit | Barclays Securitization | VIE
Debt Instrument [Line Items]
Maximum borrowing under facility					813,592,000
Balance											£ 26.0	€ 5.3
Borrowings outstanding					$ 813,592,000					$ 782,000,000.0
Deferring or waiving debt service payments, term					18 months	18 months
LTV based covenants, term					6 months	6 months
Repayments of secured debt arrangements					$ 18,500,000
Increase in financing spread					0.25%	0.25%
Amended and Restated JPMorgan Facility | Line of Credit | JP Morgan Facility
Debt Instrument [Line Items]
Number of subsidiaries | subsidiary	3
Maximum borrowing under facility	$ 1,300,000,000
Number of extensions available | extension	2
Extension option	1 year
Balance					$ 1,200,000,000			£ 75.6	€ 60.0

XML

Secured Debt Arrangements, Net - Assets Under Barclays Private Securitization (Details) - Line of Credit $ in Thousands, € in Millions, £ in Millions	Sep. 30, 2020 USD ($)	Sep. 30, 2020 GBP (£)	Sep. 30, 2020 EUR (€)	Jun. 30, 2020 USD ($)	Dec. 31, 2019 USD ($)
Debt Instrument [Line Items]
Borrowings outstanding	$ 3,465,337				$ 3,078,366
Barclays Securitization
Debt Instrument [Line Items]
Borrowings outstanding		£ 518.6	€ 122.5
VIE | Barclays Securitization
Debt Instrument [Line Items]
Borrowings outstanding	813,592			$ 782,000
Weighted Average | VIE | Barclays Securitization
Debt Instrument [Line Items]
Borrowings outstanding	813,592
Weighted Average | VIE | Fx contracts - GBP | Barclays Securitization
Debt Instrument [Line Items]
Borrowings outstanding	670,024
Weighted Average | VIE | Fx contracts - EUR | Barclays Securitization
Debt Instrument [Line Items]
Borrowings outstanding	$ 143,568

XML

Secured Debt Arrangements, Net - Schedule of Assets and Liabilities (Details) - USD ($) $ in Thousands		Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Jan. 01, 2020	Dec. 31, 2019
Assets:
Carrying value, net		$ 6,437,037				$ 6,375,093
Other assets		43,644				52,716
Total Assets		6,932,569				6,888,363
Liabilities:
Accounts payable, accrued expenses and other liabilities	[1]	89,222				100,712
Total Liabilities		4,613,288				4,258,388
Deferred financing costs		12,746				17,190
Allowance reserve		39,276
Off-Balance Sheet, Credit Loss, Liability		3,595	$ 4,119	$ 6,059	$ 3,088	0
Commercial Mortgage Portfolio Segment
Assets:
Carrying value, net	[2],[3]	5,427,945				$ 5,326,967
Liabilities:
Allowance reserve		20,161			$ 12,149
VIE
Assets:
Cash		921
Carrying value, net		1,224,154
Other assets		9,401
Total Assets		1,234,476
Liabilities:
Secured debt arrangements, net (net of deferred financing costs of $0.2 million)		813,431
Accounts payable, accrued expenses and other liabilities		1,084
Total Liabilities		814,515
Deferred financing costs		200
VIE | Commercial Mortgage Portfolio Segment
Liabilities:
Allowance reserve		6,100
Off-Balance Sheet, Credit Loss, Liability		$ 300

[1] Includes $3,595 of General CECL Allowance related to unfunded commitments on commercial mortgage loans, subordinate loans and other lending assets, net in 2020.

[2] Includes $5,405,220 and $4,852,087 pledged as collateral under secured debt arrangements in 2020 and 2019, respectively

[3] Net of $236,207 CECL Allowances in 2020, comprised of $196,931 Specific CECL Allowance and $39,276 General CECL Allowance. Net of $56,981 provision for loan loss in 2019.

XML

Secured Debt Arrangements, Net - Schedule of Net Income (Details) - USD ($) $ in Thousands		3 Months Ended						9 Months Ended
		Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Securitization or Asset-backed Financing Arrangement, Financial Asset for which Transfer is Accounted as Sale [Line Items]
Interest income from commercial mortgage loans		$ 74,522			$ 81,136			$ 232,018	$ 236,880
Interest expense		(34,824)			(39,341)			(113,527)	(109,147)
Net interest income		68,555			85,216			213,982	253,036
Reversal of (provision for) loan losses	[1]	6,342			(35,000)			(151,954)	(20,000)
Foreign currency translation gain (loss)		27,002			(19,129)			(8,388)	(20,012)
Net income (loss)		49,338	$ 60,201	$ (127,842)	$ 29,089	$ 61,424	$ 67,758	$ (18,303)	$ 158,271
VIE
Securitization or Asset-backed Financing Arrangement, Financial Asset for which Transfer is Accounted as Sale [Line Items]
Interest income from commercial mortgage loans		15,075
Interest expense		(4,278)
Net interest income		10,797
Reversal of (provision for) loan losses		(2,318)
Foreign currency translation gain (loss)		17,078
Net income (loss)		$ 25,557

[1] Comprised of $550 and $(139,950) of Specific CECL Reversal (Allowance) and $5,792 and $(12,004) of General CECL Reversal (Allowance) for the three and nine months ended September 30, 2020, respectively.

XML

Secured Debt Arrangements, Net - Remaining Maturities of Borrowings (Details) - Line of Credit $ in Thousands	Sep. 30, 2020 USD ($)
Line of Credit Facility [Line Items]
Less than 1 year	$ 503,750
1 to 3 years	1,742,491
3 to 5 years	1,231,842
More than 5 years	0
Total	3,478,083
JPMorgan
Line of Credit Facility [Line Items]
Less than 1 year	45,918
1 to 3 years	432,440
3 to 5 years	678,907
More than 5 years	0
Total	1,157,265
DB
Line of Credit Facility [Line Items]
Less than 1 year	15,594
1 to 3 years	511,149
3 to 5 years	0
More than 5 years	0
Total	526,743
Goldman
Line of Credit Facility [Line Items]
Less than 1 year	0
1 to 3 years	362,139
3 to 5 years	0
More than 5 years	0
Total	362,139
CS Facility | USD
Line of Credit Facility [Line Items]
Less than 1 year	94,299
1 to 3 years	146,994
3 to 5 years	137,488
More than 5 years	0
Total	378,781
HSBC Facility | USD
Line of Credit Facility [Line Items]
Less than 1 year	47,223
1 to 3 years	0
3 to 5 years	0
More than 5 years	0
Total	47,223
HSBC Facility | Fx contracts - EUR
Line of Credit Facility [Line Items]
Less than 1 year	157,148
1 to 3 years	0
3 to 5 years	0
More than 5 years	0
Total	157,148
Barclays Facility | USD
Line of Credit Facility [Line Items]
Less than 1 year	0
1 to 3 years	0
3 to 5 years	35,192
More than 5 years	0
Total	35,192
Barclays Securitization
Line of Credit Facility [Line Items]
Less than 1 year	143,568
1 to 3 years	289,769
3 to 5 years	380,255
More than 5 years	0
Total	$ 813,592

XML

Secured Debt Arrangements, Net - Summary of Outstanding Balances, Maximum and Average Balances of Borrowings (Details) - Line of Credit - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Line of Credit Facility [Line Items]
Balance	$ 3,478,083	$ 3,095,556
Amortized Cost of Collateral	5,405,220	4,852,087
JPMorgan
Line of Credit Facility [Line Items]
Balance	1,157,265	1,234,759
Amortized Cost of Collateral	1,976,965	1,845,400
Maximum Month-End Balance	1,192,288	1,234,759
Average Month-End Balance	1,106,461	947,400
DB
Line of Credit Facility [Line Items]
Balance	526,743	513,876
Amortized Cost of Collateral	804,835	766,676
Maximum Month-End Balance	526,743	757,117
Average Month-End Balance	501,470	604,067
Goldman
Line of Credit Facility [Line Items]
Balance	362,139	322,170
Amortized Cost of Collateral	548,671	513,559
Maximum Month-End Balance	362,139	324,821
Average Month-End Balance	343,882	246,318
CS Facility | USD
Line of Credit Facility [Line Items]
Balance	378,781	218,644
Amortized Cost of Collateral	523,272	308,884
Maximum Month-End Balance	378,781	218,644
Average Month-End Balance	339,425	182,646
CS Facility | Fx contracts - GBP
Line of Credit Facility [Line Items]
Balance		93,915
Amortized Cost of Collateral	0	129,723
Maximum Month-End Balance	90,111	150,811
Average Month-End Balance	57,459	134,694
HSBC Facility | USD
Line of Credit Facility [Line Items]
Balance	47,223	50,625
Amortized Cost of Collateral	67,203	66,960
Maximum Month-End Balance	50,625	50,625
Average Month-End Balance	48,357	50,625
HSBC Facility | Fx contracts - GBP
Line of Credit Facility [Line Items]
Balance	0	34,634
Amortized Cost of Collateral	0	49,976
Maximum Month-End Balance	34,500	50,784
Average Month-End Balance	32,900	42,296
HSBC Facility | Fx contracts - EUR
Line of Credit Facility [Line Items]
Balance	157,148	154,037
Amortized Cost of Collateral	204,040	190,780
Maximum Month-End Balance	160,034	154,037
Average Month-End Balance	152,982	151,889
Barclays Facility | USD
Line of Credit Facility [Line Items]
Balance	35,192
Amortized Cost of Collateral	49,929
Maximum Month-End Balance	35,193
Average Month-End Balance	27,372
Barclays Facility | Fx contracts - GBP
Line of Credit Facility [Line Items]
Balance	0	290,347
Amortized Cost of Collateral	0	738,455
Maximum Month-End Balance	666,810	290,347
Average Month-End Balance	347,590	139,004
Barclays Facility | Fx contracts - EUR
Line of Credit Facility [Line Items]
Balance	0	182,549
Amortized Cost of Collateral	0	241,674
Maximum Month-End Balance	180,595	182,549
Average Month-End Balance	94,028	$ 181,159
Barclays Securitization
Line of Credit Facility [Line Items]
Balance	813,592
Amortized Cost of Collateral	1,230,305
Maximum Month-End Balance	839,563
Average Month-End Balance	$ 814,844

XML

Senior Secured Term Loan, Net (Details) - USD ($)	1 Months Ended	3 Months Ended			9 Months Ended
	May 31, 2019	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Debt Instrument [Line Items]
Repayments of senior secured term loan principal			$ 1,300,000		$ 3,750,000	$ 1,250,000
Deferred financing costs		$ 7,565,000			7,565,000		$ 7,277,000
Realized loss on interest rate swap		564,000		$ 10,307,000	39,207,000	$ 23,420,000
Interest rate swap
Debt Instrument [Line Items]
Realized loss on interest rate swap			$ 53,900,000
Interest rate cap
Debt Instrument [Line Items]
Debt interest rate cap			3 years
London Interbank Offered Rate (LIBOR) | Interest rate swap
Debt Instrument [Line Items]
Fixed interest rate	2.12%
London Interbank Offered Rate (LIBOR) | Interest rate cap
Debt Instrument [Line Items]
Fixed interest rate			0.75%
Secured Debt
Debt Instrument [Line Items]
Debt instrument, face amount	$ 500,000,000.0
Debt instrument, issuance price as a percentage	99.50%
Secured debt arrangements, net (net of deferred financing costs of $12,746 and $17,190 in 2020 and 2019, respectively)		493,800,000			493,800,000		497,500,000
Secured debt arrangements, net (net of deferred financing costs of $12,746 and $17,190 in 2020 and 2019, respectively)		484,200,000			484,200,000		488,000,000.0
Deferred financing costs		7,600,000			7,600,000		7,300,000
Unamortized discount		$ 2,000,000.0			$ 2,000,000.0		$ 2,300,000
Debt instrument, covenant, non-recourse debt to tangible net worth ratio, maximum	3
Debt instrument, covenant, unencumbered assets to pari-passu indebtedness ratio, maximum	1.25
Effective interest rate	4.87%		3.50%
Secured Debt | Interest rate cap
Debt Instrument [Line Items]
Deferred financing costs			$ 1,100,000
Secured Debt | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Basis spread on variable rate	2.75%

XML

Convertible Senior Notes, Net (Details)			3 Months Ended					7 Months Ended	9 Months Ended		12 Months Ended
	Mar. 15, 2019 USD ($)	Aug. 02, 2018 USD ($) shares	Sep. 30, 2020 USD ($) $ / shares	Dec. 31, 2019 USD ($)	Sep. 30, 2019 USD ($)	Mar. 31, 2019 USD ($) shares	Mar. 31, 2014 USD ($)	Mar. 15, 2019 USD ($) shares	Sep. 30, 2020 USD ($) $ / shares	Sep. 30, 2019 USD ($)	Dec. 31, 2017 USD ($) offering	Dec. 31, 2014 USD ($) offering	Dec. 31, 2018 USD ($)
Debt Instrument [Line Items]
Cash payment for debt redemption									$ 0	$ 704,000
Conversions of convertible senior notes for common stock						$ 33,778,000
Common Stock
Debt Instrument [Line Items]
Conversions of convertible senior notes for common stock (in shares) | shares						1,967,361
Conversions of convertible senior notes for common stock						$ 20,000
Share price (in dollars per share) | $ / shares			$ 9.01						$ 9.01
Additional Paid-In-Capital
Debt Instrument [Line Items]
Conversions of convertible senior notes for common stock						$ 33,758,000
Convertible Debt
Debt Instrument [Line Items]
Debt instrument, face amount			$ 575,000,000						$ 575,000,000
Interest expense			7,200,000		$ 7,200,000				21,600,000	21,900,000
Non-cash interest expense			1,500,000		$ 1,500,000				4,500,000	$ 4,600,000
Convertible Debt | 2019 and 2022 Notes | Additional Paid-In-Capital
Debt Instrument [Line Items]
Conversions of convertible senior notes for common stock									15,400,000
Convertible Debt | 2019 Notes
Debt Instrument [Line Items]
Number of debt offerings issued | offering												2
Debt instrument, face amount												$ 254,800,000
Stated interest rate												5.50%
Proceeds from issuance of convertible senior notes							$ 248,600,000
Principal amount redeemed		$ 206,200,000						$ 47,900,000
Cash payment for debt redemption	$ 700,000	$ 39,300,000						$ 200,000
Convertible Debt | 2019 Notes | Common Stock
Debt Instrument [Line Items]
Conversions of convertible senior notes for common stock (in shares) | shares		10,020,328				1,967,361		2,775,509
Conversions of convertible senior notes for common stock						$ 33,800,000
Convertible Debt | 2019 Notes | Additional Paid-In-Capital
Debt Instrument [Line Items]
Conversions of convertible senior notes for common stock		$ 166,000,000.0						$ 13,900,000
Convertible Debt | 2022 Notes
Debt Instrument [Line Items]
Number of debt offerings issued | offering											2
Debt instrument, face amount			$ 345,000,000						$ 345,000,000		$ 345,000,000.0
Stated interest rate			4.75%						4.75%		4.75%
Proceeds from issuance of convertible senior notes											$ 337,500,000
Convertible senior notes, net			$ 339,700,000						$ 339,700,000
Unamortized discount			5,300,000						5,300,000
Convertible Debt | 2022 Notes | Additional Paid-In-Capital
Debt Instrument [Line Items]
Conversions of convertible senior notes for common stock									11,000,000.0
Convertible Debt | 2023 Notes
Debt Instrument [Line Items]
Debt instrument, face amount			$ 230,000,000						$ 230,000,000				$ 230,000,000.0
Stated interest rate			5.38%						5.38%				5.375%
Proceeds from issuance of convertible senior notes				$ 223,700,000
Convertible senior notes, net			$ 224,900,000						$ 224,900,000
Unamortized discount			$ 5,100,000						5,100,000
Convertible Debt | 2023 Notes | Additional Paid-In-Capital
Debt Instrument [Line Items]
Conversions of convertible senior notes for common stock									$ 4,400,000

XML

Convertible Senior Notes, Net - Summary of Note Terms (Details) - Convertible Debt	9 Months Ended
	Sep. 30, 2020 USD ($)	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)
Debt Instrument [Line Items]
Principal Amount	$ 575,000,000
Conversion rate basis, principal amount	1,000
2022 Notes
Debt Instrument [Line Items]
Principal Amount	$ 345,000,000		$ 345,000,000.0
Coupon Rate	4.75%		4.75%
Effective Rate	5.60%
Conversion Rate	0.0502260
Remaining Period of Amortization	1 year 10 months 24 days
2023 Notes
Debt Instrument [Line Items]
Principal Amount	$ 230,000,000	$ 230,000,000.0
Coupon Rate	5.38%	5.375%
Effective Rate	6.16%
Conversion Rate	0.0487187
Remaining Period of Amortization	3 years 14 days

XML

Derivatives - Summary of Non-Designated Foreign Exchange Forwards (Details) - Not Designated as Hedging Instrument $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2020 USD ($) contract	Dec. 31, 2019 USD ($) contract
Interest rate swap liability
Derivative [Line Items]
Number of Contracts | contract	1	1
Aggregate Notional Amount (in thousands) | $	$ 500,000	$ 500,000
Weighted-Average Years to Maturity	2 years 8 months 15 days	6 years 4 months 13 days
Fx contracts - GBP | Foreign currency forward, net
Derivative [Line Items]
Number of Contracts | contract	106	156
Aggregate Notional Amount (in thousands) | $	$ 422,585	$ 735,349
Weighted-Average Years to Maturity	2 years 1 month 28 days	1 year 5 months 26 days
Fx contracts - EUR | Foreign currency forward, net
Derivative [Line Items]
Number of Contracts | contract	70	44
Aggregate Notional Amount (in thousands) | $	$ 238,817	$ 168,879
Weighted-Average Years to Maturity	2 years 9 months 14 days	3 years 2 months 19 days

XML

Derivatives - Summary of Amounts Recognized on Consolidated Statements of Operations Related to Company's Derivatives (Details) - USD ($)	3 Months Ended			9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gain (loss) on derivative instruments - unrealized interest rate swap				$ 33,000,000	$ (11,391,000)
Gain (loss) on sale of derivatives	$ (564,000)		$ (10,307,000)	(39,207,000)	(23,420,000)
Foreign currency forward, net
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gain (loss) on derivative instruments - unrealized interest rate swap	(35,076,000)		16,227,000	18,356,000	12,029,000
Gain (loss) on sale of derivatives	(34,537,000)		24,153,000	32,959,000	28,619,000
Foreign currency forward, net | Gain (Loss) on Derivative Instruments
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instruments - interest rate swap realized	539,000		7,926,000	14,603,000	16,590,000
Interest rate cap and swaps
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gain (loss) on derivative instruments - unrealized interest rate swap	(564,000)		(10,307,000)	14,644,000	(23,420,000)
Gain (loss) on sale of derivatives	(564,000)		(10,307,000)	(39,207,000)	(23,420,000)
Interest rate cap
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount	1,100,000			1,100,000
Interest rate cap | Gain (Loss) on Derivative Instruments
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instruments - interest rate swap realized	(564,000)		0	174,000	0
Derivative notional amount	500,000,000.0		0	500,000,000.0	0
Interest Rate Swap, Instrument One | Gain (Loss) on Derivative Instruments
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gain (loss) on derivative instruments - unrealized interest rate swap	0		(10,307,000)	14,470,000	(23,420,000)
Interest Rate Swap, Instrument Two | Gain (Loss) on Derivative Instruments
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instruments - interest rate swap realized	0		0	(53,851,000)	0
Interest rate swap liability
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on sale of derivatives		$ (53,900,000)
Interest rate swap liability | Gain (Loss) on Derivative Instruments
Derivative Instruments, Gain (Loss) [Line Items]
Derivative notional amount	$ 0		$ 500,000,000.0	$ 0	$ 500,000,000.0

XML

Derivatives - Additional Information (Details) - USD ($) $ in Millions	Sep. 30, 2020	Jun. 30, 2020	May 31, 2019
Secured Debt
Derivative [Line Items]
Effective interest rate		3.50%	4.87%
Interest rate cap
Derivative [Line Items]
Derivative notional amount	$ 1.1
London Interbank Offered Rate (LIBOR) | Interest rate swap liability
Derivative [Line Items]
Fixed interest rate			2.12%
London Interbank Offered Rate (LIBOR) | Interest rate cap
Derivative [Line Items]
Fixed interest rate		0.75%
Cap interest rate			0.75%

XML

Derivatives - Summarizes Gross Asset and Liability Amounts Related to Derivatives (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Derivative [Line Items]
Gross Amount of Recognized Assets	$ 20,961	$ 0
Gross Amounts Offset in our Condensed Consolidated Balance Sheet	(7,307)	0
Net Amounts of Assets Presented in our Condensed Consolidated Balance Sheet	13,654	0
Gross Amount of Recognized Liability	0	27,157
Gross Amounts Offset in our Condensed Consolidated Balance Sheet	0	(7,811)
Net Amounts of Liability Presented in our Condensed Consolidated Balance Sheet	0	19,346
Forward currency contracts
Derivative [Line Items]
Gross Amount of Recognized Assets	20,788	0
Gross Amounts Offset in our Condensed Consolidated Balance Sheet	(7,307)	0
Net Amounts of Assets Presented in our Condensed Consolidated Balance Sheet	13,481	0
Gross Amount of Recognized Liability	0	12,687
Gross Amounts Offset in our Condensed Consolidated Balance Sheet	0	(7,811)
Net Amounts of Liability Presented in our Condensed Consolidated Balance Sheet	0	4,876
Interest rate cap
Derivative [Line Items]
Gross Amount of Recognized Assets	173	0
Gross Amounts Offset in our Condensed Consolidated Balance Sheet	0	0
Net Amounts of Assets Presented in our Condensed Consolidated Balance Sheet	173	0
Interest rate swap
Derivative [Line Items]
Gross Amount of Recognized Liability	0	14,470
Gross Amounts Offset in our Condensed Consolidated Balance Sheet	0	0
Net Amounts of Liability Presented in our Condensed Consolidated Balance Sheet	$ 0	$ 14,470

XML

Accounts Payable, Accrued Expenses and Other Liabilities (Details) - USD ($) $ in Thousands		Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Jan. 01, 2020	Dec. 31, 2019
Payables and Accruals [Abstract]
Accrued dividends payable		$ 53,689				$ 74,771
Collateral deposited under derivative agreements		12,780				2,930
Accrued interest payable		13,013				16,089
Accounts payable and other liabilities		6,145				6,922
Off-Balance Sheet, Credit Loss, Liability		3,595	$ 4,119	$ 6,059	$ 3,088	0
Total	[1]	$ 89,222				$ 100,712

[1] Includes $3,595 of General CECL Allowance related to unfunded commitments on commercial mortgage loans, subordinate loans and other lending assets, net in 2020.

XML

Related Party Transactions (Details) $ in Thousands, £ in Millions	1 Months Ended			3 Months Ended		9 Months Ended
	Jan. 31, 2020 USD ($)	Jan. 31, 2020 GBP (£)	May 31, 2019 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2019 USD ($)	Sep. 30, 2020 USD ($)	Sep. 30, 2019 USD ($)	Dec. 31, 2019 USD ($)
Related Party Transaction [Line Items]
Related party expenses				$ 9,927	$ 10,434	$ 30,152	$ 30,306
Base management fees incurred but not yet paid				9,927		$ 9,927		$ 10,430
Sale of Mezzanine Loan
Related Party Transaction [Line Items]
Proceeds from sale of loan	$ 81,300	£ 62.2
Sale of Unfunded Commitment of Senior Mortgage
Related Party Transaction [Line Items]
Proceeds from sale of loan	$ 65,300	£ 50.0
Arrangement fees
Related Party Transaction [Line Items]
Related party expenses			$ 600
Limited Liability Company
Related Party Transaction [Line Items]
Rate of management fees						1.50%
Extension period						1 year
Period of termination						180 days
Termination fee calculation period						24 months
Limited Liability Company | Management fees
Related Party Transaction [Line Items]
Base management fees incurred but not yet paid				9,900		$ 9,900		$ 10,400
Affiliated Entity | Management fees
Related Party Transaction [Line Items]
Related party expenses				9,900	10,400	30,200	30,300
Affiliated Entity | Reimbursements
Related Party Transaction [Line Items]
Related party expenses				$ 600	$ 500	$ 1,700	$ 2,000

XML

Share-Based Payments - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Apr. 16, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Recognized stock-based compensation expense	$ 4,212	$ 3,889	$ 12,727	$ 12,084
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense	300		300
RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense	$ 22,900		$ 22,900
LTIP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized (in shares)					7,000,000
Common stock, shares delivered (in shares)			503,411	433,585
LTIP | RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock units vested (in shares)			868,421	730,980
Adjustments to additional paid in capital, income tax deficiency from share-based compensation			$ 6,500	$ 5,000

XML

Share-Based Payments - Summary of Grants, Exchanges and Forfeitures of Restricted Stock and RSUs (Details) - LTIP $ in Thousands	9 Months Ended
	Sep. 30, 2020 USD ($) shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Grant Date Fair Value | $	$ 906
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding, beginning balance (in shares)	25,356
Granted (in shares)	82,235
Vested (in shares)	(25,356)
Forfeitures (in shares)	0
Outstanding, ending balance (in shares)	82,235
RSU
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding, beginning balance (in shares)	2,007,355
Granted (in shares)	54,867
Vested (in shares)	(264)
Forfeitures (in shares)	(13,587)
Outstanding, ending balance (in shares)	2,048,371

XML

Share-Based Payments - Summary of Restricted Stock and RSU Vesting Dates (Details) - LTIP	Sep. 30, 2020 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting (in shares)	2,130,606
2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting (in shares)	956,738
2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting (in shares)	782,138
2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting (in shares)	373,441
2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting (in shares)	18,289
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting (in shares)	82,235
Restricted Stock | 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting (in shares)	0
Restricted Stock | 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting (in shares)	82,235
Restricted Stock | 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting (in shares)	0
Restricted Stock | 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting (in shares)	0
RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting (in shares)	2,048,371
RSU | 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting (in shares)	956,738
RSU | 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting (in shares)	699,903
RSU | 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting (in shares)	373,441
RSU | 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares vesting (in shares)	18,289

XML

Stockholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended						7 Months Ended	9 Months Ended
	Jun. 10, 2019	Aug. 02, 2018	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Mar. 15, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Class of Stock [Line Items]
Common stock, shares authorized (in shares)			450,000,000							450,000,000		450,000,000
Common stock, par value (in dollars per share)			$ 0.01							$ 0.01		$ 0.01
Preferred stock, shares authorized (in shares)			50,000,000							50,000,000		50,000,000
Preferred stock, par value (in dollars per share)			$ 0.01							$ 0.01		$ 0.01
Common stock, shares issued (in shares)			143,288,347							143,288,347		153,537,296
Common stock, shares, outstanding (in shares)			143,288,347							143,288,347		153,537,296
Preferred stock, shares issued (in shares)			6,770,393							6,770,393		6,770,393
Preferred stock, shares outstanding (in shares)			6,770,393							6,770,393		6,770,393
Unpaid dividends (in dollars per share)			$ 0.50	$ 0.50	$ 0.50	$ 0.50	$ 0.50	$ 0.50
Increase to additional paid in capital as a result of conversion of 2019 Notes								$ 33,778
Proceeds from issuance of common stock net of offering costs							$ 314,800
Common Stock
Class of Stock [Line Items]
Conversions of convertible senior notes for common stock (in shares)								1,967,361
Increase to additional paid in capital as a result of conversion of 2019 Notes								$ 20
Issuance of common stock (in shares)							17,250,000
Common Stock | Follow On Public Offering
Class of Stock [Line Items]
Shares issued, price per share (in dollars per share)							$ 18.27
Issuance of common stock (in shares)							17,250,000
2019 Notes | Convertible Debt | Common Stock
Class of Stock [Line Items]
Conversions of convertible senior notes for common stock (in shares)		10,020,328						1,967,361	2,775,509
Shares issued, price per share (in dollars per share)								$ 17.17
Increase to additional paid in capital as a result of conversion of 2019 Notes								$ 33,800
Series B Preferred Stock
Class of Stock [Line Items]
Preferred stock dividend percentage										8.00%
Unpaid dividends (in dollars per share)			$ 0.50			$ 0.50				$ 1.50	$ 1.50
Series C Preferred Stock
Class of Stock [Line Items]
Preferred stock dividend percentage	8.00%
Redemption of preferred stock (in shares)	6,900,000
Redemption price (in dollars per share)	$ 25.00
Unpaid dividends (in dollars per share)	$ 0.2223										$ 0.7223

XML

Stockholders' Equity - Dividends Declared (Details) - $ / shares		3 Months Ended						9 Months Ended
	Jun. 10, 2019	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Class of Stock [Line Items]
Dividends declared (in dollars per share)		$ 0.35	$ 0.35	$ 0.40	$ 0.46	$ 0.46	$ 0.46	$ 1.10	$ 1.38
Dividends declared (in dollars per share)		0.50	$ 0.50	$ 0.50	0.50	$ 0.50	$ 0.50
Common Stock
Class of Stock [Line Items]
Dividends declared (in dollars per share)		0.35			0.46			1.10	1.38
Series B Preferred Stock
Class of Stock [Line Items]
Dividends declared (in dollars per share)		$ 0.50			$ 0.50			$ 1.50	1.50
Series C Preferred Stock
Class of Stock [Line Items]
Dividends declared (in dollars per share)	$ 0.2223								$ 0.7223

XML

Stockholders' Equity - Common Stock Repurchases (Details) - $ / shares	3 Months Ended			9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2020
Equity [Abstract]
Shares repurchased (in shares)	5,038,619	5,495,976	300,000	10,834,595
Share repurchase, average price per share (in dollars per share)	$ 9.01	$ 7.96	$ 8.12	$ 8.45

XML

Commitments and Contingencies (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Schedule of Equity Method Investments [Line Items]
Total damages including punitive	$ 70,000
Damages sought by plaintiff	700,000
Unfunded loan commitments	1,426,404	$ 1,952,887
Commercial Mortgage and Subordinated Portfolio Segment
Schedule of Equity Method Investments [Line Items]
Unfunded loan commitments	$ 1,400,000
Term of unfunded loan commitment	4 years 1 month 6 days

XML

Fair Value of Financial Instruments - Carrying Value and Estimated Fair Value of Company's Financial Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Carrying Value
Accounts, Notes, Loans and Financing Receivable [Line Items]
Cash and cash equivalents	$ 438,234	$ 452,282
Carrying Value | Level III
Accounts, Notes, Loans and Financing Receivable [Line Items]
Secured debt arrangements, net	(3,465,337)	(3,078,366)
Senior secured term loan, net	(484,191)	(487,961)
Carrying Value | Level III | 2022 Notes
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes	(339,695)	(337,755)
Carrying Value | Level III | 2023 Notes
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes	(224,916)	(223,818)
Carrying Value | Level III | Commercial Mortgage Portfolio Segment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	5,427,945	5,326,967
Carrying Value | Level III | Subordinate Mortgage Portfolio Segment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	1,009,092	1,048,126
Estimate of Fair Value Measurement
Accounts, Notes, Loans and Financing Receivable [Line Items]
Cash and cash equivalents	438,234	452,282
Estimate of Fair Value Measurement | Level III
Accounts, Notes, Loans and Financing Receivable [Line Items]
Secured debt arrangements, net	(3,465,337)	(3,078,366)
Senior secured term loan, net	(471,531)	(499,988)
Estimate of Fair Value Measurement | Level III | 2022 Notes
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes	(326,867)	(348,060)
Estimate of Fair Value Measurement | Level III | 2023 Notes
Accounts, Notes, Loans and Financing Receivable [Line Items]
Notes	(206,126)	(234,600)
Estimate of Fair Value Measurement | Level III | Commercial Mortgage Portfolio Segment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	5,337,301	5,380,693
Estimate of Fair Value Measurement | Level III | Subordinate Mortgage Portfolio Segment
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans	$ 982,961	$ 1,050,961

XML

Net Income (Loss) per Share - Basic and Diluted Net Income per Share of Common Stock Using Two-Class Method (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Basic Earnings
Net income (loss)	$ 49,338	$ 60,201	$ (127,842)	$ 29,089	$ 61,424	$ 67,758	$ (18,303)	$ 158,271
Less: Preferred dividends	(3,385)			(3,385)			(10,155)	(15,139)
Net income (loss) available to common stockholders	45,953			25,704			(28,458)	143,132
Less: Dividends on participating securities	(717)			(847)			(2,238)	(2,547)
Basic Earnings	45,236			24,857			(30,696)	140,585
Diluted Earnings
Net income (loss) available to common stockholders	45,953			25,704			(28,458)	143,132
Less: Dividends on participating securities	(717)			0			(2,238)	0
Add: Interest expense on Notes	0			0			0	0
Diluted Earnings	$ 45,236			$ 25,704			$ (30,696)	$ 143,132
Number of Shares:
Basic weighted-average shares of common stock outstanding (in shares)	146,612,313			153,531,678			150,679,773	144,638,237
Diluted weighted-average shares of common stock outstanding (in shares)	146,612,313			153,531,678			150,679,773	144,638,237
Earnings Per Share Attributable to Common Stockholders
Basic (in dollars per share)	$ 0.31			$ 0.16			$ (0.20)	$ 0.97
Diluted (in dollars per share)	$ 0.31			$ 0.16			$ (0.20)	$ 0.97

XML

Net Income (Loss) per Share - Additional Information (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of dilutive securities - Convertible Notes (in shares)		28,533,271	28,533,271	29,041,856
RSU
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of dilutive securities - Convertible Notes (in shares)	2,051,311
Unvested RSUs excluded from calculation of diluted net income per share (in shares)		1,839,631	2,028,573	1,845,086

XML

Subsequent Events (Details) - USD ($)	1 Months Ended
	Oct. 26, 2020	Sep. 30, 2020	Dec. 31, 2019
Subsequent Event [Line Items]
Principal balance		$ 6,476,313,000	$ 6,375,093,000
Subsequent Event
Subsequent Event [Line Items]
Funded amount of mortgages	$ 33,000,000.0
Proceeds from loan repayments	1,300,000
Payments and proceeds received on securities	25,000,000.0
Debt Securities, Available-for-sale	110,000,000.0
Subsequent Event | Urban Predevelopment - Miami, FL
Subsequent Event [Line Items]
Principal balance	$ 180,000,000.0